Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
b1fa38f5a7d44f2767042c0f3c36e8a2843c5f3a7678e91b64f4e14417aa8d1c.png
complex
<table><tr><td rowspan="2">Sample</td><td colspan="9">Residual level, mg/kg</td><td><i>&#956;</i>g/product</td></tr><tr><td>2,6-TDI</td><td>IPDI-1</td><td>IPDI-2</td><td>2,4-TDI</td><td>PI</td><td>CHI</td><td>4,4&#8242;-MDI</td><td>H12MDI</td><td>Total</td><td>Total</td></tr><tr><td>Glove 1</td><td>0.013</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>0.064</td><td>ND</td><td>0.077</td><td>0.40</td></tr><tr><td>Glove 2</td><td>ND</td><td>ND</td><td>0.011</td><td>ND</td><td>ND</td><td>ND</td><td>3.0</td><td>0.022</td><td>3.0</td><td>18.7</td></tr><tr><td>Pastry bag</td><td>0.029</td><td>ND</td><td>ND</td><td>0.004</td><td>ND</td><td>ND</td><td>0.014</td><td>ND</td><td>0.047</td><td>7.4</td></tr><tr><td></td><td>2,6-TDA</td><td>IPDA</td><td></td><td>2,4-TDA</td><td>ANL</td><td>CHA</td><td>4,4&#8242;-MDA</td><td>H12MDA</td><td>Total</td><td>Total</td></tr><tr><td>Glove 1</td><td>ND</td><td>ND</td><td></td><td>ND</td><td>1.0</td><td>ND</td><td>29</td><td>ND</td><td>30</td><td>106</td></tr><tr><td>Glove 2</td><td>ND</td><td>ND</td><td></td><td>ND</td><td>0.73</td><td>0.43</td><td>0.92</td><td>3.5</td><td>5.6</td><td>35</td></tr><tr><td>Pastry bag</td><td>ND</td><td>ND</td><td></td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td></tr></table>
af45c88a9138aeb934bdf7aad1da51c7a87edb8b3eea736fa000e1bf628fad15.png
complex
<table><tr><td># layers</td><td># hidden units</td><td>Sens.</td><td>Spec.</td><td>F1</td><td>Macro Ave.</td><td>Mic. Ave.</td></tr><tr><td>1</td><td>512</td><td>0.823</td><td>0.904</td><td>0.724</td><td>0.864</td><td>0.89</td></tr><tr><td>1</td><td>1024</td><td>0.83</td><td>0.911</td><td>0.738</td><td>0.87</td><td>0.896</td></tr><tr><td>1</td><td>1536</td><td>0.828</td><td>0.909</td><td>0.735</td><td>0.869</td><td>0.895</td></tr><tr><td>1</td><td>2048</td><td>0.818</td><td>0.913</td><td>0.735</td><td>0.865</td><td>0.896</td></tr><tr><td>2</td><td>512</td><td>0.836</td><td>0.909</td><td>0.739</td><td>0.872</td><td>0.896</td></tr><tr><td>2</td><td>1024</td><td>0.822</td><td>0.91</td><td>0.733</td><td>0.866</td><td>0.894</td></tr><tr><td>2</td><td>1536</td><td>0.824</td><td>0.912</td><td>0.736</td><td>0.868</td><td>0.896</td></tr><tr><td>2</td><td>2048</td><td>0.816</td><td>0.911</td><td>0.731</td><td>0.864</td><td>0.894</td></tr><tr><td>3</td><td>512</td><td>0.827</td><td>0.907</td><td>0.731</td><td>0.867</td><td>0.893</td></tr><tr><td>3</td><td>1024</td><td>0.835</td><td>0.904</td><td>0.73</td><td>0.869</td><td>0.892</td></tr><tr><td>3</td><td>1536</td><td>0.833</td><td>0.904</td><td>0.73</td><td>0.869</td><td>0.892</td></tr><tr><td>3</td><td>2048</td><td>0.831</td><td>0.906</td><td>0.732</td><td>0.869</td><td>0.893</td></tr><tr><td>4</td><td>512</td><td>0.813</td><td>0.91</td><td>0.727</td><td>0.862</td><td>0.893</td></tr><tr><td>4</td><td>1024</td><td>0.83</td><td>0.905</td><td>0.73</td><td>0.867</td><td>0.892</td></tr><tr><td>4</td><td>1536</td><td>0.829</td><td>0.909</td><td>0.736</td><td>0.869</td><td>0.895</td></tr><tr><td>4</td><td>2048</td><td>0.799</td><td>0.914</td><td>0.726</td><td>0.857</td><td>0.894</td></tr><tr><td colspan="2">Baseline method</td><td>0.971</td><td>0.765</td><td>0.632</td><td>0.868</td><td>0.801</td></tr></table>
e62c81974a96dfdcacb83886a1a56e7fbaab91f7ffa04f01d0a257aa1c9c0704.png
complex
<table><tr><td>Number of conditions</td><td>OR</td><td>95% CI</td><td>p-value</td></tr><tr><td>No chronic health condition</td><td colspan="3">REFERENCE</td></tr><tr><td>Arthritis only</td><td>1.64</td><td>1.13 &#8211; 2.38</td><td>0.0099</td></tr><tr><td>Arthritis and one other condition</td><td>2.95</td><td>1.82 &#8211; 4.80</td><td>&lt;.0001</td></tr><tr><td>Arthritis and two other conditions</td><td>2.80</td><td>1.50 &#8211; 5.26</td><td>0.0013</td></tr><tr><td>Arthritis and three or more other conditions</td><td>8.68</td><td>5.24 &#8211; 14.38</td><td>&lt;.0001</td></tr></table>
d3159ec3602382f0f369fffd2a3c8c09312254c673d9a252d78477fd3c5ae82f.png
complex
<table><tr><td></td><td colspan="4">Risky sexual practices</td></tr><tr><td></td><td>Bivariate model</td><td>Model-I</td><td>Model-II</td><td>Final model</td></tr><tr><td>Variables/characteristics</td><td>Crude IRR (95% CI)</td><td>Adj. IRR (95% CI)</td><td>Adj. IRR (95% CI)</td><td>Adj. IRR (95% CI)</td></tr><tr><td>Parental monitoring</td><td></td><td></td><td></td><td></td></tr><tr><td> Low</td><td>1 (Ref)</td><td>1 (Ref)</td><td>1 (Ref)</td><td>1 (Ref)</td></tr><tr><td> Medium</td><td>0.84 (0.676, 1.048)</td><td>0.71 (0.705, 1.102)</td><td>0.89 (0.717, 1.128)</td><td>0.92 (0.729, 1.148)</td></tr><tr><td> High</td><td>0.65 (0.479, 0.895)a</td><td>0.88 (0.515, 0.974)a</td><td>0.70 (0.508, 0.971)a</td><td>0.72 (0.520, 0.986)a</td></tr><tr><td>SRH communication</td><td></td><td></td><td></td><td></td></tr><tr><td> Very poor</td><td>1 (Ref)</td><td>1 (Ref)</td><td>1 (Ref)</td><td>1 (Ref)</td></tr><tr><td> Poor</td><td>0.84 (0.646, 1.107)</td><td>0.90 (0.687, 1.192)</td><td>0.92 (0.699, 1.221)</td><td>0.94 (0.723, 1.271)</td></tr><tr><td> Satisfactory</td><td>0.73 (0.579, 0.926)a</td><td>0.80 (0.629, 1.025)</td><td>0.79 (0.622, 1.025)</td><td>0.82 (0.637, 1.051)</td></tr><tr><td>Parenting styles</td><td></td><td></td><td></td><td></td></tr><tr><td> Neglectful</td><td>1 (Ref)</td><td>1 (Ref)</td><td>1 (Ref)</td><td>1 (Ref)</td></tr><tr><td> Permissive</td><td>0.92 (0.674, 1.256)</td><td>0.92 (0.674, 1.257)</td><td>0.96 (0.703, 1.331)</td><td>0.94 (0.685, 1.300)</td></tr><tr><td> Authoritarian</td><td>0.82 (0.572, 1.178)</td><td>0.90 (0.625, 1.300)</td><td>1.00 (0.688, 1.464)</td><td>1.00 (0.686, 1.471)</td></tr><tr><td> Authoritative</td><td>0.71 (0.536, 0.965)a</td><td>0.77 (0.571, 1.039)</td><td>0.86 (0.627, 1.178)</td><td>0.85 (0.619, 1.168)</td></tr><tr><td>Sex of the adolescent</td><td></td><td></td><td></td><td></td></tr><tr><td> Male</td><td>1 (Ref)</td><td></td><td>1 (Ref)</td><td>1 (Ref)</td></tr><tr><td> Female</td><td>1.16 (0.949, 1.413)</td><td></td><td>1.19 (0.963, 1.490)</td><td>1.23 (0.985, 1.537)</td></tr><tr><td>Adolescent living arrangements</td><td></td><td></td><td></td><td></td></tr><tr><td> With biological mother and father</td><td>1 (Ref)</td><td></td><td>1 (Ref)</td><td>1 (Ref)</td></tr><tr><td> Other living arrangements</td><td>1.09 (0.898, 1.344)</td><td></td><td>1.01 (0.819, 1.262)</td><td>1.03 (0.825, 1.272)</td></tr><tr><td>Family wealth index</td><td></td><td></td><td></td><td></td></tr><tr><td> Low</td><td>1 (Ref)</td><td></td><td>1 (Ref)</td><td>1 (Ref)</td></tr><tr><td> Medium</td><td>1.16 (0.901, 1.482)</td><td></td><td>1.11 (0.862, 1.426)</td><td>1.11 (0.859, 1.423)</td></tr><tr><td> High</td><td>0.78 (0.591, 1.056)</td><td></td><td>0.81 (0.598, 1.084)</td><td>0.82 (0.607, 1.100)</td></tr><tr><td> Data-not obtained</td><td>0.95 (0.702, 1.283)</td><td></td><td>0.89 (0.657, 1.228)</td><td>0.89 (0.649, 1.214)</td></tr><tr><td>Expendable pocket money per month</td><td></td><td></td><td></td><td></td></tr><tr><td> &#8804;100 ETB</td><td>1 (Ref)</td><td></td><td>1 (Ref)</td><td>1 (Ref)</td></tr><tr><td> 101&#8211;200 ETB</td><td>0.92 (0.716, 1.190)</td><td></td><td>0.92 (0.714, 1.197)</td><td>0.88 (0.676, 1.140)</td></tr><tr><td> Greater than 200 ETB</td><td>1.11 (0.881, 1.390)</td><td></td><td>1.09 (0.861, 1.403)</td><td>1.05 (0.817, 1.346)</td></tr><tr><td>Schooling of the adolescents</td><td></td><td></td><td></td><td></td></tr><tr><td> In-school</td><td>1 (Ref)</td><td></td><td>1 (Ref)</td><td>1 (Ref)</td></tr><tr><td> Out-of-school</td><td>1.39 (1.111, 1.751)a</td><td></td><td>1.23 (0.953, 1.576)</td><td>1.23 (0.958, 1.591)</td></tr><tr><td>Ever drunk alcohol</td><td></td><td></td><td></td><td></td></tr><tr><td> No</td><td>1 (Ref)</td><td></td><td></td><td>1 (Ref)</td></tr><tr><td> Yes</td><td>0.93 (0.765, 1.136)</td><td></td><td></td><td>0.89 (0.713, 1.106)</td></tr><tr><td>Ever chewed Khat</td><td></td><td></td><td></td><td></td></tr><tr><td> No</td><td>1 (Ref)</td><td></td><td></td><td>1 (Ref)</td></tr><tr><td> Yes</td><td>1.26 (1.035, 1.537)a</td><td></td><td></td><td>1.33 (1.065, 1.659)a</td></tr></table>
6f1f6ea491ac7a1d8e014046765eca5bd2c7612ed5350eefefc7b8f3bf5d969b.png
simple
<table><tr><td>Parameter</td><td>Value</td></tr><tr><td>Highest heart rate</td><td>119 &#177; 25 beats/minute</td></tr><tr><td>Highest respiratory rate</td><td>31.7 &#177; 8.9 breaths/minute</td></tr><tr><td>Mean APACHE II score</td><td>19.8 &#177; 7.8</td></tr><tr><td>Mean SAPS II score</td><td>40.2 &#177; 16.1</td></tr><tr><td>Mean white cell count</td><td>13.2 &#177; 10.1 &#215; 10<sup>9</sup>/l</td></tr><tr><td>Mean haemoglobin</td><td>12.4 &#177; 2.2 g/dl (lowest value: 7.8 g/dl)</td></tr><tr><td>Mean platelet count</td><td>217 &#177; 218 &#215; 10<sup>9</sup>/l</td></tr><tr><td>Mean [urea]</td><td>13.6 &#177; 7.6 mmol/l</td></tr><tr><td>Mean [creatinine]</td><td>222 &#177; 218 &#956;mol/l</td></tr></table>
f2421505b4e684ba8386f6174bddff9bca71dd67df61d2574635eae887fb2291.png
complex
<table><tr><td></td><td colspan="2">Within-group difference</td><td rowspan="2">Between-group difference</td><td rowspan="2">Between-group <i>P</i>-value</td></tr><tr><td></td><td>Acu-TENS</td><td>Placebo-TENS</td></tr><tr><td>Heart rate (beat min<sup>&#8722;1</sup>)</td><td>&#8722;4.50 (0.49)</td><td>0.79 (0.21)</td><td>&#8722;5.29 (0.37)</td><td> .000</td></tr><tr><td>SBP (mmHg)</td><td>&#8722;4.95 (0.89)</td><td>0.35 (1.14)</td><td>&#8722;5.30 (0.85)</td><td> .206</td></tr><tr><td>Rate pressure product</td><td>&#8722;940.9 (123.9)</td><td>140.9 (123.6)</td><td>&#8722;1081.0 (115.2)</td><td> .010</td></tr></table>
12230df13e5e2c61b772f96b5dcdc38ae65da0997c26d89e1d29c00f58280850.png
simple
<table><tr><td>Item</td><td>Home care group (n = 69)</td><td>Hospital care group (n = 69)</td><td>P</td><td>Standardized difference</td></tr><tr><td>Gender (n, male/female)</td><td>35/34</td><td>36/33</td><td>0.87</td><td>0.03</td></tr><tr><td>Age (yr, mean &#177; SD)</td><td>70.7 &#177; 13.9</td><td>70.7 &#177; 10.8</td><td>0.99</td><td>0.002</td></tr><tr><td>Primary site (n)</td><td></td><td></td><td>1.00</td><td></td></tr><tr><td>Lung</td><td>11</td><td>13</td><td></td><td>0.08</td></tr><tr><td>Stomach/esophagus</td><td>22</td><td>23</td><td></td><td>0.03</td></tr><tr><td>Liver/biliary tract/pancreas</td><td>17</td><td>15</td><td></td><td>0.07</td></tr><tr><td>Large intestine</td><td>9</td><td>8</td><td></td><td>0.04</td></tr><tr><td>Breast</td><td>2</td><td>2</td><td></td><td>0</td></tr><tr><td>Others</td><td>8</td><td>8</td><td></td><td>0</td></tr><tr><td>Performance status (n)</td><td></td><td></td><td>0.99</td><td></td></tr><tr><td>0</td><td>0</td><td>0</td><td></td><td>(incalculable)</td></tr><tr><td>1</td><td>12</td><td>12</td><td></td><td>0</td></tr><tr><td>2</td><td>22</td><td>20</td><td></td><td>0.06</td></tr><tr><td>3</td><td>27</td><td>28</td><td></td><td>0.03</td></tr><tr><td>4</td><td>8</td><td>9</td><td></td><td>0.04</td></tr><tr><td>Use anti-cancer agents (n, used/unused)<sup>a</sup></td><td>1/68</td><td>2/67</td><td>1.00</td><td>0.10</td></tr></table>
38cc3d2380ae1cd7c670ea7c7c0f26019ef548ae0b240349ea88857ccf170ad6.png
simple
<table><tr><td></td><td><i>Group 1 n = 131 (70.4%)</i></td><td><i>Group 2 n = 55 (29.6%)</i></td><td>p<i>-value</i></td><td><i>All patients</i></td></tr><tr><td>Males/females</td><td>67/64</td><td>22/33</td><td>0.199</td><td>89/97</td></tr><tr><td>Mean age (years)</td><td>53.50 &#177; 17.10</td><td>61.78 &#177; 15.38</td><td>0.002*</td><td>55.94 &#177; 17.00</td></tr><tr><td>Urban residence</td><td>112 (85.5%)</td><td>42 (76.4%)</td><td>0.141</td><td>154 (82.8%)</td></tr><tr><td>Duration of hypertension (years)</td><td>5.57 &#177; 6.62</td><td>7.87 &#177; 8.83</td><td>0.054</td><td>6.24 &#177; 7.21</td></tr><tr><td>Dyspnoea (NYHA III or IV)</td><td>46 (35.1%)</td><td>33 (60.0%)</td><td>0.002*</td><td>79 (42.5%)</td></tr><tr><td>Peripheral oedema</td><td>34 (26.0%)</td><td>30 (54.6%)</td><td>&lt; 0.001*</td><td>64 (34.4%)</td></tr><tr><td>Smoking</td><td>6 (4.6%)</td><td>1 (1.8%)</td><td>0.676</td><td>7 (3.8%)</td></tr><tr><td>Alcohol</td><td>13 (9.9%)</td><td>4 (7.3%)</td><td>0.681</td><td>17 (9.1%)</td></tr><tr><td>Diabetes mellitus</td><td>11 (8.4%)</td><td>5 (9.1%)</td><td>0.878</td><td>16 (8.6%)</td></tr><tr><td>Stroke/TIA</td><td>15 (11.5%)</td><td>2 (3.6%)</td><td>0.103</td><td>17 (9.1%)</td></tr><tr><td>Anaemia</td><td>19 (14.5%)</td><td>18 (32.7%)</td><td>0.016*</td><td>37 (19.1%)</td></tr><tr><td>Renal failure</td><td>20 (15.3%)</td><td>15 (27.3%)</td><td>0.101</td><td>35 (18.8%)</td></tr><tr><td>Systolic BP (mmHg)</td><td>156.61 &#177; 30.50</td><td>149.25 &#177; 28.16</td><td>0.150</td><td>154.54 &#177; 29.97</td></tr><tr><td>Diastolic BP (mmHg)</td><td>95.11 &#177; 20.26</td><td>93.19 &#177; 18.51</td><td>0.570</td><td>100.88 &#177; 86.80</td></tr><tr><td>Pulse pressure (mmHg)</td><td>61.54 &#177; 22.95</td><td>56.06 &#177; 18.35</td><td>0.141</td><td>60.00 &#177; 21.85</td></tr><tr><td>Heart rate</td><td>88.52 &#177; 16.45</td><td>102.58 &#177; 19.45</td><td>&lt; 0.001*</td><td>92.47 &#177; 18.41</td></tr><tr><td>PCV (%)</td><td>28.67 &#177; 10.67</td><td>30.46 &#177; 8.61</td><td>0.534</td><td>29.57 &#177; 9.63</td></tr><tr><td>Serum urea (mmol/l)</td><td>14.30 &#177; 11.21</td><td>14.16 &#177; 10.98</td><td>0.963</td><td>14.24 &#177; 11.00</td></tr><tr><td>Serum creatinine (&#956;mol/l)</td><td>585.72 &#177; 789.49</td><td>333.33 &#177; 383.36</td><td>0.155</td><td>477.55 &#177; 654.72</td></tr></table>
0c25e394e483a1b8053e645db3f65e4ba81c100a4aad9f78026a682287b3d894.png
simple
<table><tr><td></td><td>Beta coefficient</td><td>SE</td><td>t</td><td>p-value</td></tr><tr><td>Occupation</td><td>0.558</td><td>0.187</td><td>2.98</td><td>0.003</td></tr><tr><td>Length of VMW career</td><td>0.007</td><td>0.003</td><td>2.28</td><td>0.023</td></tr><tr><td>Reason for becoming VMW</td><td>-0.649</td><td>0.089</td><td>-7.33</td><td>&lt;0.001</td></tr><tr><td>Knowledge of malaria transmission</td><td>0.989</td><td>0.136</td><td>7.30</td><td>&lt;0.001</td></tr><tr><td>Knowledge of vector species</td><td>0.307</td><td>0.151</td><td>2.04</td><td>0.042</td></tr><tr><td>Knowledge of vector breeding places</td><td>0.574</td><td>0.139</td><td>4.13</td><td>&lt;0.001</td></tr></table>
0f38dd4902480b8967f71396940bd2061d1000c3c3e1eabc3b2958d7f8e7e40c.png
simple
<table><tr><td></td><td></td><td>Coverage</td><td>EC main</td><td>EC sub</td><td>EC subsub</td></tr><tr><td>RGK</td><td>TOP1</td><td>100%</td><td>22 (61.1%)</td><td>14 (38.9%)</td><td>12 (33.3%)</td></tr><tr><td></td><td>TOP3</td><td></td><td>56 (51.9%)</td><td>30 (27.8%)</td><td>24 (22.2%)</td></tr><tr><td></td><td>TOP5</td><td></td><td>86 (47.8%)</td><td>37 (20.6%)</td><td>27 (15.0%)</td></tr><tr><td>E-zyme</td><td>TOP1</td><td>61.1%</td><td>14 (63.6%)</td><td>10 (45.5%)</td><td>8 (36.4%)</td></tr><tr><td></td><td>TOP3</td><td></td><td>42 (63.6%)</td><td>24 (36.4%)</td><td>18 (27.3%)</td></tr><tr><td></td><td>TOP5</td><td></td><td>57 (51.8%)</td><td>30 (27.3%)</td><td>24 (21.8%)</td></tr></table>
db609abdcbb2b9d82e198719c616590c48af101e91e1dd014745bc0f96ac9ec2.png
simple
<table><tr><td>Parameters</td><td>Symbol</td><td>Value</td></tr><tr><td>Duty factor</td><td><i>&#946;</i></td><td>1/2, 4/5, 5/6</td></tr><tr><td>Turning radius</td><td><i>R<sub>turning</sub></i></td><td>600 mm, 800 mm, 1000 mm</td></tr><tr><td>Straight radius</td><td><i>R<sub>Straight</sub></i></td><td><i>Inf</i></td></tr><tr><td>Running time</td><td>T</td><td>30 s</td></tr><tr><td>The moment of straight to turning</td><td>T<i><sub>S-T</sub></i></td><td>10 s</td></tr><tr><td>The moment of turning to straight</td><td>T<i><sub>T-S</sub></i></td><td>20 s</td></tr><tr><td>Gait period</td><td>T<i><sub>period</sub></i></td><td>1 s</td></tr></table>
c4877695e341530f2c4d84b23be6c761294f3e4256169ff0e3eb5ad6f33d6ce3.png
simple
<table><tr><td>Variable</td><td>Baseline</td><td>Three months</td><td><i>P</i> value</td></tr><tr><td>ESR (mean &#177; SD, mm in the first hour)</td><td>25.4 &#177; 22.4</td><td>12.8 &#177; 18.5</td><td>0.038</td></tr><tr><td>CRP (mean &#177; SD, mg/L)</td><td>17.6 &#177; 18.4</td><td>10.8 &#177; 15.9</td><td>0.058</td></tr><tr><td>Prednisone use, <i>n</i> (%)</td><td>7 (44)</td><td>7 (44)</td><td>1.0</td></tr><tr><td>Prednisone dose (mean &#177; SD, mg/day)</td><td>2.0 &#177; 2.5</td><td>2.8 &#177; 5.2</td><td>0.24</td></tr></table>
0ae2a871a72e1a3792c6a5a3d1d7ab608cfed603860ad9a9e5aae80cde477ba4.png
simple
<table><tr><td>Article</td><td>Method</td><td>MCInc/MCIc</td><td>Scans</td><td>ACC (%)</td><td>SEN (%)</td><td>SPE (%)</td><td>AUC</td></tr><tr><td>Cui et al., 2011</td><td>Multivariate predictors (MRI, CSF, and NM scores)</td><td>87/56</td><td>baseline</td><td>67.1</td><td>96.4</td><td>48.3</td><td>0.796</td></tr><tr><td>Ye et al., 2012</td><td>SLR+SS (MRI, genetic, and cognitive measures)</td><td>177/142</td><td>baseline</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td>0.859</td></tr><tr><td>Eskildsen et al., 2013</td><td>Patterns of cortical thinning</td><td>134/122</td><td>6 months</td><td>75.8</td><td>75.4</td><td>76.1</td><td>0.809</td></tr><tr><td></td><td></td><td>134/123</td><td>12 months</td><td>72.9</td><td>75.8</td><td>70.2</td><td>0.762</td></tr><tr><td>Raamana et al., 2015</td><td>Thickness network fusion</td><td>130/56</td><td>baseline</td><td>64.0</td><td>65.0</td><td>64.0</td><td>0.680</td></tr><tr><td>Proposed</td><td>Combination of MRI and thickness network</td><td>83/76</td><td>baseline</td><td>66.0</td><td>55.3</td><td>75.9</td><td>0.735</td></tr><tr><td></td><td></td><td>83/61</td><td>6 months</td><td>76.4</td><td>65.6</td><td>84.3</td><td>0.813</td></tr><tr><td></td><td></td><td>83/63</td><td>12 months</td><td>74.7</td><td>65.1</td><td>81.9</td><td>0.785</td></tr><tr><td></td><td></td><td>83/42</td><td>18 months</td><td>73.9</td><td>70.5</td><td>77.1</td><td>0.773</td></tr></table>
4bece50312800a3646d2de051a6e0b72df9b7bc09f7947d24ab1018ddd35d241.png
complex
<table><tr><td colspan="2">Performance measures</td><td>Base case</td><td>Case 1</td><td>Case 2</td><td>Case 3</td><td>Case 4</td></tr><tr><td rowspan="4">Examination quantity</td><td>Total</td><td>326.9</td><td>321.3</td><td>324.6</td><td>324.0</td><td>324.0</td></tr><tr><td>Emergency patients</td><td>132.6</td><td>134.1</td><td>133.2</td><td>132.7</td><td>132.0</td></tr><tr><td>Outpatients</td><td>127.4</td><td>122.3</td><td>126.2</td><td>125.4</td><td>125.0</td></tr><tr><td>Inpatients</td><td>66.8</td><td>64.9</td><td>65.1</td><td>65.9</td><td>67.0</td></tr><tr><td rowspan="4">Wait time (min)</td><td>Total</td><td>53.9</td><td>29.3</td><td>30.4</td><td>31.1</td><td>30.1</td></tr><tr><td>Emergency patients</td><td>1.8</td><td>2.0</td><td>1.9</td><td>2.0</td><td>1.9</td></tr><tr><td>Outpatients</td><td>96.6</td><td>53.6</td><td>54.7</td><td>56.6</td><td>54.8</td></tr><tr><td>Inpatients</td><td>78.0</td><td>43.0</td><td>44.5</td><td>45.8</td><td>44.2</td></tr><tr><td>Equipment utilization</td><td></td><td>99.3%</td><td>97.9%</td><td>98.8%</td><td>98.5%</td><td>98.7%</td></tr></table>
95b8a3a3f242ad386172926be280af7601d18fe98f5cf6580875cffdd65c0937.png
simple
<table><tr><td></td><td>kappa</td></tr><tr><td>presence of activity periods</td><td>0.905*</td></tr><tr><td>presence of rhythmical activity</td><td>0.786*</td></tr><tr><td></td><td>ICC (95% CI)</td></tr><tr><td>amount of activity periods</td><td>0.967 (0.951&#8211;0.978)*</td></tr><tr><td>dominant frequency</td><td>0.739 (0.624&#8211;0.822)*</td></tr><tr><td>second prevalent frequency</td><td>0.787 (0.672&#8211;0.864)*</td></tr><tr><td>third prevalent frequency</td><td>0.789 (0.672&#8211;0.867)*</td></tr><tr><td>minimal frequency</td><td>0.351 (0.149&#8211;0.525)#</td></tr><tr><td>maximal frequency</td><td>0.831 (0.750&#8211;0.887)*</td></tr><tr><td>highest value of acceleration peaks</td><td>0.841 (0.768&#8211;0.893)*</td></tr></table>
c8e4a6b728fe3360f39f0924b3106bf7f04fb0e8e7fe5961c7006987e94174ae.png
simple
<table><tr><td>Theory</td><td>Favourable impact of coach change on team performance</td><td>Slope of the favourable impact over time</td></tr><tr><td>Vicious-circle theory</td><td>NO</td><td></td></tr><tr><td>Ritual scapegoating theory</td><td>NO</td><td></td></tr><tr><td>Common-sense theory</td><td>YES</td><td>=</td></tr><tr><td>Current study</td><td>YES</td><td>&gt; in the short term and= in the long term</td></tr></table>
0420441f3594304649b7c3004daf0e7eea9b5ac2e3d2a1fb2def706b1ab08593.png
simple
<table><tr><td>Normal versus tumor biomarkers</td><td>LN negative versus LN positive biomarkers</td></tr><tr><td><i>SLC39A5</i>, <i>C3orf32</i>, <i>TP73</i>, <i>CD1B</i>, <i>PCDHGA4</i>, <i>PCDHGA11</i>, <i>PCDHGA9</i>, <i>PCDHGA1</i>, <i>PCDHGB1</i>, <i>PCDHGB6</i>, <i>PCDHGA12</i>, <i>PCDHGB3</i>, <i>PCDHGB7</i>, <i>PCDHGA6</i>, <i>PCDHGA8</i>, <i>PCDHGA10</i>, <i>PCDHGA5</i>, <i>PCDHGB4</i>, <i>PCDHGA3</i>, <i>PCDHGA2</i>, <i>PCDHGB2</i>, <i>PCDHGA7</i>, <i>PCDHGB5</i>, <i>C20orf197</i>, <i>SLC16A5</i>, <i>FUT8</i>, <i>SLC15A2</i>, <i>C17orf93</i>, <i>PRAC</i>, <i>OCLN</i>, <i>TMEM144</i>, <i>FGF2</i>, <i>PDX1</i>, <i>CCL1</i>, <i>LILRB5</i>, <i>LCE3D</i>, <i>GPR45</i>, <i>LPO</i>, <i>CGB5</i></td><td><i>LAT2</i>, <i>TTC13</i>, <i>ARV1</i>, <i>NMT1</i>, <i>DCAKD</i>, <i>GJA1</i>, <i>OR7A17</i>, <i>LOX</i>, <i>KRT19</i>, <i>ZNF655</i>, <i>KRTAP4</i>-<i>4</i>, <i>TAAR5</i>, <i>SEMA3E</i>, <i>HOXD1</i></td></tr></table>
6e770653677e66e9f4ef316b8c5c909c4137789e12bc42ff7e736aa2a083ede5.png
complex
<table><tr><td rowspan="2">Phytoestrogen</td><td>Corr CC</td><td rowspan="2"><i>p</i>-Value</td><td>Corr CC</td><td rowspan="2"><i>p</i>-Value</td></tr><tr><td>Habitual (&#956;g/Day) vs. Urine (&#956;g/g Creatinine)</td><td>Recent (&#956;g/Day) vs. Urine (&#956;g/g Creatinine)</td></tr><tr><td>Daidzein</td><td>&#8722;0.024</td><td>0.840</td><td>0.099</td><td>0.420</td></tr><tr><td>Genistein</td><td>&#8722;0.034</td><td>0.784</td><td>0.374</td><td>0.002</td></tr><tr><td>Equol</td><td>0.126</td><td>0.283</td><td>0.079</td><td>0.500</td></tr><tr><td>Glicitein</td><td>0.055</td><td>0.657</td><td>0.120</td><td>0.330</td></tr><tr><td>Biochanin A</td><td>0.012</td><td>0.923</td><td>0.160</td><td>0.190</td></tr><tr><td>Formononetin</td><td>&#8722;0.024</td><td>0.841</td><td>0.170</td><td>0.160</td></tr><tr><td>Total Isoflavones</td><td>0.002</td><td>0.983</td><td>0.460</td><td>0.0001</td></tr><tr><td>Secoisolariciresinol</td><td>0.009</td><td>0.934</td><td>0.230</td><td>0.060</td></tr><tr><td>Matairesinol</td><td>0.079</td><td>0.524</td><td>0.028</td><td>0.810</td></tr><tr><td>Enterolactone</td><td>&#8722;0.035</td><td>0.775</td><td>0.067</td><td>0.580</td></tr><tr><td>Enterodiol</td><td>&#8722;0.168</td><td>0.171</td><td>0.130</td><td>0.270</td></tr><tr><td>Total lignans</td><td>&#8722;0.111</td><td>0.359</td><td>0.550</td><td>0.000</td></tr><tr><td>Naringenin</td><td>0.069</td><td>0.571</td><td>0.620</td><td>0.000</td></tr><tr><td>Luteolin</td><td>&#8722;0.104</td><td>0.398</td><td>&#8722;0.200</td><td>0.090</td></tr><tr><td>Kaempferol</td><td>&#8722;0.084</td><td>0.496</td><td>0.040</td><td>0.690</td></tr><tr><td>Quercetin</td><td>0.154</td><td>0.212</td><td>0.027</td><td>0.820</td></tr><tr><td>Total Flavonoids</td><td>0.055</td><td>0.653</td><td>0.240</td><td>0.043</td></tr><tr><td>Coumestrol</td><td>&#8722;0.035</td><td>0.800</td><td>0.120</td><td>0.320</td></tr><tr><td>Resveratrol</td><td>0.337</td><td>0.005</td><td>0.005</td><td>0.960</td></tr><tr><td>Total Phytoestrogens</td><td>0.730</td><td>0.000</td><td>0.410</td><td>0.0007</td></tr></table>
311fe71e3999a1b4acd1719a75434739ccffeee0118a4477ee49851fc73c5fb0.png
simple
<table><tr><td>Viruses detected</td><td>Patients with acute diarrhea (N = 145) (%)</td></tr><tr><td>Norovirus GII</td><td>59 (40.7)</td></tr><tr><td>Norovirus GI</td><td>17 (11.7)</td></tr><tr><td>Astrovirus</td><td>5 (3.5)</td></tr><tr><td>Rotavirus</td><td>2 (1.4)</td></tr><tr><td>Adenovirus 40/41</td><td>0 (0.0)</td></tr><tr><td>Coinfections</td><td>11 (8.0)</td></tr><tr><td><i>Norovirus GI + GII</i></td><td><i>5 (3.5)</i></td></tr><tr><td><i>Norovirus GI + Rotavirus A</i></td><td><i>1 (0.7)</i></td></tr><tr><td><i>Norovirus GI + Astrovirus</i></td><td><i>1 (0.7)</i></td></tr><tr><td><i>Norovirus GII + Astrovirus</i></td><td><i>4 (2.8)</i></td></tr><tr><td>At least one virus detected</td><td>94 (64.8)</td></tr><tr><td>No virus detected</td><td>51 (35.2)</td></tr></table>
51028004166ae07414b1b400c980787a9f504b527ee86ecf9f23e65a86e8db11.png
simple
<table><tr><td> </td><td>Lab #1 (Sequencing)</td><td>Lab #2 (Sequencing)</td><td>Lab #3 (Sequencing)</td><td>Lab #4 (Primer Extension)</td><td>Lab #5 (Real Time PCR)</td></tr><tr><td>Specimen Requirements</td><td>Preferred sample type*:Slides from FFPE block 1H&amp;E stained slide sections with tumor circled; 4 matching unstained slides,10 microns each.</td><td>Preferred sample type: Archival FFPE or frozen surgical biopsies confirmed to contain &gt;50% tumor by a surgical pathologist.1 H&amp;E slide; 5 unstained sections,10 microns each.</td><td>Preferred sample type: FFPE tissue 6 unstained sections,10 microns each.</td><td>Preferred sample type: Pre-cut slides from FFPE. Send all slides within 5&#8211;7 days of cutting. Air dry. Do not oven dry. Store specimen at room temperature (20&#8211;23.5&#176;C). 5 unstained sections, 7 microns each</td><td>Preferred sample type: FFPE block, unstained slides, or fresh snap frozen biopsy 5 unstained sections, 7 microns each</td></tr><tr><td>Genotyping</td><td>Method: PCR amplification followed by Direct Sanger sequencing (Big Dye v. 1.1)Detected mutations: KRAS codons 12 and 13</td><td>Method: PCR amplification followed by standard bidirectional sequencing on ABI 3100. Detected mutations: KRAS codons 12 and 13</td><td>Method: PCR amplification followed by sequencing.Detected mutations: KRAS codons 12,13 and 61</td><td>Method: Single nucleotide primer extension with fragment analysis by capillary electrophoresis using a modified SNaPshot assay. Detected mutations: KRAS codons 12 and 13</td><td>Methods are propietary: qualitative real time PCR Detected mutations: KRAS codons 12 and 13</td></tr><tr><td>Lower Limit of Detection</td><td>20% when &#8805; 40% tumor cells present</td><td>20%</td><td>15-20%</td><td>10% when &#8805; 2% tumor cells present</td><td>1-5%</td></tr></table>
8a6fe8bcb6a5634a8ffc1ad85167788294fe3b3d97e6dc947df096e2ed891459.png
simple
<table><tr><td>Behavior</td><td>HIV positives</td></tr><tr><td>Had sex past year</td><td>71.3</td></tr><tr><td>Had steady partner past year</td><td>50.3</td></tr><tr><td>Used condoms with steady partner past month</td><td> </td></tr><tr><td>Never</td><td>47.7</td></tr><tr><td>Seldom</td><td>23.9</td></tr><tr><td>Often</td><td>13.6</td></tr><tr><td>Always</td><td>14.8</td></tr><tr><td>Had sex with casual female partner past year</td><td>35.4</td></tr><tr><td>Used condoms with casual female partners past month</td><td> </td></tr><tr><td>Never</td><td>42.3</td></tr><tr><td>Seldom</td><td>22.5</td></tr><tr><td>Often</td><td>13.5</td></tr><tr><td>Always</td><td>21.6</td></tr><tr><td>Sold sex last year</td><td>2.7</td></tr><tr><td>Purchased sex last year</td><td>20.0</td></tr><tr><td>Condom use with FSW last month</td><td> </td></tr><tr><td>Never</td><td>45.2</td></tr><tr><td>Seldom</td><td>20.2</td></tr><tr><td>Often</td><td>6.7</td></tr><tr><td>Always</td><td>27.9</td></tr><tr><td>Gave used needle to other IDU last week</td><td>21.1</td></tr></table>
583f07c427a646a496f521f37a56f54ca52f12ef1f5b11b78d05bf375b1e939a.png
complex
<table><tr><td></td><td>CspA</td><td>CspZ</td><td>ErpP<sup>a</sup></td><td>ErpC<sup>a</sup></td><td>ErpA<sup>a</sup></td><td>p43</td><td>BBK32</td><td>BGA66</td><td>BGA71</td><td>CD59-like protein</td></tr><tr><td rowspan="7">Synonyms and other designations</td><td>CRASP-1</td><td>CRASP-2</td><td>CRASP-3</td><td>CRASP-4</td><td>CRASP-5</td><td rowspan="7">&#8211;</td><td rowspan="7">&#8211;</td><td rowspan="7">&#8211;</td><td rowspan="7">&#8211;</td><td rowspan="7">&#8211;</td></tr><tr><td>BbCRASP-1</td><td>BbCRASP-2</td><td>BbCRASP-3 BBN38</td><td>BbCRASP-4</td><td>BbCRASP-5</td></tr><tr><td>BBA68</td><td>BBH06</td><td></td><td></td><td>ErpI</td></tr><tr><td>ZS7.A68</td><td></td><td></td><td></td><td>ErpN</td></tr><tr><td rowspan="3">FHBP</td><td rowspan="3"></td><td rowspan="3"></td><td rowspan="3"></td><td>BBP38</td></tr><tr><td>BBL39</td></tr><tr><td>OspE</td></tr><tr><td>Gene name</td><td><i>cspA</i></td><td><i>cspZ</i></td><td><i>erpP</i></td><td><i>erpC</i></td><td><i>erpA</i></td><td>ND</td><td><i>bbk32</i></td><td><i>bga66</i></td><td><i>bga71</i></td><td>ND</td></tr><tr><td>Origin</td><td>Bb, Ba, Bs</td><td>Bb</td><td>Bb</td><td>Bb</td><td>Bb</td><td>Bb</td><td>Bb</td><td>Bba</td><td>Bba</td><td>Bb</td></tr><tr><td>Confers serum resistance</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>No</td><td>ND</td><td>Yes</td><td>Yes</td><td>Yes</td><td>ND</td></tr><tr><td rowspan="3">Interaction with complement regulators/components</td><td>FH</td><td>FH</td><td>FHR-1</td><td>FHR-1</td><td>FHR-1</td><td rowspan="3">C4Bp</td><td rowspan="3">C1r</td><td rowspan="3">C7, C8, C9, TCC</td><td rowspan="3">C7, C8, C9, TCC</td><td rowspan="3">TCC</td></tr><tr><td>FHL-1</td><td>FHL-1</td><td>FHR-2</td><td>FHR-2</td><td>FHR-2</td></tr><tr><td>C7, C8, C9, TCC</td><td></td><td>FHR-5</td><td></td><td>FHR-5</td></tr><tr><td>Interaction with plasmin(ogen)</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td><td>ND</td></tr><tr><td>Affected complement pathways</td><td>AP, TP</td><td>AP</td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td><td>CP/LP(?)</td><td>CP</td><td>TP</td><td>TP</td><td>TP</td></tr></table>
998783c085d5745756c2069d766c316a3ebf9679b700ddd4a8ea302c8929c5fc.png
simple
<table><tr><td></td><td>Danish early-vaccination era data set</td><td>Global post-vaccination era data set</td></tr><tr><td>Length of sequences</td><td>800</td><td>800</td></tr><tr><td>Number of sequences</td><td>18</td><td>40</td></tr><tr><td>Average number of differences</td><td>12.2</td><td>31.0</td></tr><tr><td># synonymous substitutions</td><td>26</td><td>131</td></tr><tr><td># non-synonymous substitutions</td><td>32</td><td>71</td></tr><tr><td>Average Pi (nucleotide diversity)</td><td></td><td></td></tr><tr><td>1. all sites</td><td>0.014</td><td>0.040</td></tr><tr><td>2. synonymous sites</td><td>0.030</td><td>0.109</td></tr><tr><td>3. non-synonymous sites</td><td>0.009</td><td>0.019</td></tr><tr><td>Transition/transversion bias</td><td>2.2</td><td>9.4</td></tr><tr><td>Codon usage bias (ENC)</td><td>53</td><td>55</td></tr></table>
6768068831201205219a4d26ec0998e852e1d8ede6cf906dfb265813f3882be8.png
complex
<table><tr><td></td><td colspan="2">Cholelithiasis</td><td></td><td></td><td></td></tr><tr><td></td><td>Yes(n = 3725)</td><td>No(n = 11175)</td><td>OR</td><td>95% CI</td><td>P value</td></tr><tr><td>Obesity</td><td>30 (0.81%)</td><td>42 (0.38%)</td><td>2.16</td><td>1.35 - 3.45</td><td>0.001*</td></tr><tr><td>Diabetes mellitus</td><td>513 (13.77%)</td><td>1 236 (11.06%)</td><td>1.31</td><td>1.17 - 1.47</td><td>&lt; 0.001*</td></tr><tr><td>Hyperlipidemia</td><td>662 (17.77%)</td><td>1 349 (12.07%)</td><td>1.62</td><td>1.46 - 1.8</td><td>&lt; 0.001*</td></tr><tr><td>Chronic kidney disease</td><td>57 (1.53%)</td><td>136 (1.22%)</td><td>1.27</td><td>0.92 - 1.73</td><td>0.142</td></tr><tr><td>Hepatitis B</td><td>108 (2.90%)</td><td>143 (1.28%)</td><td>2.31</td><td>1.79 - 2.97</td><td>&lt; 0.001*</td></tr><tr><td>Hepatitis C</td><td>82 (2.20%)</td><td>76 (0.68%)</td><td>3.3</td><td>2.41 - 4.52</td><td>&lt; 0.001*</td></tr><tr><td>Cirrhosis</td><td>65 (1.74%)</td><td>65 (0.58%)</td><td>3.05</td><td>2.16 - 4.32</td><td>&lt; 0.001*</td></tr><tr><td>Menopause<sup>#</sup></td><td>304 (14.45%)</td><td>612 (6.70%)</td><td>1.65</td><td>1.41 - 1.93</td><td>&lt; 0.001*</td></tr></table>
8784bc5b36f867da68b7a9b2f418cacb6ef44b562b5423173afec7f524fae0d4.png
simple
<table><tr><td>Characteristics</td><td><i>Number </i>(%)</td><td>Characteristics</td><td><i>Number </i>(%)</td></tr><tr><td>Kebele</td><td> </td><td>Religion</td><td> </td></tr><tr><td> Yikaho</td><td>63(15.1)</td><td>Orthodox Christian</td><td>337(80.6)</td></tr><tr><td> Mahdid</td><td>62(14.8)</td><td>Muslims</td><td>81(19.4)</td></tr><tr><td> Bambaho</td><td>126(30.1)</td><td>Educational level</td><td> </td></tr><tr><td> Dubaba</td><td>167(40)</td><td>Illiterate</td><td>248(59.3)</td></tr><tr><td>Gender</td><td> </td><td>Primary (grades 1&#8211;8)</td><td>142(34.0)</td></tr><tr><td> Male</td><td>262(62.7)</td><td>Secondary and above</td><td>28(6.7)</td></tr><tr><td> Female</td><td>156(37.3)</td><td>Occupation</td><td> </td></tr><tr><td>Age (years)</td><td> </td><td>Farmer</td><td>349(83.5)</td></tr><tr><td> 18-24</td><td>67(16.0)</td><td>Others</td><td>69(16.5)</td></tr><tr><td> 25-49</td><td>303(72.5)</td><td>Family size</td><td> </td></tr><tr><td> 50-64</td><td>35(8.4)</td><td>1-4</td><td>230(55.0)</td></tr><tr><td> 65+</td><td>13(3.1)</td><td>5+</td><td>188(45.0)</td></tr><tr><td>Ethnicity</td><td> </td><td> </td><td> </td></tr><tr><td> Amhara</td><td>293(70.1)</td><td> </td><td> </td></tr><tr><td> Agew</td><td>63(15.1)</td><td> </td><td> </td></tr><tr><td> Gumuz</td><td>62(14.8)</td><td> </td><td> </td></tr><tr><td>Marital status</td><td> </td><td> </td><td> </td></tr><tr><td> Unmarried</td><td>48(11.5)</td><td> </td><td> </td></tr><tr><td> Married</td><td>365(85.2)</td><td> </td><td> </td></tr><tr><td> Others</td><td>14(3.3)</td><td> </td><td> </td></tr></table>
8bba829f4e301c5ee01f0674d86aff30b3ec9a7ec4ffc68ede976ec9e577aff9.png
complex
<table><tr><td>Protein</td><td>Gene</td><td>Hz vs WT (fold change)</td><td><i>P</i> value</td><td>Hz + IGF-1 vs Hz (fold change)</td><td><i>P</i> value</td></tr><tr><td colspan="6">IGF-1R and Intracellular signaling</td></tr><tr><td> Insulin-like growth factor 1 receptor</td><td><i>igf1r</i></td><td>1.44</td><td>0.0001</td><td>1.29</td><td>0.001</td></tr><tr><td> Neuroblastoma ras oncogene</td><td><i>nras</i></td><td>1.53</td><td>0.0004</td><td>&#8722;1.08</td><td>0.001</td></tr><tr><td> Jun oncogene</td><td><i>jun</i></td><td>&#8722;2.03</td><td>0.0006</td><td>1.05</td><td>0.01</td></tr><tr><td> FBJ osteosarcoma oncogene</td><td><i>fos</i></td><td>&#8722;1.44</td><td>0.001</td><td>&#8722;1.16</td><td>0.13</td></tr><tr><td colspan="6">Inflammation and apoptosis</td></tr><tr><td> Chemokine (C-C motif) receptor 5</td><td><i>ccr5</i></td><td>4.38</td><td>0.0001</td><td>&#8722;4.87</td><td>0.0001</td></tr><tr><td> Chemokine (C-C motif) ligand 6</td><td><i>ccl6</i></td><td>4.34</td><td>0.0002</td><td>&#8722;4.02</td><td>0.0001</td></tr><tr><td> Colony stimulating factor 1 receptor</td><td><i>csf1r</i></td><td>2.49</td><td>0.0004</td><td>&#8722;2.41</td><td>0.0006</td></tr><tr><td> Complement component 1, q subcomponent, &#945; p</td><td><i>c1qa</i></td><td>5.40</td><td>0.0002</td><td>&#8722;3.43</td><td>0.0006</td></tr><tr><td> Lysozyme 2</td><td><i>lyz2</i></td><td>2.99</td><td>0.0019</td><td>&#8722;2.31</td><td>0.004</td></tr><tr><td> Lymphocyte antigen 96</td><td><i>ly96</i></td><td>1.71</td><td>0.003</td><td>&#8722;1.38</td><td>0.04</td></tr><tr><td>Interleukin 10 receptor beta</td><td><i>il10rb</i></td><td>1.75</td><td>0.004</td><td>&#8722;1.80</td><td>0.004</td></tr><tr><td> Serum amyloid A 1</td><td><i>saa1</i></td><td>3.74</td><td>0.0004</td><td>&#8722;1.70</td><td>0.006</td></tr><tr><td> Secreted phosphoprotein 1</td><td><i>spp1</i></td><td>2.44</td><td>0.001</td><td>&#8722;1.80</td><td>0.005</td></tr><tr><td> Allograft inflammatory factor 1</td><td><i>aif1</i></td><td>1.95</td><td>0.0001</td><td>&#8722;2.82</td><td>0.00006</td></tr><tr><td> Apoptotic peptidase activating factor 1</td><td><i>apaf</i></td><td>1.05</td><td>0.05</td><td>&#8722;1.05</td><td>0.05</td></tr><tr><td colspan="6">Cytoskeleton</td></tr><tr><td> Tubulin, beta 2A</td><td><i>tubb2a</i></td><td>&#8722;2.49</td><td>0.001</td><td>1.56</td><td>0.002</td></tr><tr><td> Vinculin</td><td><i>vcl</i></td><td>&#8722;1.49</td><td>0.003</td><td>1.31</td><td>0.06</td></tr><tr><td> MAP/microtubule affinity-regulating kinase 2</td><td><i>mark2</i></td><td>&#8722;1.52</td><td>0.01</td><td>1.34</td><td>0.05</td></tr><tr><td> Actin, beta</td><td><i>actb</i></td><td>1.65</td><td>0.0006</td><td>&#8722;1.58</td><td>0.0001</td></tr><tr><td> Serine/threonine kinase 11</td><td><i>stk11</i></td><td>&#8722;1.38</td><td>0.019</td><td>1.36</td><td>0.05</td></tr><tr><td> Myosin IB</td><td><i>myo1b</i></td><td>1.43</td><td>0.05</td><td>&#8722;1.37</td><td>0.03</td></tr><tr><td colspan="6">Intercellular junctions</td></tr><tr><td> Claudin 1</td><td><i>cldn1</i></td><td>&#8722;1.04</td><td>0.21</td><td>&#8722;1.23</td><td>0.18</td></tr><tr><td> Claudin 7</td><td><i>cldn7</i></td><td>1.48</td><td>0.003</td><td>&#8722;1.15</td><td>0.12</td></tr><tr><td> Claudin 14</td><td><i>cldn14</i></td><td>2.37</td><td>0.0006</td><td>&#8722;1.78</td><td>0.0003</td></tr><tr><td> Junction adhesion molecule 2</td><td><i>Jam2</i></td><td>1.23</td><td>0.03</td><td>&#8722;1.60</td><td>0.006</td></tr><tr><td> Cadherin 5</td><td><i>cdh5</i></td><td>1.70</td><td>0.0006</td><td>&#8722;1.80</td><td>0.0001</td></tr><tr><td> Desmocollin 2</td><td><i>dsc2</i></td><td>1.46</td><td>0.003</td><td>&#8722;1.46</td><td>0.001</td></tr><tr><td colspan="6">Extracellular matrix</td></tr><tr><td> Integrin beta 2</td><td>itgb2</td><td>&#8722;2.46</td><td>0.0006</td><td>2.03</td><td>0.0001</td></tr><tr><td> Connective tissue growth factor</td><td>ctgf/bp8</td><td>&#8722;1.60</td><td>0.001</td><td>&#8722;1.57</td><td>0.006</td></tr><tr><td> Proteoglycan 4</td><td>prg4</td><td>2.21</td><td>0.006</td><td>&#8722;2.24</td><td>0.0001</td></tr><tr><td> Collagen, type I, alpha 2</td><td>col1a2</td><td>&#8722;1.58</td><td>0.001</td><td>1.13</td><td>0.02</td></tr><tr><td> Collagen, type III, alpha 1</td><td>col3a1</td><td>&#8722;1.71</td><td>0.0003</td><td>1.08</td><td>0.38</td></tr><tr><td> Collagen, type V, alpha 2</td><td>col5a2</td><td>1.66</td><td>0.0001</td><td>&#8722;3.99</td><td>0.0006</td></tr><tr><td> Fibronectin 1</td><td>fn1</td><td>1.50</td><td>0.005</td><td>&#8722;1.45</td><td>0.003</td></tr></table>
91d5e0c25b710cf574e522dbb09fc5cc35882ea6ed8f8de9c3a802bee52aed6a.png
simple
<table><tr><td>Animal</td><td>Model</td><td>Preconditioning time/approach</td><td>TLR/ischemia</td><td>Result and mechanism</td><td>Author</td><td>Reference</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 24-h reperfusion</td><td>72 h/12-min ischemia</td><td>Ischemic preconditioning</td><td>Decrease brain infarction volume, and IRF gene participate in brain protection</td><td>Stevens SL</td><td>[79]</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 6-h reperfusion</td><td>24 h/IP</td><td>TLR2, Pam3CSK4</td><td>Decrease brain infarction and edema, improve neurological function, and maintain BBB function</td><td>Hua F</td><td>[60]</td></tr><tr><td>Mice</td><td>MCAO, 45-min ischemia, 24-h reperfusion</td><td>72 h/subcutaneous injection</td><td>TLR3, poly-ICLC</td><td>Decrease brain infarction volume and improve neurological function</td><td>Packard AEB</td><td>[63]</td></tr><tr><td>Mice</td><td>MCAO, 120-min ischemia, 22-h reperfusion</td><td>24 h/systemic injection</td><td>TLR3 poly-IC</td><td>Decrease brain infarction volume and neurological defect and lower the levels of TNF-&#945; and IL-6 in cortex and striatum</td><td>Pan LN</td><td>[66]</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 24-h reperfusion</td><td>1 h/IP</td><td>TLR3 poly-IC</td><td>Decrease brain infarction and prevention of Fas/FADD interaction</td><td>Zhang X</td><td>[67]</td></tr><tr><td>Spontaneously hypertension rats</td><td>MCAO, 120-min ischemia, 22-h reperfusion</td><td>2, 3, 4 days/IV</td><td>TLR4 LPS</td><td>Decrease brain infarction volume, mediated by TNF-&#945;</td><td>Tasaki K</td><td>[72]</td></tr><tr><td>Mice</td><td>MCAO, 120-min ischemia, 47-h reperfusion</td><td>48 h/IP</td><td>TLR4 LPS</td><td>Decrease brain infarction volume, inhibit the infiltration of neutrophil and activation of the microglia</td><td>Rosenzweig HL</td><td>[73]</td></tr><tr><td>Mice</td><td>MCAO, 40-, 45-, 60-min ischemia, 24-h reperfusion</td><td>72 h/IP</td><td>TLR4 LPS</td><td>Decrease brain infarction volume that was mediated by IRF3</td><td>Marsh B</td><td>[61]</td></tr><tr><td>Mice</td><td>MCAO, 40-to 60-min ischemia, 24-h reperfusion</td><td>72 h/subcutaneous injection</td><td>TLR4 LPS</td><td>Decrease brain infarction volume, and TRIF-IRF3 play vital role</td><td>Vartanian KB</td><td>[58]</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 24-h reperfusion</td><td>72 h/IP</td><td>TLR4</td><td>Decrease brain infarction volume, and inhibit TNF-&#945; signaling pathway after cerebral ischemia</td><td>Rosenzweig HL</td><td>[76]</td></tr><tr><td>Mice</td><td>MCAO, 45-to 60-min ischemia, 23-h reperfusion</td><td>72 h/subcutaneous injection</td><td>TLR7 GDQ</td><td>Decrease brain infarction volume and neurological functional score that was protected through I type interferon</td><td>Leung PY</td><td>[62]</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 72-h reperfusion</td><td>30 min/IV</td><td>TLR8 R848</td><td>Increase neurological function defect and mortality, activate pro-apoptotic JNK pathway and inflammation</td><td>Tang SC</td><td>[56]</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 24-h reperfusion</td><td>72 h/IP</td><td>TLR9 CpG-ODN</td><td>Decrease brain infarction volume and TNF-&#945; play a vital role</td><td>Stevens SL</td><td>[64]</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 24-h reperfusion</td><td>72 h/IP or subcutaneous injection</td><td>TLR9 CpG-ODN</td><td>Decrease brain infarction volume and IRF gene participate in cerebral protection after ischemia</td><td>Stevens SL</td><td>[79]</td></tr><tr><td>Mice</td><td>MCAO, 60-min ischemia, 24-h reperfusion</td><td>1 h/IP</td><td>TLR9 CpG-ODN</td><td>Decrease brain infarction and activation of PI3K/Akt signaling</td><td>Lu C</td><td>[78]</td></tr></table>
cde8bb1980614675d9148428adc87a9d278fbb74feae5448597cdc211d81b231.png
complex
<table><tr><td>Variable</td><td>Category</td><td>A/A</td><td>G/A</td><td>Total</td><td><i>P</i> value</td></tr><tr><td rowspan="2">Surfactant</td><td>Yes</td><td>26 (92.9%)</td><td>2 (7.1%)</td><td>28 (100%)</td><td rowspan="2">0.271</td></tr><tr><td>No</td><td>174 (82.9%)</td><td>36 (17.1%)</td><td>210 (100%)</td></tr><tr><td rowspan="2">Ventilator</td><td>Yes</td><td>31 (93.9%)</td><td>2 (6.1%)</td><td>33 (100%)</td><td rowspan="2">0.094</td></tr><tr><td>No</td><td>169 (82.4%)</td><td>36 (17.6%)</td><td>205 (100%)</td></tr><tr><td rowspan="2">Death</td><td>Yes</td><td>22 (95.7%)</td><td>1 (4.3%)</td><td>23 (100%)</td><td rowspan="2">0.139</td></tr><tr><td>No</td><td>178 (82.8%)</td><td>37 (17.2%)</td><td>215 (100%)</td></tr></table>
818dbd9e0f573af20c0f1f0bcdaeaa95ae552de592145c73ab1ce71db5bf4efd.png
simple
<table><tr><td>Sl. number</td><td>Age</td><td>Gender</td><td>Site</td><td>Size</td><td>Histopathological category</td></tr><tr><td>Case1</td><td>40</td><td>Female</td><td>Gingiva</td><td>1-2 cm</td><td>Cellular phase</td></tr><tr><td>Case2</td><td>40</td><td>Female</td><td>Buccal mucosa</td><td>1-2 cm</td><td>Capillary phase, LCH type</td></tr><tr><td>Case3</td><td>09</td><td>Male</td><td>Buccal mucosa</td><td>&lt;1 cm</td><td>Capillary phase, non-LCH type</td></tr><tr><td>Case4</td><td>23</td><td>Female</td><td>Gingiva</td><td>1-2 cm</td><td>Involutionary phase</td></tr></table>
f47cff45be410019c55f9fd45580c89899b493c5a50c51b650bc7ad59482fd7e.png
complex
<table><tr><td>Population</td><td>Region of interest</td><td>E<sub>max</sub>, %</td><td>EC<sub>50</sub>, ng/mL</td></tr><tr><td rowspan="3">EC</td><td>Hippocampus</td><td>89.1 (CV%: 9.6)</td><td>2.05 (CV%: 33.4)</td></tr><tr><td>Striatum</td><td>88.8 (CV%: 7.5)</td><td>1.67 (CV%: 29.7)</td></tr><tr><td>Frontal cortex</td><td>80.1 (CV%: 8.9)</td><td>1.57 (CV% 36.2)</td></tr><tr><td rowspan="3">AD</td><td>Hippocampus</td><td>85.9 (CV%: 4.1)</td><td>1.29 (CV%: 21.5)</td></tr><tr><td>Striatum</td><td>87.8 (CV%: 1.8)</td><td>1.11 (CV%: 10.7)</td></tr><tr><td>Frontal cortex</td><td>81.1 (CV%: 3.2)</td><td>1.06 (CV%: 19.6)</td></tr></table>
90558615782c6f66262e92b9101d3b3493759320c01998073eaffe07468c880b.png
simple
<table><tr><td>Factors</td><td>Moxi</td><td>(%)</td><td>Non-Moxi</td><td>(%)</td></tr><tr><td>Number</td><td>276</td><td> </td><td>1992</td><td> </td></tr><tr><td>Age</td><td>44.78</td><td> </td><td>38.5</td><td> </td></tr><tr><td>Sex (male)</td><td>150</td><td>(54.3)</td><td>1129</td><td>(56.7)</td></tr><tr><td>Site of disease</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Pulmonary</td><td>165</td><td>59.8</td><td>1182</td><td>59.3</td></tr><tr><td>Meningeal</td><td>12</td><td>4.3</td><td>9</td><td>0.5</td></tr><tr><td>Central Nervous System</td><td>2</td><td>0.7</td><td>4</td><td>0.2</td></tr><tr><td>Ocular</td><td>10</td><td>3.6</td><td>12</td><td>0.6</td></tr><tr><td>Other extra-pulmonary</td><td>87</td><td>31.5</td><td>786</td><td>39.4</td></tr><tr><td>Country of origin</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Australian</td><td>22</td><td>8.0</td><td>219</td><td>11.0</td></tr><tr><td>Overseas</td><td>254</td><td>92.0</td><td>1773</td><td>89.0</td></tr><tr><td>HIV status</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Positive</td><td>5</td><td>1.8</td><td>32</td><td>1.6</td></tr><tr><td>Negative</td><td>67</td><td>24.3</td><td>328</td><td>16.5</td></tr><tr><td>Unknown</td><td>204</td><td>73.9</td><td>1632</td><td>81.9</td></tr><tr><td>Diagnosis method</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Culture</td><td>217</td><td>78.6</td><td>1521</td><td>76.3</td></tr><tr><td>Histological</td><td>13</td><td>4.7</td><td>161</td><td>8.1</td></tr><tr><td>PCR/NAT</td><td>19</td><td>6.9</td><td>116</td><td>5.8</td></tr><tr><td>Radiological</td><td>9</td><td>3.3</td><td>126</td><td>6.3</td></tr><tr><td>Clinical</td><td>17</td><td>6.2</td><td>58</td><td>2.9</td></tr><tr><td>Microscopic Examination</td><td>1</td><td>0.4</td><td>10</td><td>0.5</td></tr><tr><td>Sensitivities - Of culture positive cases</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Fully sensitive</td><td>148</td><td>68.2</td><td>1410</td><td>92.6</td></tr><tr><td>MDRTB</td><td>39</td><td>18.0</td><td>0</td><td>0.0</td></tr><tr><td>XDRTB</td><td>2</td><td>0.9</td><td>0</td><td>0.0</td></tr><tr><td>Other resistance patterns</td><td>26</td><td>12.0</td><td>103</td><td>6.8</td></tr><tr><td> Isoniazid Resistance</td><td>24</td><td>92.3</td><td>97</td><td>94.2</td></tr><tr><td> Rifampicin resistance</td><td>1</td><td>3.8</td><td>0</td><td>0.0</td></tr><tr><td> Pyrazinamide resistance</td><td>1</td><td>3.8</td><td>2</td><td>1.9</td></tr><tr><td> Ethambutol resistance</td><td>0</td><td>0.0</td><td>3</td><td>2.9</td></tr><tr><td> Other agents</td><td>0</td><td>0.0</td><td>1</td><td>1.0</td></tr><tr><td>Sensitivity results pending</td><td>2</td><td>0.9</td><td>9</td><td>0.6</td></tr></table>
822a4d6aac4df167fe17e75188c816374dafd8b815267ea562b536cdcd56773a.png
complex
<table><tr><td>Sample</td><td>Spiked Level (mg/kg)</td><td>Recovery (%)</td><td>RSD <sup>a</sup> (%)</td></tr><tr><td rowspan="3">fresh tea leaf</td><td>0.01</td><td>92.3 &#177; 6.51</td><td>10.2</td></tr><tr><td>0.05</td><td>84.3 &#177; 5.84</td><td>10.4</td></tr><tr><td>0.5</td><td>77.7 &#177; 4.67</td><td>8.6</td></tr></table>
2fdf7984d613489942e5707230b2feda384cfd4fbdf95319a202c55b514733e0.png
complex
<table><tr><td rowspan="2">Fractions/compounds</td><td colspan="4">IC<sub>50</sub>(&#956;g/ml)</td></tr><tr><td>LLC</td><td>A2780</td><td>HepG2</td><td>A549</td></tr><tr><td>HE</td><td>660.11 &#177; 16.71</td><td>246.97 &#177; 18.78</td><td>288.95 &#177; 17.84</td><td>294.96 &#177; 24.46</td></tr><tr><td>WE</td><td>614.74 &#177; 19.55</td><td>208.38 &#177; 23.57</td><td>279.09 &#177; 13.06</td><td>461.26 &#177; 28.38</td></tr><tr><td>CE</td><td>97.55 &#177; 4.02</td><td>88.50 &#177; 5.26</td><td>128.26 &#177; 12.55</td><td>172.59 &#177; 6.59</td></tr><tr><td>TAFU</td><td>39.37 &#177; 2.36</td><td>27.65 &#177; 1.84</td><td>51.10 &#177; 2.84</td><td>58.60 &#177; 3.99</td></tr><tr><td>Verticine</td><td>16.53 &#177; 0.82</td><td>48.41 &#177; 2.58</td><td>53.38 &#177; 3.16</td><td>97.58 &#177; 3.72</td></tr><tr><td>Vericinone</td><td>3.03 &#177; 0.32</td><td>17.03 &#177; 0.89</td><td>14.64 &#177; 0.65</td><td>47.39 &#177; 1.90</td></tr><tr><td>Imperialine</td><td>66.26 &#177; 3.46</td><td>39.18 &#177; 2.21</td><td>84.26 &#177; 4.46</td><td>117.84 &#177; 6.29</td></tr><tr><td>Peimisine</td><td>20.75 &#177; 1.44</td><td>17.43 &#177; 0.80</td><td>92.07 &#177; 4.89</td><td>36.11 &#177; 1.70</td></tr></table>
f13f667de8281cb7bb22d86da6cdaeb3a2985f535fae177447fdb44a4209fa04.png
complex
<table><tr><td>FGD content analysis</td><td>Men &#8211; young FGD</td></tr><tr><td>Meaning unit</td><td>I think smoking is not related to sugar disease but there must be small part that can affect sugar disease; most smokers, including me, we usually deny</td></tr><tr><td>Condensed meaning unit</td><td>Smoking is related to diabetes &#8216;but small part&#8217;; smokers deny bad effect of smoking;</td></tr><tr><td rowspan="3">Codes</td><td>Smoking only partly related to diabetes</td></tr><tr><td>Smokers deny bad effect of smoking</td></tr><tr><td>Aware of healthy lifestyle but ignoring</td></tr><tr><td rowspan="6">Codes cluster</td><td>Diabetes content area:</td></tr><tr><td>-</td></tr><tr><td>Risk factors content area:</td></tr><tr><td>Smoking only partly related to diabetes</td></tr><tr><td>Smokers deny bad effect of smoking</td></tr><tr><td>Aware of healthy lifestyle but ignoring</td></tr></table>
04c3e16c09cd9be10e0b1d09f24e7a00d90061101bd73c2358ff90e99bdd4432.png
simple
<table><tr><td>Plate temperature <i>T</i><sub><i>w </i></sub> (K)</td><td>RaK</td><td>Nu</td><td>Nu<sub>avg</sub></td><td>Nu/RaK<sup>0.5</sup></td><td>Nu/RaK<sup>0.5</sup>[[1-4]]</td></tr><tr><td>303</td><td>69.5325</td><td>3.6319</td><td>6.6569</td><td>0.4356</td><td>&#8776;0.44</td></tr><tr><td>313</td><td>139.0649</td><td>5.0880</td><td>8.959</td><td>0.4315</td><td>0.44</td></tr><tr><td>323</td><td>208.5974</td><td>6.2634</td><td>10.5969</td><td>0.4337</td><td>0.44</td></tr><tr><td>333</td><td>278.1298</td><td>7.2200</td><td>11.8779</td><td>0.4329</td><td>0.44</td></tr><tr><td>353</td><td>417.2597</td><td>8.8231</td><td>13.8479</td><td>0.4320</td><td>0.44</td></tr><tr><td>373</td><td>556.2597</td><td>10.1248</td><td>15.3437</td><td>0.43</td><td>0.44</td></tr></table>
057d27600b9223d410a47295f77a5ee583be9c44a63dc10cde5ff6ff130667d1.png
complex
<table><tr><td>Ligand</td><td colspan="2"><i>Mutagenicity</i></td><td colspan="3"><i>Carcinogenicity</i></td></tr><tr><td></td><td><i>Salmonella typhimurium</i>(CPDB)</td><td><i>Salmonella typhimurium</i>(Kazius/Bursi)</td><td><i>Rodent</i>(<i>multiple sex</i>)</td><td><i>Rat</i>(<i>both sex</i>)</td><td><i>Mouse</i>(<i>both sex</i>)</td></tr><tr><td>SAHA</td><td>no</td><td>no</td><td>no</td><td>no</td><td>yes</td></tr><tr><td>1a</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td></tr><tr><td>1b</td><td>no</td><td>no</td><td>no</td><td>no</td><td>yes</td></tr><tr><td>1c</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td></tr><tr><td>1d</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td></tr><tr><td>1e</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>no</td></tr><tr><td>1f</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td></tr><tr><td>2a</td><td>no</td><td>no</td><td>no</td><td>no</td><td>yes</td></tr><tr><td>2b</td><td>no</td><td>no</td><td>no</td><td>no</td><td>yes</td></tr><tr><td>2c</td><td>no</td><td>no</td><td>no</td><td>no</td><td>yes</td></tr><tr><td>2d</td><td>no</td><td>no</td><td>no</td><td>no</td><td>yes</td></tr><tr><td>2e</td><td>no</td><td>no</td><td>no</td><td>no</td><td>yes</td></tr><tr><td>2f</td><td>no</td><td>no</td><td>no</td><td>no</td><td>yes</td></tr></table>
3c77707be995a952e19c94fc508a014ecc8e774ed758236afca144d8f61d9101.png
simple
<table><tr><td>Variable</td><td>n(%) n = 105</td></tr><tr><td>Age (mean(SD))</td><td>63.4 (20.1)</td></tr><tr><td>Age category</td><td>-</td></tr><tr><td>20&#8211;49</td><td>24(23)</td></tr><tr><td>50&#8211;74</td><td>38(36)</td></tr><tr><td>75&#8211;84</td><td>25(24)</td></tr><tr><td>85+</td><td>18(17)</td></tr><tr><td>Female</td><td>67(64)</td></tr><tr><td>Secondary care antibiotic use</td><td>77(73)</td></tr><tr><td>Trimethoprim <sup>1</sup></td><td>63(82)</td></tr><tr><td>Co-amoxiclav <sup>1</sup></td><td>22(29)</td></tr><tr><td>Amoxicillin <sup>1</sup></td><td>66(86)</td></tr><tr><td>Nitrofurantoin <sup>1</sup></td><td>3(4)</td></tr><tr><td>Visited hospital in previous 12 months</td><td>53(50)</td></tr><tr><td>Antibiotic use in previous 12 months</td><td>-</td></tr><tr><td>Yes</td><td>21(20)</td></tr><tr><td>Unknown <sup>2</sup></td><td>79(75)</td></tr><tr><td>Co-morbidity</td><td>-</td></tr><tr><td>Asthma</td><td>14(13)</td></tr><tr><td>Diabetes mellitus</td><td>16(15)</td></tr><tr><td>COPD</td><td>3(3)</td></tr><tr><td>History of smoking</td><td>46(44)</td></tr></table>
766efaa3f81afbc802d8d51bd6beb18b4d64fc5d73dcbf17a133c8169a666ede.png
complex
<table><tr><td></td><td></td><td></td><td colspan="2">msSNP</td><td colspan="4">Location error by the composite likelihood approach</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td colspan="2">Causal SNP out</td><td colspan="2">Causal SNP in</td></tr><tr><td>SNP density (kb/SNP)</td><td>No. SNPs</td><td>No. regions</td><td>&#967;<sup>2</sup><sub>1</sub></td><td>Location error</td><td>LD</td><td>kb</td><td>LD</td><td>kb</td></tr><tr><td>Full (11)</td><td>15701</td><td>126</td><td>2324</td><td>153</td><td>57</td><td>13</td><td>55</td><td>14</td></tr><tr><td>1/2 (22)</td><td>7850</td><td>125</td><td>1762</td><td>-2</td><td>5</td><td>-19</td><td>5</td><td>-20</td></tr><tr><td>1/3 (33)</td><td>5233</td><td>118</td><td>2324</td><td>153</td><td>153</td><td>40</td><td>6</td><td>40</td></tr><tr><td>1/4 (44)</td><td>3925</td><td>106</td><td>1762</td><td>-2</td><td>-65</td><td>-56</td><td>-57</td><td>-53</td></tr><tr><td>1/5 (54)</td><td>3140</td><td>94</td><td>2274</td><td>42</td><td>-24</td><td>-35</td><td>-15</td><td>-36</td></tr><tr><td>1/6 (65)</td><td>2616</td><td>82</td><td>1285</td><td>20</td><td>20</td><td>20</td><td>10</td><td>15</td></tr><tr><td>1/8 (87)</td><td>1962</td><td>64</td><td>1601</td><td>65</td><td>-58</td><td>-64</td><td>-47</td><td>-58</td></tr><tr><td>1/10 (109)</td><td>1570</td><td>52</td><td>726</td><td>-106</td><td>-55</td><td>-59</td><td>-24</td><td>-46</td></tr><tr><td>1/15 (163)</td><td>1046</td><td>34</td><td>486</td><td>-887</td><td>294</td><td>26</td><td>0</td><td>3</td></tr><tr><td>1/20 (217)</td><td>785</td><td>26</td><td>726</td><td>-106</td><td>-97</td><td>-160</td><td>-26</td><td>-43</td></tr><tr><td>1/25 (272)</td><td>628</td><td>20</td><td>348</td><td>-9</td><td>69</td><td>-120</td><td>60</td><td>-79</td></tr><tr><td>1/30 (326)</td><td>523</td><td>17</td><td>229</td><td>188</td><td>362</td><td>-25</td><td>0</td><td>-25</td></tr></table>
8eb2e0ea85a446baeba9b8de2bb554e8e7bb4c31833444ccf9e00ea17cb164b1.png
complex
<table><tr><td rowspan="2">Epidemiological and demographic variable</td><td colspan="2">Number of cases</td><td>Deaths</td><td>Case fatality rate</td><td>Incidence rate</td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>/100,000</td></tr><tr><td colspan="6">Region of probable infection site</td></tr><tr><td> North</td><td>95</td><td>3.5</td><td>40</td><td>42.1</td><td>0.34</td></tr><tr><td> Northeast</td><td>11</td><td>0.4</td><td>5</td><td>45.4</td><td>&lt;0.01</td></tr><tr><td> Southeast</td><td>423</td><td>14.2</td><td>194</td><td>45.8</td><td>0.05</td></tr><tr><td> South</td><td>574</td><td>19.3</td><td>192</td><td>33.4</td><td>0.25</td></tr><tr><td> Midwest</td><td>472</td><td>15.9</td><td>184</td><td>38.9</td><td>0.90</td></tr><tr><td> Left blank or unknown</td><td>177</td><td>10.3</td><td>63</td><td>34.4</td><td>&#8211;</td></tr><tr><td colspan="6">Infection zone</td></tr><tr><td> Urban</td><td>151</td><td>8.6</td><td>60</td><td>39.7</td><td>&#8211;</td></tr><tr><td> Rural</td><td>1261</td><td>72.0</td><td>460</td><td>36.5</td><td>&#8211;</td></tr><tr><td> Periurban</td><td>110</td><td>6.3</td><td>48</td><td>42.7</td><td>&#8211;</td></tr><tr><td> Left blank or unknown</td><td>230</td><td>13.1</td><td>108</td><td>51.3</td><td>&#8211;</td></tr><tr><td colspan="6">Gender</td></tr><tr><td> Male</td><td>1338</td><td>76.4</td><td>503</td><td>37.6</td><td>0.04</td></tr><tr><td> Female</td><td>414</td><td>23.6</td><td>173</td><td>41.6</td><td>&lt;0.01</td></tr><tr><td> Left blank</td><td>0</td><td>0.0</td><td>0</td><td>0.0</td><td>&lt;0.01</td></tr><tr><td colspan="6">Ethnic group</td></tr><tr><td> White</td><td>1047</td><td>59.8</td><td>368</td><td>35.1</td><td>&#8211;</td></tr><tr><td> Black</td><td>91</td><td>5.2</td><td>40</td><td>44.0</td><td>&#8211;</td></tr><tr><td> Asian</td><td>18</td><td>1.0</td><td>4</td><td>22.2</td><td>&#8211;</td></tr><tr><td> Mixed race</td><td>363</td><td>20.7</td><td>165</td><td>45.5</td><td>&#8211;</td></tr><tr><td> Indigenous</td><td>38</td><td>2.2</td><td>3</td><td>7.9</td><td>&#8211;</td></tr><tr><td> Left blank</td><td>195</td><td>11.1</td><td>96</td><td>49.2</td><td>&#8211;</td></tr><tr><td colspan="6">Age</td></tr><tr><td> Less than 1 year</td><td>7</td><td>0.4</td><td>4</td><td>57.14</td><td>0.01</td></tr><tr><td> 1&#8211;4 years</td><td>6</td><td>0.3</td><td>1</td><td>16.7</td><td>&lt;0.01</td></tr><tr><td> 5&#8211;9 years</td><td>20</td><td>1.1</td><td>7</td><td>35.0</td><td>0.01</td></tr><tr><td> 10&#8211;14 years</td><td>43</td><td>2.5</td><td>16</td><td>37.2</td><td>0.02</td></tr><tr><td> 15&#8211;19 years</td><td>91</td><td>5.2</td><td>58</td><td>63.7</td><td>0.03</td></tr><tr><td> 20&#8211;34 years</td><td>426</td><td>24.3</td><td>282</td><td>66.2</td><td>0.04</td></tr><tr><td> 35&#8211;49 years</td><td>662</td><td>37.8</td><td>205</td><td>31.0</td><td>0.09</td></tr><tr><td> 50&#8211;64 years</td><td>363</td><td>20.7</td><td>92</td><td>25.3</td><td>0.09</td></tr><tr><td> 65+</td><td>134</td><td>7.6</td><td>11</td><td>8.2</td><td>0.05</td></tr></table>
02818efcd34f705ea0365b81f547c34240e54a427cfe9265b24d53dd72c4d02b.png
complex
<table><tr><td></td><td colspan="2">Univariate</td><td colspan="2">Multivariate<sup>a</sup></td></tr><tr><td>Group</td><td>OR (95 % CI)</td><td><i>P</i></td><td>OR (95 % CI)</td><td><i>P</i></td></tr><tr><td>Moderate to severe hypoatremia</td><td>1.91 (1.197&#8211;3.033)</td><td>0.007</td><td>3.61 (1.438&#8211;9.049)</td><td>0.006</td></tr><tr><td>Mild hyponatremia</td><td>1.65 (1.047&#8211;2.610)</td><td>0.031</td><td>2.45 (1.051&#8211;5.705)</td><td>0.038</td></tr><tr><td>Normonatremia</td><td>1 (Reference)</td><td></td><td>1 (Reference)</td><td></td></tr><tr><td>Mild hypernatremia</td><td>1.03 (0.560&#8211;1.908)</td><td>0.917</td><td>1.06 (0.461&#8211;2.438)</td><td>0.890</td></tr><tr><td>Moderate to severe hypernatremia</td><td>2.32 (1.203&#8211;4.453)</td><td>0.012</td><td>2.94 (1.119&#8211;7.722)</td><td>0.029</td></tr></table>
eb0b44c00e8cdc5494401f92df47b04d416a64b733263f20b555b3d6143da21a.png
simple
<table><tr><td></td><td>No incident diabetes (n = 2590)</td><td>Incident diabetes (n = 297)</td><td>p&#8804;*</td></tr><tr><td>Age (years)</td><td>44 &#177; 17</td><td>47 &#177; 15</td><td>0.101</td></tr><tr><td>Sex (% women)</td><td>60</td><td>61</td><td>0.662</td></tr><tr><td>Systolic BP (mmHg)</td><td>122 &#177; 17</td><td>127 &#177; 17</td><td>0.02</td></tr><tr><td>Diastolic BP (mmHg)</td><td>75 &#177; 11</td><td>78 &#177; 11</td><td>0.003</td></tr><tr><td>Heart rate (bpm)</td><td>68 &#177; 11</td><td>70 &#177; 11</td><td>0.02</td></tr><tr><td>Body mass index (kg/m<sup>2</sup>)</td><td>30 &#177; 7</td><td>35 &#177; 7</td><td>0.0001</td></tr><tr><td>Waist circumference (cm)</td><td>100 &#177; 16</td><td>113 &#177; 16</td><td>0.0001</td></tr><tr><td>GFR<sub>MDRD</sub> (mL/min/1.73 m<sup>2</sup>)</td><td>92 [78&#8211;108]</td><td>92 [79&#8211;109]</td><td>0.178<sup>&#8224;</sup></td></tr><tr><td>Cholesterol (mg/dL)</td><td>187 &#177; 37</td><td>187 &#177; 39</td><td>0.370</td></tr><tr><td>HDL-c (mg/dL)</td><td>50 &#177; 15</td><td>44 &#177; 14</td><td>0.0001</td></tr><tr><td>Triglycerides (mg/dL)</td><td>120 [86&#8211;171]</td><td>147 [107&#8211;196]</td><td>0.002<sup>&#8224;</sup></td></tr><tr><td>Fasting glucose (mg/dL)</td><td>96 &#177; 13</td><td>109 &#177; 25</td><td>0.0001</td></tr><tr><td>Fasting insulin (mIU/mL)</td><td>11 [7&#8211;17]</td><td>21 [13&#8211;31]</td><td>0.0001<sup>&#8224;</sup></td></tr><tr><td>HOMA-R</td><td>2.6 [1.6&#8211;4.2]</td><td>5.2 [3.4&#8211;8.3]</td><td>0.0001<sup>&#8224;</sup></td></tr><tr><td>Fibrinogen (mg/dL)</td><td>347 [304&#8211;399]</td><td>367 [322&#8211;427]</td><td>0.01<sup>&#8224;</sup></td></tr><tr><td>PAI-1 (mg/dL)</td><td>42 [26&#8211;65]</td><td>58 [38&#8211;93]</td><td>0.01<sup>&#8224;</sup></td></tr><tr><td>Fat-free mass (kg)</td><td>53 &#177; 12</td><td>59 &#177; 14</td><td>0.04</td></tr><tr><td>Adipose mass (kg)</td><td>35 &#177; 10</td><td>40 &#177; 8</td><td>0.0001</td></tr><tr><td>LVDD index (cm/m)</td><td>3.09 &#177; 0.25</td><td>3.16 &#177; 0.29</td><td>0.008</td></tr><tr><td>LV mass index (g/m<sup>2.7</sup>)</td><td>38.0 &#177; 8.8</td><td>42.2 &#177; 10.3</td><td>0.0001</td></tr><tr><td>Relative wall thickness<sup>a</sup></td><td>0.32 &#177; 0.05</td><td>0.33 &#177; 0.04</td><td>0.006</td></tr><tr><td>LAV index (mL/m<sup>2</sup>)<sup>b</sup></td><td>11.4 &#177; 3.0</td><td>13.1 &#177; 3.0</td><td>0.0001</td></tr><tr><td>Ejection fraction (%)</td><td>63 &#177; 5</td><td>64 &#177; 5</td><td>0.2</td></tr><tr><td>Urinary albumin/creatinine</td><td>6.55 [4.22&#8211;12.08]</td><td>8.32 [4.95&#8211;16.56]</td><td>0.152<sup>&#8224;</sup></td></tr></table>
dc334b8fe329e1c29c364d9584abb90fc87389f2e4e2692fde6afeb6090fc4de.png
complex
<table><tr><td></td><td colspan="2">NH White</td><td colspan="2">NH Black</td><td colspan="2">Hispanic</td><td colspan="2">Asian/PI</td></tr><tr><td></td><td><i>n</i>=11,347</td><td>86.92%</td><td><i>n</i>=772</td><td>5.91%</td><td><i>n</i>=601</td><td>4.60%</td><td><i>n</i>=334</td><td>2.56%</td></tr><tr><td colspan="9">Screening service</td></tr><tr><td colspan="9">Well visit (<i>n</i> = 13,054)</td></tr><tr><td>Yes (%)</td><td>1374</td><td>12.11</td><td>78</td><td>10.10</td><td>70</td><td>11.65</td><td>49</td><td>14.67</td></tr><tr><td>OR (95% CI)</td><td>ref</td><td>ref</td><td>0.82</td><td>0.64, 1.04</td><td>0.96</td><td>0.74, 1.24</td><td>1.25</td><td>0.92, 1.70</td></tr><tr><td>aOR (95% CI)d</td><td>ref</td><td>ref</td><td>0.82</td><td>0.64, 1.05</td><td>0.81</td><td>0.62, 1.05</td><td>0.98</td><td>0.72, 1.35</td></tr><tr><td colspan="9">Influenza vaccination (<i>n</i> = 13,054)</td></tr><tr><td>Yes (%)</td><td>7643</td><td>67.36</td><td>347</td><td>44.95</td><td>317</td><td>52.75</td><td>222</td><td>66.47</td></tr><tr><td>OR (95% CI)</td><td>ref</td><td>ref</td><td>0.40</td><td>0.34, 0.45</td><td>0.54</td><td>0.46, 0.64</td><td>0.96</td><td>0.76, 1.21</td></tr><tr><td>aOR (95% CI)d</td><td>ref</td><td>ref</td><td>0.40</td><td>0.33, 0.44</td><td>0.61</td><td>0.51, 0.72</td><td>1.15</td><td>0.91, 1.45</td></tr><tr><td colspan="9">2 Influenza vaccinations a(<i>n</i> = 13,054)</td></tr><tr><td>Yes (%)</td><td>4828</td><td>42.55</td><td>155</td><td>20.08</td><td>143</td><td>23.79</td><td>136</td><td>40.72</td></tr><tr><td>OR (95% CI)</td><td>ref</td><td>ref</td><td>0.34</td><td>0.28, 0.41</td><td>0.42</td><td>0.35, 0.51</td><td>0.93</td><td>0.74, 1.15</td></tr><tr><td>aOR (95% CI)d</td><td>ref</td><td>ref</td><td>0.33</td><td>0.27, 0.39</td><td>0.47</td><td>0.39, 0.57</td><td>1.08</td><td>0.86, 1.36</td></tr><tr><td colspan="9">Breast cancer screeningb (<i>n</i> = 6145)</td></tr><tr><td>Yes (%)</td><td>3876</td><td>74.15</td><td>283</td><td>65.36</td><td>218</td><td>69.21</td><td>117</td><td>68.82</td></tr><tr><td>OR (95% CI)</td><td>ref</td><td>ref</td><td>0.66</td><td>0.53, 0.81</td><td>0.78</td><td>0.61, 1.00</td><td>0.77</td><td>0.55, 1.07</td></tr><tr><td>aOR (95% CI)d</td><td>ref</td><td>ref</td><td>0.64</td><td>0.52, 0.79</td><td>0.82</td><td>0.64, 1.05</td><td>0.82</td><td>0.58, 1.14</td></tr><tr><td colspan="9">Diabetes screeningc (<i>n</i> = 5933)</td></tr><tr><td>Yes (%)</td><td>1684</td><td>32.23</td><td>123</td><td>37.85</td><td>94</td><td>37.75</td><td>54</td><td>40.30</td></tr><tr><td>OR (95% CI)</td><td>ref</td><td>ref</td><td>1.28</td><td>1.01, 1.61</td><td>1.28</td><td>0.98, 1.66</td><td>1.42</td><td>1.00, 2.01</td></tr><tr><td>aOR (95% CI)d</td><td>ref</td><td>ref</td><td>1.34</td><td>1.06, 1.71</td><td>1.35</td><td>1.03, 1.77</td><td>1.47</td><td>1.02, 2.10</td></tr></table>
26d68574acead4ff5561b7b536cb9147456b2f1da33355d0d08c6136b299525b.png
complex
<table><tr><td>Prognostic feature</td><td>P value</td><td>OR</td><td colspan="2">95% CI</td></tr><tr><td>Gender [male/female]</td><td>0.185</td><td>2.745</td><td>0.618</td><td>12.193</td></tr><tr><td>ECOG 1 vs. 0</td><td>0.020</td><td>0.336</td><td>0.134</td><td>0.842</td></tr><tr><td>ECOG 2 vs. 0</td><td>0.047</td><td>0.121</td><td>0.015</td><td>0.974</td></tr><tr><td>ICIQ group mild vs. moderate</td><td>0.394</td><td>1.76</td><td>0.48</td><td>6.449</td></tr><tr><td>ICIQ group mild vs. severe</td><td>0.382</td><td>0.504</td><td>0.109</td><td>2.342</td></tr><tr><td>Surgeon experience &lt;100 vs. &gt;100 prev. rCx [y/n]</td><td>0.021</td><td>3.442</td><td>1.203</td><td>9.847</td></tr><tr><td>Nerve-sparing [y/n]</td><td>0.165</td><td>2.029</td><td>0.747</td><td>5.511</td></tr><tr><td>Radiation therapy [y/n]</td><td>0.999</td><td>0</td><td>0</td><td>.</td></tr><tr><td>Symptoms [y/n]</td><td>0.109</td><td>0.458</td><td>0.176</td><td>1.192</td></tr><tr><td>Urge [y/n]</td><td>0.259</td><td>0.486</td><td>0.139</td><td>1.702</td></tr><tr><td>Daytime continence [y/n]</td><td>0.032</td><td>3.131</td><td>1.101</td><td>8.908</td></tr><tr><td>Daily pad usage 2 vs. 0-1</td><td>0.817</td><td>0.859</td><td>0.238</td><td>3.105</td></tr><tr><td>Daily pad usage &gt;2 vs. 0-1</td><td>0.995</td><td>0.996</td><td>0.274</td><td>3.616</td></tr></table>
fef4c3de1c30af724f279d0110676e2059f453969e18fa90ebc35582352ac69e.png
simple
<table><tr><td></td><td>Effect</td><td>&#946;</td><td>SE</td><td>P-Value</td></tr><tr><td>MVPA</td><td>Intercept</td><td>3.233</td><td>0.397</td><td>&lt;0.001</td></tr><tr><td></td><td>Maturity Offset</td><td>&#8722;0.077</td><td>0.098</td><td>0.434</td></tr><tr><td></td><td>Maturity Offset* Maturity Offset</td><td>0.026</td><td>0.009</td><td>0.005</td></tr><tr><td></td><td>Sex (ref = girl)</td><td>1.574</td><td>0.335</td><td>&lt;0.001</td></tr><tr><td></td><td>Family Support</td><td>0.677</td><td>0.128</td><td>&lt;0.001</td></tr><tr><td></td><td>Maturity Offset* Family Support</td><td>&#8722;0.080</td><td>0.028</td><td>0.004</td></tr><tr><td></td><td>Family Support* Sex (ref = girl)</td><td>&#8722;0.298</td><td>0.118</td><td>0.012</td></tr><tr><td></td><td>Friend Support</td><td>0.267</td><td>0.055</td><td>&lt;0.001</td></tr><tr><td></td><td>Mother&#8217;s Ed</td><td>0.355</td><td>0.192</td><td>0.065</td></tr><tr><td>MVPA-</td><td>Intercept</td><td>2.070</td><td>0.274</td><td>&lt;0.001</td></tr><tr><td>PM Weekday</td><td>Maturity Offset</td><td>&#8722;0.251</td><td>0.050</td><td>&lt;0.001</td></tr><tr><td></td><td>Maturity Offset* Maturity Offset</td><td>0.026</td><td>0.009</td><td>0.004</td></tr><tr><td></td><td>Sex (ref = girl)</td><td>0.385</td><td>0.126</td><td>0.002</td></tr><tr><td></td><td>Family Support</td><td>0.315</td><td>0.065</td><td>&lt;0.001</td></tr><tr><td></td><td>Friend Support</td><td>0.352</td><td>0.056</td><td>&lt;0.001</td></tr><tr><td></td><td>Mother&#8217;s Ed</td><td>0.455</td><td>0.194</td><td>0.019</td></tr></table>
f1141fff0398cace5b51cbad4dff0b493b7394003740cdbb654d6c280254e19a.png
complex
<table><tr><td rowspan="2"></td><td colspan="3">Men (<i>n</i> = 416)</td><td colspan="3">Women (<i>n</i> = 538)</td><td colspan="3">Both sexes (<i>n</i> = 954)</td></tr><tr><td>Prevalence</td><td>95% CI</td><td>Cases/All</td><td>Prevalence</td><td>95% CI</td><td>Cases/All</td><td>Prevalence</td><td>95% CI</td><td>Cases/All</td></tr><tr><td colspan="10">Combined Astana city and Akmol village</td></tr><tr><td> Prevalence of HC among all</td><td>28.4%</td><td>24.0&#8211;32.7</td><td>118/416</td><td>44.1%</td><td>39.8&#8211;48.3</td><td>237/538</td><td>37.2%</td><td>34.1&#8211;40.3</td><td>355/954</td></tr><tr><td> Awareness among all cases of HC</td><td>47.5%</td><td>38.3&#8211;56.6</td><td>56/118</td><td>61.2%</td><td>54.9&#8211;67.4</td><td>145/237</td><td>56.6%</td><td>51.4&#8211;61.8</td><td>201/355</td></tr><tr><td> Treatment among all cases of HC</td><td>33.1%</td><td>24.4&#8211;41.7</td><td>39/118</td><td>44.3%</td><td>37.9&#8211;50.7</td><td>105/237</td><td>40.6%</td><td>35.4&#8211;45.7</td><td>144/355</td></tr><tr><td> Treatment among aware</td><td>67.9%</td><td>55.2&#8211;80.5</td><td>38/56</td><td>71.7%</td><td>64.3&#8211;79.1</td><td>104/145</td><td>70.7%</td><td>64.3&#8211;77.0</td><td>142/201</td></tr><tr><td> Control among all cases of HC</td><td>26.3%</td><td>18.2&#8211;34.3</td><td>31/118</td><td>21.9%</td><td>16.6&#8211;27.2</td><td>52/237</td><td>23.4%</td><td>19.0&#8211;27.8</td><td>83/355</td></tr><tr><td> Control among treated</td><td>79.5%</td><td>66.2&#8211;92.7</td><td>31/39</td><td>49.5%</td><td>39.8&#8211;59.2</td><td>52/105</td><td>57.6%</td><td>49.5&#8211;65.8</td><td>83/144</td></tr><tr><td colspan="10">Astana city (urban, <i>n</i> = 480)</td></tr><tr><td> Prevalence of HC among all</td><td>38.2%</td><td>31.7&#8211;44.7</td><td>84/220</td><td>57.3%</td><td>51.3&#8211;63.4</td><td>149/260</td><td>48.5%</td><td>44.1&#8211;53.0</td><td>233/480</td></tr><tr><td> Awareness among all cases of HC</td><td>56.0%</td><td>45.1&#8211;66.8</td><td>47/84</td><td>72.5%</td><td>65.2&#8211;79.7</td><td>108/149</td><td>66.5%</td><td>60.4&#8211;72.6</td><td>155/233</td></tr><tr><td> Treatment among all cases of HC</td><td>36.9%</td><td>26.4&#8211;47.4</td><td>31/84</td><td>49.7%</td><td>41.5&#8211;57.8</td><td>74/149</td><td>45.1%</td><td>38.6&#8211;51.5</td><td>105/233</td></tr><tr><td> Treatment among aware</td><td>63.8%</td><td>49.6&#8211;78.1</td><td>30/47</td><td>68.5%</td><td>59.6&#8211;77.4</td><td>74/108</td><td>67.1%</td><td>59.6&#8211;74.6</td><td>104/155</td></tr><tr><td> Control among all cases of HC</td><td>29.8%</td><td>19.8&#8211;39.7</td><td>25/84</td><td>24.8%</td><td>17.8&#8211;31.9</td><td>37/149</td><td>26.6%</td><td>20.9&#8211;32.3</td><td>62/233</td></tr><tr><td> Control among treated</td><td>80.7%</td><td>65.9&#8211;95.4</td><td>25/31</td><td>50.0%</td><td>38.3&#8211;61.7</td><td>37/74</td><td>59.1%</td><td>49.5&#8211;68.6</td><td>62/105</td></tr><tr><td colspan="10">Akmol village (rural, <i>n</i> = 474)</td></tr><tr><td> Prevalence of HC among all</td><td>17.4%</td><td>12.0&#8211;22.7</td><td>34/196</td><td>31.7%</td><td>26.2&#8211;37.2</td><td>88/278</td><td>25.7%</td><td>21.8&#8211;29.7</td><td>122/474</td></tr><tr><td> Awareness among all cases of HC</td><td>26.5%</td><td>10.8&#8211;42.1</td><td>9/34</td><td>42.1%</td><td>31.5&#8211;52.6</td><td>37/88</td><td>37.7%</td><td>29.0&#8211;46.4</td><td>46/122</td></tr><tr><td> Treatment among all cases of HC</td><td>23.5%</td><td>8.5&#8211;38.6</td><td>8/34</td><td>35.2%</td><td>25.0&#8211;45.4</td><td>31/88</td><td>32.0%</td><td>23.6&#8211;40.4</td><td>39/122</td></tr><tr><td> Treatment among aware</td><td>88.9%</td><td>63.3&#8211;114.5</td><td>8/9</td><td>81.1%</td><td>67.8&#8211;94.3</td><td>30/37</td><td>82.6%</td><td>71.2&#8211;94.0</td><td>38/46</td></tr><tr><td> Control among all cases of HC</td><td>17.7%</td><td>4.1&#8211;31.1</td><td>6/34</td><td>17.1%</td><td>9.0&#8211;25.1</td><td>15/88</td><td>17.2%</td><td>10.4&#8211;24.0</td><td>21/122</td></tr><tr><td> Control among treated</td><td>75.0%</td><td>36.3&#8211;113.7</td><td>6/8</td><td>48.4%</td><td>29.8&#8211;67.0</td><td>15/31</td><td>53.9%</td><td>37.5&#8211;70.2</td><td>21/39</td></tr></table>
b7b5cec861783d22501c1d916276276aaa878abca51be4e16677c94b9f61e7aa.png
simple
<table><tr><td>Run (session)</td><td>Total Samples</td><td>Average Strokes per Minute (SPM)</td><td>Number of Observation slices</td><td>Type of run</td></tr><tr><td><i>A</i></td><td>6,500</td><td>33.4</td><td>13</td><td>inner-club competition</td></tr><tr><td><i>B</i></td><td>8,000</td><td>15.4</td><td>8</td><td>training</td></tr><tr><td><i>C</i></td><td>4,500</td><td>32.0</td><td>9</td><td>inner-club competition</td></tr><tr><td><i>D</i></td><td>5,000</td><td>31.2</td><td>10</td><td>inner-club competition</td></tr><tr><td><i>E</i></td><td>8,000</td><td>15.0</td><td>8</td><td>recovery</td></tr></table>
9f000eecdeb617d0725e9772ebd40c5fca110b5d3dfcb545a0cdc21579d99730.png
simple
<table><tr><td> </td><td> </td><td>AUC (95% CI)</td><td>Fold change<sup><i>&#8727;</i></sup></td><td><i>P</i></td></tr><tr><td>ANC, 10<sup>3</sup>/<i>&#956;</i>L</td><td> </td><td>0.6001 (0.5689&#8211;0.6313)</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>FBG, mmol/L</td><td> </td><td>0.5876 (0.5561&#8211;0.6191)</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>SCr, <i>&#956;</i>mol/L</td><td> </td><td>0.5545 (0.5225&#8211;0.5869)</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>SBP, mmHg</td><td> </td><td>0.5767 (0.5457&#8211;0.6077)</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>Model 1</td><td>ANC &#215; FBG</td><td>0.6179 (0.5872&#8211;0.6486)</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>Model 2</td><td>ANC &#215; FBG &#215; SBP</td><td>0.6282 (0.6068&#8211;0.6676)</td><td>1.67</td><td>0.5188</td></tr><tr><td>Model 3</td><td>ANC &#215; FBG &#215; SBP &#215; SCr</td><td>0.6372 (0.5978&#8211;0.6586)</td><td>3.12</td><td>0.5338</td></tr></table>
6fab6fd968367b17cea7baecb983e8df1fa567d19ba000ea825ffdfd2ded2132.png
complex
<table><tr><td colspan="3">DerSimonian and Laird results</td><td colspan="3"><i>Calculations for Hartung-Knapp-Sidik Jonkman</i></td></tr><tr><td>Study</td><td>Study results HR y<sub>i</sub></td><td>Weights w<sub>i</sub></td><td><i>ln(y</i><sub><i>i</i></sub><i>)</i></td><td><i>(ln(y</i><sub><i>i </i></sub><i>)&#8211;ln(y))</i><sup><i>2</i></sup></td><td><i>w</i><sub><i>i</i></sub>&#215;<i>(ln(y</i><sub><i>i </i></sub><i>)&#8211;ln(y))</i><sup><i>2</i></sup></td></tr><tr><td>Cornelissen 2009</td><td>0.81</td><td>5.0</td><td><i>&#8722;0.21</i></td><td><i>0.00</i></td><td><i>0.02</i></td></tr><tr><td>De Witte 1994</td><td>0.67</td><td>2.1</td><td><i>&#8722;0.40</i></td><td><i>0.06</i></td><td><i>0.13</i></td></tr><tr><td>Fielding 2009</td><td>0.80</td><td>11.5</td><td><i>&#8722;0.22</i></td><td><i>0.01</i></td><td><i>0.06</i></td></tr><tr><td>Goldstone 2008</td><td>0.91</td><td>46.7</td><td><i>&#8722;0.09</i></td><td><i>0.00</i></td><td><i>0.15</i></td></tr><tr><td>Hunault 2004</td><td>0.56</td><td>2.9</td><td><i>&#8722;0.58</i></td><td><i>0.18</i></td><td><i>0.53</i></td></tr><tr><td>Labar 2004</td><td>0.98</td><td>9.3</td><td><i>&#8722;0.02</i></td><td><i>0.02</i></td><td><i>0.16</i></td></tr><tr><td>Ribera 2005</td><td>1.24</td><td>3.9</td><td><i>0.22</i></td><td><i>0.13</i></td><td><i>0.52</i></td></tr><tr><td>Sebban 1994</td><td>0.75</td><td>12.7</td><td><i>&#8722;0.29</i></td><td><i>0.02</i></td><td><i>0.24</i></td></tr><tr><td>Takeuchi 2002</td><td>0.95</td><td>3.9</td><td><i>&#8722;0.05</i></td><td><i>0.01</i></td><td><i>0.04</i></td></tr><tr><td>Ueda 1998</td><td>0.66</td><td>2.0</td><td><i>&#8722;0.42</i></td><td><i>0.07</i></td><td><i>0.14</i></td></tr><tr><td> </td><td>y = 0.86</td><td><i>Sum: 100.0</i></td><td> </td><td> </td><td><i>Sum: 1.99</i></td></tr><tr><td colspan="6">10 studies, I<sup>2</sup> = 0.0, &#964;<sup>2</sup> = 0.0.</td></tr><tr><td colspan="6">DL pooled result [95% CI]: HR = 0.86 [0.77, 0.97]; z = &#8722;2.48; P&#8211;value = 0.013.</td></tr><tr><td colspan="6">HKSJ pooled result [95% CI]: HR = 0.86 [0.77, 0.96]; t = &#8722;3.19; P&#8211;value = 0.011 (df = 9).</td></tr></table>
6361c0f2e3f7922f16814fdde0aa2d4f98ff073f82793e41df6592124855d4f9.png
simple
<table><tr><td>Characteristics</td><td>Mean (SD); n (%)</td><td>Range:</td></tr><tr><td>Age in years</td><td>77.7 (5.89)</td><td>66-90</td></tr><tr><td>Women</td><td>25 (45.5%)</td><td>N/A</td></tr><tr><td>At least 1 fall in last 12 months</td><td>14 (25%)</td><td>N/A</td></tr><tr><td>BMI</td><td>25.8 (4.4)</td><td>14-42</td></tr><tr><td>Years of education</td><td>12.1 (3.4)</td><td>(8-20)</td></tr><tr><td>Cognition</td><td></td><td></td></tr><tr><td> MMSE Score (0-30)</td><td>26.8 (2.1)</td><td>21-30</td></tr><tr><td> MoCA score</td><td>22.4 (3.2)</td><td>15-28</td></tr><tr><td> Letter Number Sequencing (LNS)</td><td>7.6 (2.4)</td><td>3-13</td></tr><tr><td> TMT A (seconds)</td><td>55.8 (20.9)</td><td>23-102</td></tr><tr><td> TMT B (seconds)</td><td>178.8 (108.6)</td><td>55-539</td></tr><tr><td> Digit Symbol Coding</td><td>41 (14.4)</td><td>19-71</td></tr><tr><td>Gait Velocity (m/s)</td><td></td><td></td></tr><tr><td> Single Gait Velocity (sGV)</td><td>0.87 (0.2)</td><td>0.44-1.50</td></tr><tr><td> Verbal Gait Velocity (vGV)</td><td>0.65 (0.2)</td><td>0.32-1.00</td></tr><tr><td> Counting Gait Velocity (cGV)</td><td>0.63 (0.2)</td><td>0.34-1.06</td></tr></table>
11b699f27c5f4baf479879b66557c2c532d0e6eaf9330cf64e0b698ca4200e26.png
complex
<table><tr><td>RSSI location</td><td>SVD imaging biomarker</td><td>Frequency [i.e., number of patients (%)]</td><td>Median volume or score (IQR)</td><td>% [median (IQR)] of total ICV</td></tr><tr><td rowspan="9">Total brain</td><td>RSSI</td><td>187/187 (100)</td><td>0.75 (0.84) ml</td><td>0.05 (0.06)</td></tr><tr><td>WMH</td><td>187/187 (100)</td><td>16.82 (30) ml</td><td>1.18 (2.18)</td></tr><tr><td>Cavitated WMH</td><td>64/187 (34)</td><td>1.15 (1.45) ml</td><td>8.02 (9.29)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td>Lacunes</td><td>87/187 (46)</td><td>0.17 (0.22) ml</td><td>1.15 (1.48)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td rowspan="2">Perivascular spaces</td><td rowspan="2">186/187 (99)</td><td>BG score: 2 (1)</td><td rowspan="2">Not applicable</td></tr><tr><td>CS score: 3 (1)</td></tr><tr><td rowspan="2">Microbleeds</td><td rowspan="2">92/187 (49)</td><td>1 (3) (<i>n </i>= 187)</td><td rowspan="2">Not applicable</td></tr><tr><td>3 (3) (<i>n </i>= 92)</td></tr><tr><td>Old cortical stroke lesions</td><td>41/187 (22)</td><td>0.54 (2.08) ml</td><td>3.84 (16.26)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td rowspan="9">Left hemisphere</td><td>RSSI</td><td>97/187 (52)</td><td>0.71 (1.11) ml</td><td>0.05 (0.08)</td></tr><tr><td>WMH</td><td>97/97 (100)</td><td>12.61 (25.30) ml</td><td>0.94 (1.95)</td></tr><tr><td>Cavitated WMH</td><td>32/97 (33)</td><td>1.19 (1.57) ml</td><td>8.65 (11.92)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td>Lacunes</td><td>44/97 (45)</td><td>0.17 (0.20) ml</td><td>1.30 (1.40)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td rowspan="2">Perivascular spaces</td><td rowspan="2">97/97 (100)</td><td>BG score: 2 (2)</td><td rowspan="2">Not applicable</td></tr><tr><td>CS score: 3 (1)</td></tr><tr><td rowspan="2">Microbleeds</td><td rowspan="2">50/97 (52)</td><td>1 (3) (<i>n </i>= 97)</td><td rowspan="2">Not applicable</td></tr><tr><td>3 (3) (<i>n </i>= 50)</td></tr><tr><td>Old cortical stroke lesions</td><td>21/97 (22)</td><td>0.70 (3.52) ml</td><td>4.69 (27.00)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td rowspan="9">Right hemisphere</td><td>RSSI</td><td>78/187 (42)</td><td>0.79 (0.82) ml</td><td>0.5 (0.06)</td></tr><tr><td>WMH</td><td>78/78 (100)</td><td>23.09 (28.24) ml</td><td>1.64 (2.09)</td></tr><tr><td>Cavitated WMH</td><td>29/78 (37)</td><td>1.06 (1.42) ml</td><td>7.04 (8.19)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td>Lacunes</td><td>37/78 (47)</td><td>0.17 (0.35) ml</td><td>1.15 (2.11)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td rowspan="2">Perivascular spaces</td><td rowspan="2">77/78 (99)</td><td>BG score: 2 (1)</td><td rowspan="2">Not applicable</td></tr><tr><td>CS score: 3 (1)</td></tr><tr><td rowspan="2">Microbleeds</td><td rowspan="2">38/78 (49)</td><td>1 (2) (<i>n </i>= 78)</td><td rowspan="2">Not applicable</td></tr><tr><td>2 (4) (<i>n </i>= 38)</td></tr><tr><td>Old cortical stroke lesions</td><td>17/78 (22)</td><td>0.67 (1.81) ml</td><td>4.61 (11.80)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td rowspan="8">Both hemispheres</td><td>RSSI</td><td>5/187 (3)</td><td>1.77 (2.81) ml</td><td>0.14 (0.02)</td></tr><tr><td>WMH</td><td>5/5 (100)</td><td>60.47 (73.52) ml</td><td>4.98 (4.28)</td></tr><tr><td>Cavitated WMH</td><td>2/5 (40)</td><td>1.25 ml</td><td>7.78 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>Lacunes</td><td>4/5 (80)</td><td>0.17 (0.35) ml</td><td>1.18 (2.08)&#215; 10<sup>&#8722;4</sup></td></tr><tr><td rowspan="2">Perivascular spaces</td><td rowspan="2">5/5 (100)</td><td>BG score: 2 (2)</td><td rowspan="2">Not applicable</td></tr><tr><td>CS score: 2 (2)</td></tr><tr><td>Microbleeds</td><td>3/5 (60)</td><td>2</td><td>Not applicable</td></tr><tr><td>Old cortical stroke lesions</td><td>1/5 (20)</td><td>0.32 ml</td><td>1.93 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td rowspan="8">Cerebellum/ brainstem</td><td>RSSI</td><td>7/187 (4)</td><td>0.33 (0.20) ml</td><td>0.02 (0.02)</td></tr><tr><td>WMH</td><td>7/7 (100)</td><td>19.69 (16.66) ml</td><td>1.27 (1.19)</td></tr><tr><td>Cavitated WMH</td><td>1/7 (14)</td><td>0.49 ml</td><td>3.14 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>Lacunes</td><td>2/7 (28)</td><td>0.09 ml</td><td>0.61 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td rowspan="2">Perivascular spaces</td><td rowspan="2">7/7 (100)</td><td>BG score: 2 (1)</td><td rowspan="2">Not applicable</td></tr><tr><td>CS score: 2 (2)</td></tr><tr><td>Microbleeds</td><td>1/7 (29)</td><td>1</td><td>Not applicable</td></tr><tr><td>Old cortical stroke lesions</td><td>2/7 (28)</td><td>0.61 ml</td><td>4.92 &#215; 10<sup>&#8722;4</sup></td></tr></table>
ad9474519e5fc99599e65bca1f541b668af8d7fd28cb29448e57282da63357d1.png
simple
<table><tr><td>Name</td><td>Sel</td><td>Rec</td><td>VRec</td><td>VarN</td><td>M</td><td>MM</td><td>CEM</td><td>Seq</td><td>Tree</td><td>Ref</td></tr><tr><td>FPG</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>No</td><td>JH</td></tr><tr><td>EasyPop</td><td>No</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>B01</td></tr><tr><td>SimuPop</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>Yes</td><td>P05</td></tr><tr><td>FREEGENE</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>No</td><td>No</td><td>No</td><td>No</td><td>H07</td></tr><tr><td>GenomePop</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>Yes</td><td>No</td><td>C08</td></tr></table>
a17f7f6ab2f36b64e20c4c8699b4598504d3ac1c6abc2b10f2f2ccbee8ad224d.png
complex
<table><tr><td>Variable</td><td>Number of workers</td><td>Cases</td><td>LBP (%)</td><td>&#967;<sup>2</sup></td><td><i>P</i></td></tr><tr><td>Age</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt; 25</td><td>48</td><td>41</td><td>85.4</td><td rowspan="3">0.839</td><td rowspan="3">0.657</td></tr><tr><td> 25~</td><td>90</td><td>81</td><td>90.0</td></tr><tr><td> 30~</td><td>13</td><td>12</td><td>92.3</td></tr><tr><td>Working-age</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt; 1</td><td>27</td><td>24</td><td>88.9</td><td rowspan="3">0.194</td><td rowspan="3">0.907</td></tr><tr><td> 1~</td><td>64</td><td>56</td><td>87.5</td></tr><tr><td> 3~</td><td>60</td><td>54</td><td>90.0</td></tr><tr><td>Weight (kg)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt; 60</td><td>31</td><td>27</td><td>87.1</td><td rowspan="3">0.856</td><td rowspan="3">0.652</td></tr><tr><td> 60~</td><td>60</td><td>55</td><td>91.7</td></tr><tr><td> 70~</td><td>60</td><td>52</td><td>86.7</td></tr><tr><td>Height (cm)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt; 170</td><td>53</td><td>48</td><td>90.6</td><td rowspan="3">3.949</td><td rowspan="3">0.139</td></tr><tr><td> 170~</td><td>49</td><td>40</td><td>81.6</td></tr><tr><td> 175~</td><td>49</td><td>46</td><td>93.9</td></tr><tr><td>Physical exercise</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> yes</td><td>38</td><td>34</td><td>89.5</td><td rowspan="2">0.027</td><td rowspan="2">1.000</td></tr><tr><td> no</td><td>113</td><td>100</td><td>88.5</td></tr><tr><td>Smoking</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Yes</td><td>57</td><td>51</td><td>89.5</td><td rowspan="2">0.049</td><td rowspan="2">1.000</td></tr><tr><td> No</td><td>94</td><td>83</td><td>88.3</td></tr><tr><td>Drinking</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Yes</td><td>130</td><td>114</td><td>87.7</td><td rowspan="2">1.030</td><td rowspan="2">0.469</td></tr><tr><td> No</td><td>21</td><td>20</td><td>95.2</td></tr><tr><td>Using the computer time during your spare time(h)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt; 1</td><td>17</td><td>17</td><td>100</td><td rowspan="4">11.926</td><td rowspan="4">0.008</td></tr><tr><td> 1~</td><td>32</td><td>26</td><td>81.2</td></tr><tr><td> 2~</td><td>51</td><td>50</td><td>98.0</td></tr><tr><td> 3~</td><td>51</td><td>41</td><td>80.4</td></tr><tr><td>The height of chair(cm)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt; 35</td><td>17</td><td>15</td><td>88.2</td><td rowspan="3">0.086</td><td rowspan="3">0.958</td></tr><tr><td>&gt; 50</td><td>21</td><td>19</td><td>90.5</td></tr><tr><td> 35&#8211;50</td><td>111</td><td>98</td><td>88.3</td></tr><tr><td>The height of desk (cm)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>&lt; 50</td><td>76</td><td>68</td><td>89.5</td><td rowspan="3">9.691</td><td rowspan="3">0.008</td></tr><tr><td>&gt; 72</td><td>50</td><td>48</td><td>96.0</td></tr><tr><td> 50&#8211;72</td><td>25</td><td>18</td><td>72.0</td></tr><tr><td>Legroom underneath the desk</td><td colspan="5"></td></tr><tr><td> Yes</td><td>111</td><td>96</td><td>86.5</td><td rowspan="2">1.906</td><td rowspan="2">0.240</td></tr><tr><td> No</td><td>38</td><td>36</td><td>94.7</td></tr><tr><td>Whether the keyboard and mouse at the same height</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Yes</td><td>137</td><td>120</td><td>87.6</td><td rowspan="2">1.681</td><td rowspan="2">0.362</td></tr><tr><td> No</td><td>12</td><td>12</td><td>100.0</td></tr><tr><td>Backrest</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Yes</td><td>45</td><td>36</td><td>80.0</td><td rowspan="2">3.610</td><td rowspan="2">0.069</td></tr><tr><td> No</td><td>46</td><td>43</td><td>93.5</td></tr></table>
becc62a63955c52d0f6914fd1c8c090ef86f450d0a6e3371ba13655e1a441750.png
complex
<table><tr><td rowspan="3"> </td><td colspan="5">Educational levels</td></tr><tr><td>Junior high school</td><td>High school</td><td>Junior or career college</td><td>University or higher education</td><td><i>P</i> for trend</td></tr><tr><td>Men</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Number of subjects</td><td>10 350</td><td>8437</td><td>1074</td><td>1968</td><td> </td></tr><tr><td> Age, years</td><td>50.5</td><td>48.1</td><td>47.5</td><td>46.7</td><td>&lt;0.001</td></tr><tr><td> Previous history of stroke, ischemic heart disease, or cancer, %</td><td>3.6</td><td>3.0</td><td>2.8</td><td>2.3</td><td>&lt;0.001</td></tr><tr><td> Current drinker, %</td><td>64.3</td><td>69.3</td><td>65.1</td><td>65.9</td><td>0.006</td></tr><tr><td> Current smoker, %</td><td>54.9</td><td>53.1</td><td>51.0</td><td>47.0</td><td>&lt;0.001</td></tr><tr><td> High perceived mental stress, %</td><td>20.0</td><td>29.3</td><td>33.9</td><td>43.8</td><td>&lt;0.001</td></tr><tr><td> Living with spouse, %</td><td>76.0</td><td>86.4</td><td>87.9</td><td>90.6</td><td>&lt;0.001</td></tr><tr><td> Full-time worker, %</td><td>96.0</td><td>97.4</td><td>97.8</td><td>97.8</td><td>&lt;0.001</td></tr><tr><td>Women</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Number of subjects</td><td>12 624</td><td>8894</td><td>2305</td><td>504</td><td> </td></tr><tr><td> Age, years</td><td>50.7</td><td>48.0</td><td>46.3</td><td>45.7</td><td>&lt;0.001</td></tr><tr><td> Previous history of stroke, ischemic heart disease, or cancer, %</td><td>4.1</td><td>3.3</td><td>3.9</td><td>3.1</td><td>0.08</td></tr><tr><td> Current drinker, %</td><td>9.0</td><td>11.0</td><td>11.0</td><td>10.2</td><td>&lt;0.001</td></tr><tr><td> Current smoker, %</td><td>7.6</td><td>6.8</td><td>6.5</td><td>6.5</td><td>0.02</td></tr><tr><td> High perceived mental stress, %</td><td>18.5</td><td>22.8</td><td>29.3</td><td>40.9</td><td>&lt;0.001</td></tr><tr><td> Living with spouse, %</td><td>69.6</td><td>81.6</td><td>81.6</td><td>83.2</td><td>&lt;0.001</td></tr><tr><td> Full-time worker, %</td><td>74.0</td><td>76.7</td><td>76.5</td><td>85.9</td><td>&lt;0.001</td></tr></table>
a96722b77b47b42248d6af7e2b566eed1f0175a928a4f02261704af3cb47fc59.png
complex
<table><tr><td>Participant characteristics</td><td>N (%)</td></tr><tr><td colspan="2">Gender</td></tr><tr><td> Men</td><td>1 (6)</td></tr><tr><td> Women</td><td>16 (94)</td></tr><tr><td>Mean age (years)</td><td>38 (range 30&#8211;47)</td></tr><tr><td>Mean age of allergic children (years)</td><td>3 (range 0.5-10)</td></tr><tr><td colspan="2">First health care contact</td></tr><tr><td> Emergency Department</td><td>10 (59)</td></tr><tr><td> Family Physician</td><td>4 (23)</td></tr><tr><td> Other</td><td>3 (18)</td></tr><tr><td colspan="2">Allergen associated with first reaction</td></tr><tr><td> Tree nuts</td><td>6 (35)</td></tr><tr><td> Peanuts</td><td>4 (24)</td></tr><tr><td> Fish</td><td>2 (12)</td></tr></table>
9a475df7b52c4af61baf53714780093a1bf1a02d336f8fc023a4f9b983dfcaf0.png
complex
<table><tr><td colspan="6">IC<sub>50</sub> (ng mL<sup>&#8722;1</sup>): median (values obtained with two independent experiments)</td></tr><tr><td></td><td>Fraction Weight (%)</td><td>Distribution of PnTX-G (%)</td><td>KB cells (72 h of incubation)</td><td>Neuro2A cells (24 h of incubation)</td><td>Undifferentiated Caco-2 cells (48 h of incubation)</td></tr><tr><td>F1</td><td>4.9</td><td>0</td><td>1023 (958, 1088)</td><td>N.R. (45%)</td><td>N.R. (44.5%)</td></tr><tr><td>F2</td><td>50.3</td><td>0</td><td>0.21 (0.18, 0.24)</td><td>11 (5&#8211;17)</td><td>N.R. (41.6%)</td></tr><tr><td>F3</td><td>26.5</td><td>100</td><td>2.59 (2.55, 2.63)</td><td>25 (44&#8211;6)</td><td>N.R. (42.6%)</td></tr><tr><td>F4</td><td>4.6</td><td>0</td><td>53.6 (45.4, 61.8)</td><td>575 (760&#8211;390)</td><td>N.R. (25.2%)</td></tr><tr><td>F5</td><td>13.8</td><td>0</td><td>62.7 (55.9, 69.5)</td><td>1140 (800&#8211;1480)</td><td>N.R. (41.1%)</td></tr></table>
9c1af9f2aa603d0f6159a93e2d758b8cc7bcc773d452517deaf571b5b90d5de9.png
simple
<table><tr><td>Question</td><td>Percent of responses correct (2011&#8211;2012)</td><td>Percent of responses correct (2012&#8211;2013)</td><td>Percent of responses correct (2013&#8211;2014)</td></tr><tr><td>There is no cure for asthma</td><td>80.8</td><td>84.9</td><td>90.3</td></tr><tr><td>Although asthma causes breathing problems, asthma episodes are not dangerous</td><td>93.8</td><td>96.4</td><td>97.9</td></tr><tr><td>Taking medications every day can help prevent an asthma episode</td><td>&#8211;</td><td>87.9</td><td>86.5</td></tr><tr><td>A person should take steroids for asthma to grow muscle mass for better athletic ability</td><td>86.8</td><td>89.7</td><td>91.2</td></tr><tr><td>Inhaled steroids have the same side effects as steroids taken by mouth</td><td>55.0</td><td>68.5</td><td>66.8</td></tr><tr><td>Very little can be done to reduce environmental triggers of asthma</td><td>69.0</td><td>76.1</td><td>78.2</td></tr><tr><td>Asthma medications are not addictive</td><td>51.4</td><td>55.9</td><td>66.6</td></tr><tr><td>People with asthma should not participate in sports</td><td>97.2</td><td>96.4</td><td>98.2</td></tr><tr><td>Asthma episodes always occur suddenly, without warning</td><td>71.5</td><td>78.1</td><td>84.4</td></tr><tr><td>Asthma can be caused by emotional stress or other psychological problems</td><td>31.9</td><td>82.0</td><td>83.6</td></tr><tr><td>A rescue or reliever medication (albuterol) helps during an asthma episode by making you breathe faster</td><td>47.6</td><td>63.3</td><td>65.1</td></tr></table>
8ac62725676875d146781f5694f83393e79ede61b5c675dcd039d51d862cad34.png
complex
<table><tr><td></td><td>No decrease in haemoglobin, <i>n</i> (%)</td><td>With a decrease in haemoglobin, <i>n</i> (%)</td></tr><tr><td>Celecoxib <i>N</i> = 872</td><td>841 (96.44)</td><td>31 (3.56)</td></tr><tr><td>Diclofenac <i>N</i> = 438</td><td>412 (94.06)</td><td>26 (5.94)</td></tr><tr><td></td><td colspan="2">OR = 1.71 (1.00&#8211;2.92)</td></tr></table>
ef6f1d8ea4e4a8799a44495d81a4ebb3f4372996612b5974e691bc4b78ebeab0.png
complex
<table><tr><td> </td><td colspan="2">NTM lung diseases patients (N = 84)</td><td colspan="2">Non-NTM BE patients (N = 47)</td><td><i>P </i>value</td></tr><tr><td>Any isolates</td><td>17 </td><td>(20.2%)</td><td>12 </td><td>(25.5%)</td><td>1.00</td></tr><tr><td>Single isolate in one patient</td><td>15 </td><td>(19.7%)</td><td>12 </td><td>(26.7%)</td><td>0.38</td></tr><tr><td><i>Klebsiella pneumoniae</i></td><td>4</td><td>(4.8%)</td><td>5</td><td>(10.6%)</td><td>0.28</td></tr><tr><td><i>Streptococcus pneumoniae</i></td><td>1</td><td>(1.2%)</td><td>1</td><td>(2.1%)</td><td>1.00</td></tr><tr><td><i>Streptococcus species</i>, <i>viridans</i> group</td><td>1</td><td>(1.2%)</td><td>0</td><td> </td><td>1.00</td></tr><tr><td>Methicillin-sensitive <i>Staphylococcus aureus</i></td><td>1</td><td>(1.2%)</td><td>0</td><td> </td><td>1.00</td></tr><tr><td>Methicillin-resistant <i>Staphylococcus aureus</i></td><td>2</td><td>(2.4%)</td><td>0</td><td> </td><td>0.54</td></tr><tr><td><i>Pseudomonas fluorescens</i></td><td>1</td><td>(1.2%)</td><td>0</td><td> </td><td>1.00</td></tr><tr><td><i>Pseudomonas putida</i></td><td>1</td><td>(1.2%)</td><td>0</td><td> </td><td>1.00</td></tr><tr><td><i>Pseudomonas aeruginosa</i></td><td>2</td><td>(2.4%)</td><td>5</td><td>(10.6%)</td><td>0.10</td></tr><tr><td><i>Aeromonas hydrophila</i></td><td>1</td><td>(1.2%)</td><td>1</td><td>(2.1%)</td><td>1.00</td></tr><tr><td><i>Neisseria species</i></td><td>1</td><td>(1.2%)</td><td>0</td><td> </td><td>1.00</td></tr><tr><td>Multiple microorganisms</td><td>2 </td><td>(2.4%)</td><td>0 </td><td> </td><td>0.54</td></tr><tr><td>Methicillin-sensitive <i>Staphylococcus aureus</i> and <i>Pseudomonas fluorescens</i></td><td>1</td><td>(1.2%)</td><td>0</td><td> </td><td>1.00</td></tr><tr><td>Methicillin-resistant <i>Staphylococcus aureus</i> and <i>Klebsiellapneumoniae</i></td><td>1</td><td>(1.2%)</td><td>0</td><td> </td><td>1.00</td></tr></table>
31cfdfacad74050631aa36354b7df556aa9250907c0a2a553374a60fda6f1ba8.png
complex
<table><tr><td>Disease condition</td><td colspan="2">No (<i>n</i>, %)</td><td colspan="2">Somewhat (<i>n</i>, %)</td><td colspan="2">Yes (<i>n</i>, %)</td></tr><tr><td>Endocrine disorders (diabetes mellitus, thyroid disease)</td><td>81</td><td>36.7 %</td><td>65</td><td>29.4 %</td><td>75</td><td>33.9 %</td></tr><tr><td>Acute coronary syndrome</td><td>3</td><td>1.4 %</td><td>41</td><td>18.6 %</td><td>177</td><td>80.1 %</td></tr><tr><td>Hypertension</td><td>119</td><td>54.1 %</td><td>60</td><td>27.3 %</td><td>41</td><td>18.6 %</td></tr><tr><td>Thromboembolic disease (DVT and PE)</td><td>65</td><td>29.4 %</td><td>53</td><td>24.0 %</td><td>103</td><td>46.6 %</td></tr><tr><td>Asthma/COPD</td><td>192</td><td>86.9 %</td><td>18</td><td>8.1 %</td><td>11</td><td>5.0 %</td></tr><tr><td>Trauma</td><td>76</td><td>34.5 %</td><td>61</td><td>27.7 %</td><td>83</td><td>37.7 %</td></tr><tr><td>Partner abuse</td><td>6</td><td>2.7 %</td><td>48</td><td>21.7 %</td><td>167</td><td>75.6 %</td></tr><tr><td>Carotid/vertebral artery dissections</td><td>162</td><td>73.6 %</td><td>35</td><td>15.9 %</td><td>23</td><td>10.5 %</td></tr><tr><td>Neurologic conditions (multiple sclerosis, myasthenia gravis, CVA, seizures, headache)</td><td>67</td><td>30.3 %</td><td>60</td><td>27.1 %</td><td>94</td><td>42.5 %</td></tr><tr><td>GI conditions (biliary disease, dyspepsia, IBS, appendicitis, abdominal pain)</td><td>55</td><td>24.9 %</td><td>64</td><td>29.0 %</td><td>102</td><td>46.2 %</td></tr><tr><td>Substance abuse</td><td>121</td><td>55.0 %</td><td>63</td><td>28.6 %</td><td>36</td><td>16.4 %</td></tr><tr><td>Depression/suicide</td><td>39</td><td>17.8 %</td><td>51</td><td>23.3 %</td><td>129</td><td>58.9 %</td></tr><tr><td>Urinary tract disorders</td><td>18</td><td>8.1 %</td><td>45</td><td>20.4 %</td><td>158</td><td>71.5 %</td></tr><tr><td>Sexually transmitted diseases</td><td>25</td><td>11.3 %</td><td>49</td><td>22.2 %</td><td>147</td><td>66.5 %</td></tr><tr><td>HIV/AIDS</td><td>144</td><td>65.5 %</td><td>46</td><td>20.9 %</td><td>30</td><td>13.6 %</td></tr><tr><td>Autoimmune disease</td><td>27</td><td>12.3 %</td><td>67</td><td>30.5 %</td><td>126</td><td>57.3 %</td></tr><tr><td>Pulmonary disease (sarcoidosis, PPH)</td><td>129</td><td>58.4 %</td><td>53</td><td>24.0 %</td><td>39</td><td>17.6 %</td></tr><tr><td>Osteoporosis/fracture management</td><td>41</td><td>18.6 %</td><td>44</td><td>19.9 %</td><td>136</td><td>61.5 %</td></tr><tr><td>Pain management</td><td>150</td><td>68.2 %</td><td>44</td><td>20.0 %</td><td>26</td><td>11.8 %</td></tr><tr><td>Pharmacokinetics</td><td>135</td><td>61.4 %</td><td>63</td><td>28.6 %</td><td>22</td><td>10.0 %</td></tr><tr><td>Communication styles</td><td>60</td><td>27.1 %</td><td>81</td><td>36.7 %</td><td>80</td><td>36.2 %</td></tr></table>
d2313a3e47fcefa7f94ec325273d14220c5d212a6c22550c98a68fb5deb84b94.png
simple
<table><tr><td></td><td>Explicit LearningGroup (n = 40)</td><td>Implicit Learning Group (n = 40)</td><td>ControlGroup (n = 40)</td></tr><tr><td>T1Intervention</td><td>30 side-step cutting trials -Detailed verbal instructions on performance will be given</td><td>30 side-step cutting trials - Best performance will be shown</td><td>30 side-step cutting trials -No feedback on performance will be given</td></tr><tr><td>T2Retention test (one week post intervention)</td><td>30 side-step cutting trials -No feedback on performance will be given</td><td>30 side-step cutting trials -No feedback on performance will be given</td><td>30 side-step cutting trials -No feedback on performance will be given</td></tr><tr><td>T3Retention test (one month post intervention)</td><td>30 side-step cutting trials -No feedback on performance will be given</td><td>30 side-step cutting trials -No feedback on performance will be given</td><td>30 side-step cutting trials -No feedback on performance will be given</td></tr></table>
33f7f80d295bb41fab74787d0792e22fb3bddd17f70e072f8b41a347c8b0caeb.png
complex
<table><tr><td>Population/Gender (N)</td><td colspan="7">G6PD variant allele frequency</td></tr><tr><td></td><td>Mahidol</td><td>Viangchan</td><td>Chinese 4</td><td>Union</td><td>Canton</td><td>Kaiping</td><td>Gaohe</td></tr><tr><td>Thai</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Male (84)</td><td>0.04</td><td>0.01</td><td>-</td><td>0.01</td><td>0.02</td><td>0.012</td><td>-</td></tr><tr><td>Female (233)</td><td>0.01</td><td>0.006</td><td>0.006</td><td>0.002</td><td>-</td><td>0.002</td><td>0.002</td></tr><tr><td>Burmese</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Male (11)</td><td>0.18</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Female (172)</td><td>0.07</td><td>-</td><td>-</td><td>-</td><td>-</td><td>0.003</td><td>-</td></tr></table>
c1a904d6c0069fde146e82a237f4d4b594619df61ef7c2b73f10a698631cc19a.png
simple
<table><tr><td>Models</td><td>BM</td><td>GM-A</td><td>GM-B</td><td>LRM-1</td><td>LRM-2</td></tr><tr><td>BM</td><td>100 % (46)</td><td>78 % (36)</td><td>74 % (34)</td><td>76 % (35)</td><td>76 % (35)</td></tr><tr><td>GM-A</td><td>.</td><td>100 % (46)</td><td>96 % (44)</td><td>87 % (40)</td><td>91 % (42)</td></tr><tr><td>GM-B</td><td>.</td><td>.</td><td>100 % (46)</td><td>87 % (40)</td><td>91 % (42)</td></tr><tr><td>LRM-1</td><td>.</td><td>.</td><td>.</td><td>100 % (46)</td><td>96 % (44)</td></tr><tr><td>LRM-2</td><td>.</td><td>.</td><td>.</td><td>.</td><td>100 % (46)</td></tr></table>
e9ef5d1fca18cbda8134cc90c1c9339787580ca96eb9bdf917b763b16981eb6b.png
simple
<table><tr><td>Demographic information</td><td>Patients</td></tr><tr><td>Sex Ratio</td><td>12 women and 7 men</td></tr><tr><td>Age (years)</td><td>56 &#177; 8.96</td></tr><tr><td>Height (cm)</td><td>164.52 &#177; 5.09</td></tr><tr><td>Weight (kg)</td><td>76.52 &#177; 12.87</td></tr><tr><td>BMI (Kg/m<sup>2</sup>)</td><td>28.33 &#177; 4.65</td></tr><tr><td>Diabetic History (years)</td><td>11.84 &#177; 6.93</td></tr></table>
08661e8f83016a8ad1d000ca197a20bcf642af16fab6d164ea0db18ad3ec159b.png
complex
<table><tr><td></td><td><i>A. niger</i> DS03043</td><td><i>A. niger</i> CBS513.88</td></tr><tr><td colspan="3">A</td></tr><tr><td> &#956; (h<sup>&#8722;1</sup>)</td><td>0.14 &#177; 0.01</td><td>0.10 &#177; 0.01</td></tr><tr><td> q<sub>S</sub> (mmol/gDCW h)</td><td>1.83 &#177; 0.01</td><td>1.46 &#177; 0.01</td></tr><tr><td> q<sub>GA</sub> (&#956;mol/gDCW h)<sup>a</sup></td><td>0.40 &#177; 0.03</td><td>0.05 &#177; 0.00</td></tr><tr><td> q<sub>CIT</sub> (mmol/gDCW h)</td><td>0.02 &#177; 0.00</td><td>0.11 &#177; 0.01</td></tr><tr><td> q<sub>OA</sub> (mmol/gDCW h)</td><td>0.11 &#177; 0.01</td><td>0.35 &#177; 0.02</td></tr><tr><td> q<sub>O2</sub> (mmol/gDCW h)</td><td>2.94 &#177; 0.03</td><td>2.67 &#177; 0.02</td></tr><tr><td> q<sub>CO2</sub> (mmol/gDCW h)</td><td>3.21 &#177; 0.02</td><td>2.79 &#177; 0.05</td></tr><tr><td colspan="3">B</td></tr><tr><td> Y<sub>X/S</sub> (mmol/mmol)</td><td>0.49 &#177; 0.03</td><td>0.47 &#177; 0.02</td></tr><tr><td> Y<sub>GA/S</sub> (mmol/mmol)</td><td>0.12 &#177; 0.01</td><td>0.02 &#177; 0.00</td></tr><tr><td> Y<sub>CIT/S</sub> (mmol/mmol)</td><td>0.01 &#177; 0.00</td><td>0.07 &#177; 0.01</td></tr><tr><td> Y<sub>OA/S</sub> (mmol/mmol)</td><td>0.02 &#177; 0.00</td><td>0.07 &#177; 0.01</td></tr><tr><td> Y<sub>CO2/S</sub> (mmol/mmol)</td><td>0.30 &#177; 0.02</td><td>0.32 &#177; 0.03</td></tr><tr><td> Carbon recovery</td><td>94 %</td><td>95 %</td></tr></table>
a3bab1742c70aa981ca412e19fa98ce9bf468622499ef4975d4c2b2cd0f784d6.png
simple
<table><tr><td>Axillary vs. tympanic temperature</td><td>Correlation Coefficient</td><td>Bias &#177; SD</td><td>95% CI</td><td>Limits of agreement</td></tr><tr><td> </td><td>0.697</td><td>&#8722;0.093 &#177; 0.72</td><td>&#8722;0.20; 0.02</td><td>&#8722;1.54 to 1.36</td></tr></table>
a71bf353944f4b75210260f37f2fbef1bfc8278797999e067a25a6251e8ee037.png
simple
<table><tr><td></td><td>Carbon Monoxide (ppm)</td><td>CO StdDev (ppm)</td><td>Nicotine (mg/m3)</td><td>Gravimetric TSP (mg/m3)</td><td>TSP StdDev (mg/m3)</td></tr><tr><td>Day 1</td><td>157.73</td><td>11.04</td><td></td><td>41.31</td><td>2.29</td></tr><tr><td>Day 2</td><td>172.50</td><td>11.37</td><td></td><td>50.55</td><td>3.36</td></tr><tr><td>Day 3</td><td>217.27</td><td>7.86</td><td>12.10</td><td>65.76</td><td>3.26</td></tr><tr><td>Day 4</td><td>216.36</td><td>11.42</td><td></td><td>63.77</td><td>7.60</td></tr><tr><td>Day 5</td><td>230.91</td><td>18.41</td><td></td><td>70.47</td><td>7.75</td></tr><tr><td>Day 8</td><td>243.64</td><td>8.69</td><td></td><td>75.00</td><td>6.05</td></tr><tr><td>Day 9</td><td>240.00</td><td>10.00</td><td></td><td>73.67</td><td>2.55</td></tr><tr><td>Day 10</td><td>264.09</td><td>5.84</td><td>13.70</td><td>83.58</td><td>3.02</td></tr><tr><td>Day 11</td><td>263.33</td><td>6.61</td><td></td><td>82.61</td><td>6.15</td></tr><tr><td>Day 12</td><td>265.91</td><td>13.75</td><td></td><td>85.51</td><td>7.67</td></tr><tr><td>Day 15</td><td>255.00</td><td>11.55</td><td></td><td>83.57</td><td>3.99</td></tr><tr><td>Day 16</td><td>229.09</td><td>8.01</td><td></td><td>75.12</td><td>3.43</td></tr><tr><td>Day 17</td><td>166.25</td><td>9.16</td><td></td><td>48.31</td><td>6.33</td></tr><tr><td>Day 18</td><td>167.14</td><td>3.93</td><td></td><td>50.48</td><td>2.33</td></tr><tr><td>Day 19</td><td>188.64</td><td>8.39</td><td>9.40</td><td>56.28</td><td>2.74</td></tr><tr><td>Day 22</td><td>230.00</td><td>9.57</td><td></td><td>63.77</td><td>3.84</td></tr><tr><td>Day 23</td><td>205.71</td><td>14.84</td><td></td><td>64.73</td><td>5.44</td></tr><tr><td>Day 24</td><td>213.18</td><td>6.03</td><td></td><td>71.38</td><td>2.81</td></tr><tr><td>Day 25</td><td>214.44</td><td>3.91</td><td>10.40</td><td>71.01</td><td>1.45</td></tr><tr><td>Day 26</td><td>211.82</td><td>5.13</td><td></td><td>73.43</td><td>3.02</td></tr><tr><td>Day 29</td><td>215.00</td><td>2.89</td><td></td><td>68.36</td><td>7.69</td></tr><tr><td>Day 30</td><td>213.64</td><td>3.23</td><td></td><td>66.36</td><td>1.67</td></tr><tr><td>Day 31</td><td>216.67</td><td>6.12</td><td></td><td>66.67</td><td>2.62</td></tr><tr><td>Day 32</td><td>233.64</td><td>7.45</td><td>8.80</td><td>80.44</td><td>8.17</td></tr><tr><td>Day 33</td><td>235.56</td><td>11.30</td><td></td><td>74.16</td><td>5.81</td></tr><tr><td>Day 36</td><td>231.36</td><td>8.97</td><td></td><td>71.74</td><td>2.51</td></tr><tr><td>Day 37</td><td>234.00</td><td>15.78</td><td>11.90</td><td>62.56</td><td>3.58</td></tr><tr><td>Day 38</td><td>244.09</td><td>16.40</td><td></td><td>69.56</td><td>5.07</td></tr><tr><td>Day 39</td><td>237.73</td><td>6.84</td><td>11.90</td><td>82.97</td><td>4.68</td></tr><tr><td>Day 40</td><td>232.73</td><td>5.18</td><td></td><td>71.50</td><td>7.26</td></tr><tr><td>Day 43</td><td>252.78</td><td>11.76</td><td></td><td>65.94</td><td>6.91</td></tr><tr><td>Day 44</td><td>239.55</td><td>8.50</td><td>9.70</td><td>81.64</td><td>5.86</td></tr><tr><td>Day 45</td><td>238.33</td><td>5.59</td><td></td><td>82.61</td><td>4.75</td></tr><tr><td>Day 46</td><td>247.50</td><td>6.12</td><td></td><td>76.54</td><td>6.79</td></tr><tr><td>Day 47</td><td>256.67</td><td>4.08</td><td></td><td>73.14</td><td>6.22</td></tr><tr><td>Mean:</td><td>225.21</td><td>8.73</td><td>10.86</td><td>70.11</td><td>4.7</td></tr><tr><td>StDev</td><td>27.87</td><td>3.91</td><td>1.76</td><td>10.82</td><td>2.04</td></tr></table>
4f319f889ea69f419f1328c6b0a0989f6cf731ee61a8fa6c0be27b2b92baeef4.png
complex
<table><tr><td></td><td colspan="4">Overall cohort</td><td colspan="4">PS-matched cohort</td></tr><tr><td></td><td>Group A</td><td>Group B</td><td>Difference Group B &#8211; Group A</td><td><i>p</i></td><td>Group A</td><td>Group B</td><td>Difference Group B &#8211; Group A</td><td><i>p</i></td></tr><tr><td>n. GP Visits mean (&#177;SE)</td><td>0.84 (&#177;0.09)</td><td>0.38 (&#177;0.12)</td><td>-0.46</td><td>&lt;0.001</td><td>0.85 (&#177;0.15)</td><td>0.38 (&#177;0.12)</td><td>-0.47</td><td>&lt;0.001</td></tr><tr><td>Specialist visits mean (&#177;SE)</td><td>0.66 (&#177;0.08)</td><td>0.28 (&#177;0.07)</td><td>-0.38</td><td>&lt;0.001</td><td>0.68 (&#177;0.11)</td><td>0.28 (&#177;0.07)</td><td>-0.40</td><td>&lt;0.001</td></tr><tr><td>n. Hospitalizations mean (&#177;SE)</td><td>0.13 &#177; 0.04</td><td>0.08 &#177; 0.04</td><td>-0.05</td><td>0.372</td><td>0.15 &#177; 0.06</td><td>0.08 &#177; 0.04</td><td>-0.08</td><td>0.11</td></tr><tr><td>Days of Hospitalizations mean (&#177;SE)</td><td>0.19 &#177; 0.07</td><td>0.08 &#177; 0.04</td><td>-0.12</td><td>0.348</td><td>0.28 &#177; 0.12</td><td>0.08 &#177; 0.04</td><td>-0.20</td><td>0.09</td></tr><tr><td>n. Relapses mean (&#177;SE)</td><td>0.53 (&#177;0.08)</td><td>0.28 (&#177;0.07)</td><td>-0.26</td><td>0.106</td><td>0.53 (&#177;0.12)</td><td>0.28 (&#177;0.07)</td><td>-0.25</td><td>0.12</td></tr><tr><td>Days of inactivity mean (&#177;SE)</td><td>1.62 (&#177;0.26)</td><td>0.68 (&#177;0.20)</td><td>-0.95</td><td>0.088</td><td>1.53 (&#177;0.37)</td><td>0.68 (&#177;0.20)</td><td>-0.85</td><td>0.12</td></tr></table>
76f1a84f8b9ac036cb667a5200b183a960d5b6d3b3ac84d120b0e4ae495e37d4.png
simple
<table><tr><td>Characteristics</td><td>Categories</td><td>Crude riskratios</td><td>95% confidence intervals</td><td>P-value</td></tr><tr><td>Women&#8217;s age (years)</td><td>13-19</td><td>1.00</td><td></td><td></td></tr><tr><td></td><td>20-24 </td><td>0.96</td><td>0.33 - 2.79 </td><td>0.942</td></tr><tr><td></td><td>25-29 </td><td>1.50</td><td>0.51 - 4.40 </td><td>0.460</td></tr><tr><td></td><td>30-34</td><td>4.43</td><td>1.30 - 15.09</td><td>0.017</td></tr><tr><td></td><td>35 and above</td><td>28.5</td><td>2.97 - 273.31 </td><td>0.004 </td></tr><tr><td>Parity</td><td>Multiparous </td><td>1.00</td><td></td><td></td></tr><tr><td></td><td>Primigravidae </td><td>0.26</td><td>0.13 - 0.50 </td><td>&lt; 0.001 </td></tr><tr><td>Women&#8217;s <i>KIR</i> genotype</td><td>Not <i>KIR AA</i></td><td>1.00</td><td></td><td></td></tr><tr><td></td><td><i>KIR AA</i></td><td>1.18</td><td>0.63 - 2.20</td><td>0.608 </td></tr><tr><td>Gestational age (weeks)</td><td>24-34 </td><td>1.00</td><td></td><td></td></tr><tr><td></td><td>35-37</td><td>0.52</td><td>0.23 -1.18</td><td>0.120</td></tr><tr><td></td><td>38 and above</td><td>0.32</td><td>0.15 - 0.67</td><td>0.003 </td></tr><tr><td>HIV status</td><td>Negative</td><td>1.00</td><td></td><td></td></tr><tr><td></td><td>Positive</td><td>10.42 </td><td>1.19 - 91.23 </td><td>0.034 </td></tr><tr><td>Urine protein level at recruitment</td><td>2+</td><td>1.00</td><td></td><td></td></tr><tr><td></td><td>3+</td><td>0.91</td><td>0.41- 2.01</td><td>0.815</td></tr><tr><td></td><td>4+</td><td>1.76</td><td>0.84 - 3.69</td><td>0.132 </td></tr><tr><td>Previous hypertension in pregnancy</td><td>No</td><td>1.00</td><td></td><td></td></tr><tr><td></td><td>Yes</td><td>0.79</td><td>0.30 - 2.08</td><td>0.633</td></tr><tr><td></td><td>No prior pregnancy</td><td>0.25</td><td>0.12 - 0.49</td><td>&lt; 0.001 </td></tr><tr><td>Severity of pre-eclampsia</td><td>Mild </td><td>1.00</td><td></td><td></td></tr><tr><td></td><td>Severe </td><td>3.85 </td><td>1.69 - 8.80 </td><td>0.001 </td></tr></table>
dd918547dd608e187fa8299e08647f0c910f05bf43e10905213b1da0d7aa8d0c.png
simple
<table><tr><td><i>Isolate</i></td><td><i>Geographic origin</i></td><td><i>Year</i></td><td><i>Source</i>a</td><td><i>Alternative ID</i></td><td><i>GenBank/ EBI accession number</i></td></tr><tr><td>Rs 10</td><td>New Brunswick, Canada</td><td>2009</td><td><i>Salmo salar</i> (sw)</td><td> </td><td>ERR327945</td></tr><tr><td>Rs 2</td><td>New Brunswick, Canada</td><td>2005</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327951</td></tr><tr><td>Rs 3</td><td>New Brunswick, Canada</td><td>2005</td><td><i>S. salar</i> (fw)</td><td> </td><td>ERR327947</td></tr><tr><td>Rs 4</td><td>New Brunswick, Canada</td><td>2006</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327946</td></tr><tr><td>Rs 5</td><td>New Brunswick, Canada</td><td>2007</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327950</td></tr><tr><td>Rs 6</td><td>New Brunswick, Canada</td><td>2007</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327953</td></tr><tr><td>Rs 8</td><td>New Brunswick, Canada</td><td>2008</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327944</td></tr><tr><td>BPS 91</td><td>Nanaimo, BC, Canada</td><td>1991</td><td><i>Oncorhynchus gorbuscha</i></td><td> </td><td>ERR327952</td></tr><tr><td>BQ96 91-1</td><td>Nanaimo, BC, Canada</td><td>1996</td><td><i>Oncorhynchus kisutch</i></td><td> </td><td>ERR327963</td></tr><tr><td>DR143</td><td>Alberta, Canada</td><td>1972</td><td><i>Salvelinus fontinalis (</i>fw)b</td><td> </td><td>ERR327954</td></tr><tr><td>5006</td><td>Bella Bella, BC, Canada</td><td>1996</td><td><i>O. kisutch</i> (sw)</td><td>960046</td><td>ERR327942</td></tr><tr><td>5223</td><td>Kvinnherad, Hordaland, Norway</td><td>2005</td><td><i>S. salar</i> (sw)</td><td>2005-50-579</td><td>ERR327964</td></tr><tr><td>6553</td><td>Hemne, S&#248;r-Tr&#248;ndelag, Norway</td><td>2008</td><td><i>S. salar</i> (sw)</td><td>2008-09-495</td><td>ERR327955</td></tr><tr><td>6642</td><td>Hemne, S&#248;r-Tr&#248;ndelag, Norway</td><td>2008</td><td><i>S. salar</i></td><td>2008-06-633</td><td>ERR327956</td></tr><tr><td>6694</td><td>Hemne, S&#248;r-Tr&#248;ndelag, Norway</td><td>2008</td><td><i>Oncorhynchus mykiss</i> (sw)</td><td> </td><td>ERR327962</td></tr><tr><td>6695</td><td>Hemne, S&#248;r-Tr&#248;ndelag, Norway</td><td>2008</td><td><i>O. mykiss</i> (sw)</td><td>2008-06-631</td><td>ERR327968</td></tr><tr><td>6863</td><td>Oster&#248;y, Hordaland, Norway</td><td>2009</td><td><i>O. mykiss</i> (sw)</td><td> </td><td>ERR327965</td></tr><tr><td>7439</td><td>Sognefjorden, Sogn og Fjordane, Norway</td><td>1984</td><td><i>S. salar</i></td><td>1984-40.992</td><td>ERR327971</td></tr><tr><td>7441</td><td>Storfjord, M&#248;re og Romsdal, Norway</td><td>1985</td><td><i>S. salar</i></td><td>1985-09-667</td><td>ERR327966</td></tr><tr><td>7448</td><td>Stranda, M&#248;re og Romsdal, Norway</td><td>1986</td><td><i>S. salar</i></td><td>1986-09-4366</td><td>ERR327970</td></tr><tr><td>7449</td><td>Skjerv&#248;y, Troms, Norway</td><td>1987</td><td><i>S. salar</i></td><td>1987-09-932</td><td>ERR327969</td></tr><tr><td>7450</td><td>Ask&#248;y, Hordaland, Norway</td><td>1987</td><td><i>S. salar</i></td><td>1987-09-1185</td><td>ERR327967</td></tr><tr><td>684</td><td>Aurland, Sognefjorden, Norway</td><td>1987</td><td><i>S. trutta</i> (fw)</td><td> </td><td>ERR327958</td></tr><tr><td>1205</td><td>UK</td><td>2001</td><td><i>O. mykiss</i></td><td>3104-67</td><td>ERR327930</td></tr><tr><td>5007</td><td>Scotland</td><td>2005</td><td><i>O. mykiss</i></td><td>0180-18</td><td>ERR327923</td></tr><tr><td>7105</td><td>UK</td><td>2007</td><td><i>O. mykiss</i> (fw)</td><td>P0416 T83 10-3 2</td><td>ERR327932</td></tr><tr><td>9025</td><td>Yorkshire, England, UK</td><td>2009</td><td><i>O. mykiss</i> (fw)</td><td>16251-1</td><td>ERR327912</td></tr><tr><td>96071</td><td>England, Hampshire, site Z, UK</td><td>1996</td><td><i>O. mykiss</i> (fw)</td><td> </td><td>ERR327927</td></tr><tr><td>99326</td><td>Wales, site Y, UK</td><td>1999</td><td><i>O. mykiss</i> (fw)</td><td>2119-8</td><td>ERR327938</td></tr><tr><td>99327</td><td>UK</td><td>1997</td><td><i>O. mykiss</i> (fw)</td><td>970313-2</td><td>ERR327931</td></tr><tr><td>99329</td><td>Wales, site X, UK</td><td>1998</td><td><i>O. mykiss</i> (fw)</td><td>980036-125</td><td>ERR327937</td></tr><tr><td>99332</td><td>Wales, site Y, UK</td><td>1999</td><td><i>O. mykiss</i> (fw)</td><td>2119-3</td><td>ERR327943</td></tr><tr><td>99333</td><td>Wales, site X, UK</td><td>1998</td><td><i>O. mykiss</i> (fw)</td><td>980036-102</td><td>ERR327921</td></tr><tr><td>99341</td><td>Hampshire, site Z, England, UK</td><td>1998</td><td><i>O. mykiss</i> (fw)</td><td>980109-20</td><td>ERR327949</td></tr><tr><td>99344</td><td>Hampshire, England, UK</td><td>1998</td><td><i>O. mykiss</i> (fw)</td><td>980106-1.1.5</td><td>ERR327940</td></tr><tr><td>99345</td><td>Wales, site X</td><td>1998</td><td><i>O. mykiss</i> (fw)</td><td>980070-18</td><td>ERR327948</td></tr><tr><td>NCIMB 1114</td><td>River Dee, Scotland, UK</td><td>1962</td><td><i>S. salar</i> (fw)b</td><td>5005</td><td>ERR327908</td></tr><tr><td>NCIMB 1116</td><td>River Dee, Scotland, UK</td><td>1962</td><td><i>S. salar</i> (fw)b</td><td>96056</td><td>ERR327907</td></tr><tr><td>MT239</td><td>Scotland, UK</td><td>1988</td><td><i>S. salar</i></td><td> </td><td>ERR327913</td></tr><tr><td>MT1363</td><td>Strathclyde, Scotland, UK</td><td>1993</td><td><i>O. mykiss</i> (sw)</td><td> </td><td>ERR327920</td></tr><tr><td>MT3277</td><td>Dumfries and Galloway Site A, Scotland,UK</td><td>2008</td><td><i>O. mykiss</i> (fw)</td><td> </td><td>ERR327926</td></tr><tr><td>MT3313</td><td>Central, Scotland, UK</td><td>2008</td><td><i>O. mykiss</i> (fw)</td><td> </td><td>ERR327925</td></tr><tr><td>MT3315</td><td>Strathclyde Site B, Scotland, UK</td><td>2008</td><td><i>O. mykiss</i> (fw)</td><td> </td><td>ERR327928</td></tr><tr><td>MT1262</td><td>Highlands, Scotland, UK</td><td>1992</td><td><i>S. salar</i> (fw)</td><td> </td><td>ERR327922</td></tr><tr><td>MT1351</td><td>Highlands, Scotland, UK</td><td>1993</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327904</td></tr><tr><td>MT1470</td><td>Tayside, Scotland, UK</td><td>1994</td><td><i>O. mykiss</i> (fw)</td><td> </td><td>ERR327910</td></tr><tr><td>MT1511</td><td>Strathclyde Site B, Scotland, UK</td><td>1994</td><td><i>O. mykiss</i> (fw)</td><td> </td><td>ERR327914</td></tr><tr><td>MT1880</td><td>Strathclyde, Scotland, UK</td><td>1996</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327909</td></tr><tr><td>MT2622</td><td>Strathclyde, Scotland, UK</td><td>2002</td><td><i>O. mykiss</i> (sw)</td><td> </td><td>ERR327929</td></tr><tr><td>MT2943</td><td>Highlands, Scotland, UK</td><td>2005</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327936</td></tr><tr><td>MT2979</td><td>Highlands, Scotland, UK</td><td>2005</td><td><i>O. mykiss</i> (fw)</td><td> </td><td>ERR327935</td></tr><tr><td>MT3106</td><td>Strathclyde, Scotland, UK</td><td>2006</td><td><i>O. mykiss</i> (fw)</td><td> </td><td>ERR327939</td></tr><tr><td>MT3479</td><td>Orkney, Scotland, UK</td><td>2008</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327933</td></tr><tr><td>MT3482</td><td>Strathclyde, Scotland, UK</td><td>2009</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327934</td></tr><tr><td>MT3483</td><td>Strathclyde, Scotland, UK</td><td>2009</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327941</td></tr><tr><td>MT444</td><td>Western Isles, Scotland, UK</td><td>1988</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327916</td></tr><tr><td>MT452</td><td>Dumfries and Galloway Site A, Scotland,UK</td><td>1988</td><td><i>O. mykiss</i> (fw)</td><td> </td><td>ERR327918</td></tr><tr><td>MT839</td><td>Highlands, Scotland, UK</td><td>1990</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327917</td></tr><tr><td>MT861</td><td>Scotland</td><td>1990</td><td><i>S. salar</i> (sw)</td><td> </td><td>ERR327919</td></tr><tr><td>Car 96</td><td>Washington State, USA</td><td>1996</td><td><i>O. tshawytscha</i></td><td> </td><td>ERR327957</td></tr><tr><td>D6</td><td>Oregon, USA</td><td>1982</td><td><i>O. tshawytscha</i></td><td> </td><td>ERR327961</td></tr><tr><td>GR5</td><td>Montana, USA</td><td>1997</td><td><i>T. thymallus</i> (fw)b</td><td>980036-87</td><td>ERR327959</td></tr><tr><td>WR99 c2</td><td>Washington State, USA</td><td>1999</td><td><i>O. kisutch</i></td><td> </td><td>ERR327960</td></tr><tr><td>NCIMB 2235</td><td>Oregon, USA</td><td>1974</td><td><i>O. tshawytscha</i> (sw)</td><td>ATCC33209</td><td>ERR327911</td></tr><tr><td>05372K</td><td>Grande Ronde Basin, Oregon, USA</td><td>2005</td><td><i>O. tshawytscha</i> (sw)</td><td> </td><td>ERR327906</td></tr><tr><td>Carson 5b</td><td>Confluence Tyee Creek &amp; Wind River, WA, USA</td><td>1994</td><td><i>O. tshawytscha</i> (fw)</td><td> </td><td>ERR327905</td></tr><tr><td>Cow-chs-94</td><td>Cowlitz River, Washington</td><td>1994</td><td><i>O. tshawytscha</i> (fw)</td><td> </td><td>ERR327915</td></tr><tr><td>ATCC 33209c</td><td>Oregon, USA</td><td>1974</td><td><i>O. tshawytscha</i> (sw)</td><td> </td><td>NC_010168.1</td></tr><tr><td>NCIMB 1111d</td><td>&#8212;</td><td>Not known</td><td>Not known</td><td>5004</td><td>ERR327924</td></tr></table>
e739e8d18558dbe8e0ea74df4740246c44a4125df6f88d15a6cde2ddc25a0dcf.png
complex
<table><tr><td>Location, study period (reference)</td><td>PM size</td><td>Type of fuel</td><td>Mean (&#956;g/m<sup>3</sup>)</td><td>Notes</td></tr><tr><td colspan="5">China</td></tr><tr><td>Shenyang, China, May 2006 (this study)</td><td>PM<sub>10</sub></td><td>Crop residue</td><td>Total: 100.6Cooking times: 202.1</td><td>Based on ~14 hr/day (0530&#8211;1930) for 5 consecutive days3 households</td></tr><tr><td>Jilan, China, Nov&#8211;Dec 2001, Feb&#8211;Mar 2003, 2004 (Fischer and Koshland 2007)</td><td>PM<sub>4</sub></td><td>Multiple fuels: coal, biomass, gas, electricity</td><td>Daily average: 3121-hr peak: 1,880</td><td>Based on 24-hr periods and 1-hr peak values70 household-days37 households</td></tr><tr><td>Gansu, China, Mar&#8211;Apr 2003, Dec 2003&#8211;Jan 2004 (Jin et al. 2005)</td><td>PM<sub>4</sub></td><td>Wood and crop residue</td><td>Mar&#8211;Apr 2003: 518Dec 2003&#8211;Jan 2004: 661</td><td>Based on 24-hr/day periodsMar&#8211;Apr 2003: 72 households with 1 day of measurement, 6 households with 4 days of measurementDec 2003&#8211;Jan 2004: 17 households with 1 day of measurement, 6 households with 2&#8211;3 days of measurement</td></tr><tr><td>Guizhou, China, Mar&#8211;Apr 2003, Dec 2003&#8211;Jan 2004 (Jin et al. 2005)</td><td>PM<sub>4</sub></td><td>Coal, wood, and crop residue</td><td>Mar&#8211;Apr 2003: 352Dec 2003&#8211;Jan 2004: 301</td><td>Based on 24-hr/day periodsMar&#8211;Apr 2003: 76 households with 1 day of measurement, 7 households with 2&#8211;4 days of measurementDec 2003&#8211;Jan 2004: 16 households with 1 day of measurement, 6 households with 2&#8211;3 days of measurement</td></tr><tr><td>Inner Mongolia, China, Dec 2003&#8211;Jan 2004 (Jin et al. 2005)</td><td>PM<sub>4</sub></td><td>Wood and crop residue</td><td>718</td><td>Based on 24-hr/day periods49 households with 1 day of measurement, 4 households with 3 days of measurement</td></tr><tr><td>Shaanxi, China, Mar&#8211;Apr 2003, Dec 2003&#8211;Jan 2004 (Jin et al. 2005)</td><td>PM<sub>4</sub></td><td>50% coal, 50% wood and crop residue</td><td>Mar&#8211;Apr 2003: 187Dec 2003&#8211;Jan 2004: 223</td><td>Based on 24-hr/day periodsMar&#8211;Apr 2003: 75 households with 1 day of measurement, 6 households with 4 days of measurementDec 2003&#8211;Jan 2004: 18 households with 1 day of measurement, 6 households with 3 days of measurement</td></tr><tr><td>Guizhou, China, Jan 2003 (He et al. 2005)</td><td>PM<sub>4</sub></td><td>Coal (3 households), coal and biomass (1 household)</td><td>1,944</td><td>Based on 24-hr/day periods for 4 consecutive days4 households</td></tr><tr><td>Shaanxi, China, Feb 2003 (He et al. 2005)</td><td>PM<sub>4</sub></td><td>Coal and biomass for cooking, coal for heating</td><td>205</td><td>Based on 24-hr/day periods for 4 consecutive days4 households</td></tr><tr><td>Zhejiang, Hubei, and Shaanxi, China, Jun&#8211;Aug 2002, Dec 2002&#8211;Jan 2003 (Edwards et al. 2007)</td><td>PM<sub>4</sub></td><td>Crop residues</td><td>Summer: 282.9Winter: 456.4</td><td>Based on 24-hr periods48 households for summer, 25 for winter</td></tr><tr><td colspan="5">Bolivia</td></tr><tr><td>Cantuyo, Jan 1994&#8211;Oct 1995 (Albalak et al. 1999)</td><td>PM<sub>10</sub></td><td>Dung</td><td>1,830</td><td>Based on 6-hr periods (0500&#8211;1100)/day every 6 days for 3 consecutive weeks for each month of study period12 households</td></tr><tr><td colspan="5">India</td></tr><tr><td>Pauri District, Garhwal Himalaya, northern India, Aug 1989&#8211;Jul 1990 (Saksena et al. 1992)</td><td>TSP</td><td>Wood</td><td>Cooking times: 5,600Noncooking times: 820</td><td>Based on 15-hr periods12 households</td></tr><tr><td>Tamil Nadu, southern India, Jul&#8211;Dec 1999 (Balakrishnan et al. 2002)</td><td>PM<sub>4</sub></td><td>Wood and crop residue</td><td>Indoor kitchen without partitions: 1,442Kitchen with partitions: 970</td><td>Based on 10- to 12-hr/day periods for 1&#8211;3 daysWithout partitions: 105 householdsWith partitions: 68 households</td></tr><tr><td>Andhra Pradesh, southern India, Jan&#8211;May 2001 (Balakrishnan et al. 2004)</td><td>PM<sub>4</sub></td><td>WoodDung</td><td>Wood: 500Dung: 732</td><td>Based on 22- to 24-hr/day sampling periods for 3&#8211;4 daysWood: 270 householdsDung: 97 households</td></tr><tr><td colspan="5">Guatemala</td></tr><tr><td>Quetzaltenango, May&#8211;Nov 1993 (Naeher et al. 2000)</td><td>PM<sub>2.5</sub>PM<sub>10</sub>TSP</td><td>Wood</td><td>PM<sub>2.5</sub>: 527.9,a 96.5bPM<sub>10</sub>: 717.1,a 186.3bTSP: 835.8,a 275.5b</td><td>Based on three 22-hr sampling periods3 households</td></tr><tr><td>La Victoria, Jan 1999 (Bruce et al. 2004)</td><td>PM<sub>3.5</sub></td><td>Wood and crop residue</td><td>1,019a351b</td><td>Based on one 24-hr measurement/ household11 households with open fires, 5 with planchas</td></tr><tr><td>La Victoria, Dec 1998&#8211;Jul 1999 (Albalak et al. 2001)</td><td>PM<sub>3.5</sub></td><td>Wood</td><td>1,560a280b</td><td>Based on 24-hr measurements taken 6 times at 1-month intervals10 households of each stove type</td></tr></table>
97b7dd1c7bdc7450a50bbe67e2ec3fe1a9cc7a22fc51e355abf27e0d5193cb6e.png
simple
<table><tr><td></td><td>Coefficient</td><td>Standard error</td><td><i>P</i></td><td>Adjusted <i>R</i><sup>2</sup></td></tr><tr><td><i>Overall survival</i></td><td></td><td></td><td></td><td></td></tr><tr><td>Sampling time</td><td>0.2797</td><td>0.1995</td><td>0.18</td><td>4.16%</td></tr><tr><td>Metastatic status</td><td>&#8722;0.0362</td><td>0.1089</td><td>0.744</td><td>&#8722;11.16%</td></tr><tr><td>Sample size</td><td>&#8722;0.0006</td><td>0.0006</td><td>0.401</td><td>2.35%</td></tr><tr><td>Cut-off value</td><td>0.0020</td><td>0.0016</td><td>0.229</td><td>23.59%</td></tr><tr><td>Country</td><td>0.0277</td><td>0.1945</td><td>0.889</td><td>&#8722;11.56%</td></tr><tr><td>Study quality</td><td>&#8722;0.0316</td><td>0.1196</td><td>0.795</td><td>&#8722;9.52%</td></tr><tr><td><i>Disease-free survival</i></td><td></td><td></td><td></td><td></td></tr><tr><td>Sampling time</td><td>0.2377</td><td>0.4092</td><td>0.579</td><td>&#8722;14.75%</td></tr><tr><td>Metastatic status</td><td>&#8722;0.0380</td><td>0.2159</td><td>0.865</td><td>&#8722;19.67%</td></tr><tr><td>Sample size</td><td>&#8722;0.0004</td><td>0.0011</td><td>0.739</td><td>&#8722;14.88%</td></tr><tr><td>Cut-off value</td><td>0.0017</td><td>0.0028</td><td>0.566</td><td>&#8722;7.16%</td></tr><tr><td>Country</td><td>0.0376</td><td>0.3659</td><td>0.921</td><td>&#8722;19.62%</td></tr><tr><td>Study quality</td><td>0.0832</td><td>0.2664</td><td>0.764</td><td>&#8722;17.38%</td></tr></table>
c9f3ec337d6d462051b81c9950848e0c3142b65ab3f1706946a1b521c4781ec2.png
simple
<table><tr><td>Orifices</td><td>n right</td><td>% right</td><td>n left</td><td>% left</td></tr><tr><td>1</td><td>7</td><td>7.2</td><td>6</td><td>6.3</td></tr><tr><td>2</td><td>8</td><td>8.2</td><td>17</td><td>17.7</td></tr><tr><td>3</td><td>28</td><td>28.9</td><td>21</td><td>21.9</td></tr><tr><td>4</td><td>22</td><td>22.7</td><td>21</td><td>21.9</td></tr><tr><td>5</td><td>17</td><td>17.5</td><td>15</td><td>15.6</td></tr><tr><td>6</td><td>8</td><td>8.2</td><td>10</td><td>10.4</td></tr><tr><td>7</td><td>5</td><td>5.2</td><td>5</td><td>5.2</td></tr><tr><td>8</td><td>2</td><td>2.1</td><td>1</td><td>1.0</td></tr><tr><td>sum</td><td>97</td><td>100</td><td>96</td><td>100</td></tr></table>
806d5d40aa69b27bf562012d2bd2687b3721e956e45fa0d6267b25e82ab58e21.png
simple
<table><tr><td>AGI</td><td>Annotation</td><td><i>P</i>-score</td><td>References</td></tr><tr><td>AT2G30870</td><td>ERD13, glutathione-<i>S</i>-transferase PHI 10</td><td>32</td><td>Ryu <i>et al.</i> (2009), Carter <i>et al.</i> (2004) and Marmagne <i>et al.</i> (2007)</td></tr><tr><td>AT2G45820*</td><td>Remorin, putative DNA-binding protein, salt-induced</td><td>22</td><td>Benschop <i>et al.</i> (2007), Nelson <i>et al.</i> (2006) and Kreps <i>et al.</i> (2002)</td></tr><tr><td>AT1G04690</td><td>KAB1, KV-BETA1 (potassium channel beta subunit)</td><td>18</td><td>Maathuis (2006)</td></tr><tr><td>AT3G18240*</td><td>Unknown protein, phosphorylated</td><td>18</td><td>de la Fuente van Bentem <i>et al.</i> (2008)</td></tr><tr><td>AT1G53070*</td><td>Legume lectin family protein, cell wall asscociated</td><td>15</td><td></td></tr><tr><td>AT1G09210*</td><td>CRT2, Calreticulin 2; calcium ion binding</td><td>13</td><td>Jiang <i>et al.</i> (2007)</td></tr><tr><td>AT1G56340*</td><td>CRT1, Calreticulin 1; calcium ion binding</td><td>12</td><td>Jiang <i>et al.</i> (2007)</td></tr><tr><td>AT5G38480*</td><td>GRF3, 14-3-3 PSI, overexpression confers salt tolerance</td><td>9</td><td>Marmagne <i>et al.</i> (2007) and Du <i>et al</i>. (2008)</td></tr><tr><td>AT3G02750*</td><td>PP2C, protein phosphatase 2C family, group E</td><td>9</td><td>Bassel <i>et al.</i> (2008)</td></tr><tr><td>AT5G19440</td><td>CAD, Cinnamyl-alcohol dehydrogenase, putative</td><td>9</td><td>Marmagne <i>et al.</i> (2007)</td></tr><tr><td>AT3G18820</td><td>RAB71, (Arabidopsis RAB GTPase homolog G3F); GTP binding</td><td>8</td><td>Marmagne <i>et al.</i> (2007)</td></tr><tr><td>AT2G02990</td><td>RNS1, (Ribonuclease 1); cell wall/plasma membrane associated</td><td>8</td><td></td></tr><tr><td>AT1G02090*</td><td>CSN7, MAP kinase kinase; subunit of COP9 signalosome</td><td>7</td><td></td></tr><tr><td>AT5G16050*</td><td>GRF5, 14-3-3 UPSILON (general regularory factor 5)</td><td>6</td><td>Marmagne <i>et al.</i> (2007)</td></tr><tr><td>AT2G43940</td><td>Thiol methyltransferase, putative, chloroplast envelope</td><td>6</td><td></td></tr><tr><td>AT5G07340</td><td>Calnexin, putative, vacuolar</td><td>6</td><td>Schmidt <i>et al.</i> (2007)</td></tr><tr><td>AT1G28200</td><td>FIP1 (FH interacting protein 1), VirF-interacting protein FIP1</td><td>5</td><td></td></tr><tr><td>AT1G78300</td><td>GRF2, 14-3-3 OMEGA, (general regularory factor 2)</td><td>5</td><td>Chang <i>et al.</i> (2009)</td></tr><tr><td>AT3G06300</td><td>P4H-2, (prolyl-4-hydroxylase, isoform 2); endomembrane system</td><td>5</td><td></td></tr><tr><td>AT1G77120*</td><td>ADH1, (alcohol dehdrogenase 1); salt stress-responsive</td><td>5</td><td>de la Fuente van Bentem <i>et al.</i> (2008) and Jiang <i>et al.</i> (2007)</td></tr><tr><td>AT5G67500</td><td>VDAC2 (voltage-dependent anion channel 2), seedling development</td><td>5</td><td>Yan <i>et al.</i> (2009) and Lee <i>et al.</i> (2009)</td></tr><tr><td>AT3G01280</td><td>VDAC1 (voltage-dependent anion channel 1)</td><td>5</td><td>Lee <i>et al.</i> (2009)</td></tr><tr><td>AT1G74020</td><td>SS2 (STRICTOSIDINE SYNTHASE 2); strictosidine synthase</td><td>5</td><td>Marmagne <i>et al.</i> (2007)</td></tr><tr><td>AT4G17720*</td><td>RNA recognition motif (RRM)-containing protein, phosphorylated</td><td>5</td><td>de la Fuente van Bentem <i>et al.</i> (2006)</td></tr><tr><td>AT4G18800</td><td>RABA1D (Arabidopsis RAB GTPase homolog A1D);</td><td>5</td><td>Marmagne <i>et al.</i> (2004)</td></tr><tr><td>AT3G61990</td><td><i>O</i>-methyltransferase family 3 protein, cytosolic</td><td>4</td><td></td></tr><tr><td>AT1G22280*</td><td>PAPP2C, phytochrome-associated protein phosphatase 2C; group F</td><td>4</td><td>de la Fuente van Bentem <i>et al.</i> (2008) and Phee <i>et al.</i> (2008)</td></tr><tr><td>AT3G15260*</td><td>PP2C, protein phosphatase 2C family, group F</td><td>4</td><td></td></tr></table>
144da4c86763e0033b0c3d9f0f0c0b90840673f2be5cc07449d030d76f28012c.png
complex
<table><tr><td>VARIABLE, n (%)</td><td>MAIN SAMPLE (<i>N</i> = 10283)</td><td>SUBSAMPLE (<i>N</i> = 496)</td></tr><tr><td>Age, mean (Years)</td><td>61.7<sup>a b</sup></td><td>69 <sup>c d</sup></td></tr><tr><td colspan="3">Gender</td></tr><tr><td> Male</td><td>3333 (32)</td><td>181 (37)</td></tr><tr><td> Female</td><td>6946 (68)</td><td>312 (63)</td></tr><tr><td colspan="3">Race</td></tr><tr><td> Blacks</td><td>3750 (36)</td><td>192 (41)</td></tr><tr><td> Whites</td><td>6533 (64)</td><td>281 (59)</td></tr><tr><td colspan="3">Education</td></tr><tr><td>&#8804; High or trade</td><td>2441 (24)</td><td>32 (7)</td></tr><tr><td> Some College</td><td>2237 (22)</td><td>91 (19)</td></tr><tr><td> College degree</td><td>3403 (33)</td><td>160 (34)</td></tr><tr><td>&#8805; Graduate School</td><td>2085 (21)</td><td>185 (40)</td></tr><tr><td>Income (Self) <i>mean</i> (past 12 months)</td><td>$40 K (4.4)<sup>e</sup></td><td>$31 K (4.0)<sup>f</sup></td></tr><tr><td>&lt; $10 K (1)</td><td>5353 (17)</td><td>44 (10)</td></tr><tr><td> $11&#8211;20 K (2)</td><td>1987 (20)</td><td>56 (13)</td></tr><tr><td> $21&#8211;30 K (3)</td><td>1660 (17)</td><td>63 (14)</td></tr><tr><td> $31&#8211;50 K (4)</td><td>2159 (22)</td><td>100 (22)</td></tr><tr><td> $51&#8211;75 K (5)</td><td>1233 (13)</td><td>93 (21)</td></tr><tr><td> $76&#8211;100 K (6)</td><td>532 (5)</td><td>49 (11)</td></tr><tr><td>&gt; $101 K (7)</td><td>508 (5)</td><td>43 (9)</td></tr></table>
8fc36b82584ddfdc1f14229ba8baaab046598dffc7317210b51fd2923e8abad2.png
complex
<table><tr><td>Variable</td><td>OR</td><td><i>p</i></td><td>95% conf. interval</td></tr><tr><td colspan="4">Received blood transfusion</td></tr><tr><td>Age</td><td>1.12</td><td>&lt;0.01</td><td>1.06&#8211;1.19</td></tr><tr><td>Sex</td><td>1.35</td><td>0.32</td><td>0.74&#8211;2.46</td></tr><tr><td>Bilirubin</td><td>0.81</td><td>0.01</td><td>0.69&#8211;0.95</td></tr><tr><td colspan="4">No blood transfusion</td></tr><tr><td>Age</td><td>1.01</td><td>0.85</td><td>0.94&#8211;1.07</td></tr><tr><td>Sex</td><td>1.80</td><td>0.06</td><td>0.98&#8211;3.29</td></tr><tr><td>Bilirubin</td><td>0.86</td><td>0.20</td><td>0.69&#8211;1.08</td></tr></table>
0a3cc3c52a8c5ce9b4434cb04b2f8a1bbf03df392d838641c5fc5158c9d0c5b1.png
simple
<table><tr><td></td><td>Placebo(n = 6)</td><td>Ascorbic acid(n = 5)</td></tr><tr><td>Male/Female (numbers)</td><td>2/4</td><td>3/2</td></tr><tr><td>Age (years)<sup>b</sup></td><td>16 (13-24)</td><td>19 (14-24)</td></tr><tr><td>Median nerve MNCV (m/s)<sup>a</sup></td><td>17.9 (6.0)</td><td>17.2 (1.7)</td></tr><tr><td>Median nerve minimal F response latency (ms)<sup>a</sup></td><td>83.8 (28.0)*</td><td>77.1 (10.6)</td></tr><tr><td>CMAP amplitude abductor pollicis brevis muscle (mV)<sup>a</sup></td><td>3.9 (1.1)</td><td>4.0 (1.2)</td></tr><tr><td>Three point grip (N)<sup>a</sup></td><td>50.9 (14.4)</td><td>73.8 (24.7)</td></tr><tr><td>Foot dorsiflexors (N)<sup>a</sup></td><td>79.5 (14.0)</td><td>91.1 (26.9)</td></tr><tr><td>ISS<sup>b</sup></td><td>2 (0-8)</td><td>3 (1-6)</td></tr><tr><td>CMTNS<sup>b</sup></td><td>10 (7-20)</td><td>13 (7-17)</td></tr><tr><td>ODSS<sup>b</sup></td><td>3 (2-4)</td><td>2 (2-4)</td></tr><tr><td>ALDS<sup>a</sup></td><td>86.8 (6.5)</td><td>89.0 (0.5)</td></tr><tr><td>Nine hole peg test (s)<sup>a</sup></td><td>26.3 (6.6)</td><td>23.5 (1.8)</td></tr><tr><td>50 m walking (s)<sup>a</sup></td><td>31.9 (2.0)</td><td>29.2 (3.2)</td></tr></table>
add85c7fbc26597ad2b766979a288af71fa93dbe90d47f22a4bf99bcbfaf5f45.png
complex
<table><tr><td>RT inhibitors</td><td colspan="2">EC<sub>50 </sub>(nM)<sup>a</sup></td></tr><tr><td></td><td>Subtype B HIV-1</td><td>Subtype C HIV-1</td></tr><tr><td>ZDV</td><td>12.9 &#177; 5.9</td><td>34.8 &#177; 12.9</td></tr><tr><td>3TC</td><td>45.4 &#177; 16.4</td><td>105.9 &#177; 40.2</td></tr><tr><td>TFV</td><td>334.8 &#177; 140.9</td><td>304.8 &#177; 93.1</td></tr><tr><td>NVP</td><td>50.2 &#177; 29.6</td><td>170.4 &#177; 79.5</td></tr><tr><td>EFV</td><td>0.6 &#177; 0.2</td><td>1.3 &#177; 0.4</td></tr><tr><td>ETR</td><td>0.9 &#177; 0.4</td><td>0.5 &#177; 0.01</td></tr></table>
c21536e04dd47fa6b0df15059f834f733c11d3246bc415b357b8c04c29d9b17d.png
complex
<table><tr><td></td><td colspan="2">Ibague(n = 855)</td><td colspan="2">Rural area(n = 1,556)</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td></tr><tr><td>Male</td><td>293</td><td>34.4</td><td>487</td><td>31.4</td></tr><tr><td>Female</td><td>559</td><td>65.6</td><td>1,065</td><td>68.6</td></tr><tr><td>Age group</td><td></td><td></td><td></td><td></td></tr><tr><td>Under 15</td><td>143</td><td>16.7</td><td>454</td><td>29.2</td></tr><tr><td>15 or more</td><td>713</td><td>83.3</td><td>1,101</td><td>70.8</td></tr><tr><td>Place of residence</td><td></td><td></td><td></td><td></td></tr><tr><td>Ibague</td><td>841</td><td>98.4</td><td>7</td><td>0.5</td></tr><tr><td>Rural village</td><td>14</td><td>1.6</td><td>1,544</td><td>99.5</td></tr></table>
04cf828359c53998f1fcaeeaa4081b495f3676dbced9010d74392359be36f824.png
complex
<table><tr><td rowspan="2">Treatment</td><td colspan="2">Vehicle control</td><td colspan="2">Positive control MMC(0.20 <i>&#956;</i>g/mL)</td><td colspan="2">NR-INF-02(2500.00 <i>&#956;</i>g/mL)</td><td colspan="2">NR-INF-02(791.14 <i>&#956;</i>g/mL)</td><td colspan="2">NR-INF-02(250.36 <i>&#956;</i>g/mL)</td></tr><tr><td>R1</td><td>R2</td><td>R1</td><td>R2</td><td>R1</td><td>R2</td><td>R1</td><td>R2</td><td>R1</td><td>R2</td></tr><tr><td>Total number of metaphase analyzed</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td><td>100</td></tr><tr><td>Normal</td><td>99</td><td>100</td><td>92</td><td>92</td><td>98</td><td>97</td><td>98</td><td>96</td><td>98</td><td>100</td></tr><tr><td>Chromatid break</td><td>1</td><td>&#8212;</td><td>&#8212;</td><td>4</td><td>1</td><td>&#8212;</td><td>1</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>Chromosome break</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>1</td><td>&#8212;</td><td>1</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>Deletion</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>1</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>1</td><td>&#8212;</td></tr><tr><td>Ring</td><td>&#8212;</td><td>&#8212;</td><td>3</td><td>1</td><td>1</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>1</td><td>&#8212;</td></tr><tr><td>Dicentric</td><td>&#8212;</td><td>&#8212;</td><td>5</td><td>1</td><td>&#8212;</td><td>2</td><td>&#8212;</td><td>1</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>Fragment</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>1</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>Gap</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>1</td><td>1</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>Ploidy</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>1</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>Endoreduplication</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td><td>&#8212;</td></tr><tr><td>Total aberrations</td><td>1</td><td>0</td><td>8</td><td>8</td><td>2</td><td>3</td><td>1</td><td>1</td><td>2</td><td>0</td></tr><tr><td>Total aberrations (Mean &#177; SD)</td><td colspan="2">0.50 &#177; 0.70</td><td colspan="2">8.00 &#177; 0.00*</td><td colspan="2">2.50 &#177; 0.70</td><td colspan="2">1.0 &#177; 0.00</td><td colspan="2">1.00 &#177; 1.41</td></tr><tr><td>Mitotic Index (Mean &#177; SD)</td><td colspan="2">5.35 &#177; 0.49</td><td colspan="2">2.63 &#177; 0.10*</td><td colspan="2">3.75 &#177; 1.06</td><td colspan="2">4.25 &#177; 0.35</td><td colspan="2">4.0 &#177; 0.42</td></tr></table>
39f07ddf1072265f772e3bd78a8da302a424739919ff8df6cda6d449f3ebfe6e.png
complex
<table><tr><td rowspan="2">Sample ID</td><td colspan="10">Estimated Daily Intakes (EDI)</td></tr><tr><td>Al</td><td>Mn</td><td>Pb</td><td>Cd</td><td>Hg</td><td>As</td><td>Cr</td><td>Ni</td><td>Cu</td><td>Zn</td></tr><tr><td>PNY1</td><td>9.60 &#215; 10<sup>&#8722;3</sup></td><td>8.09 &#215; 10<sup>&#8722;3</sup></td><td>8.80 &#215; 10<sup>&#8722;6</sup></td><td>5.64 &#215; 10<sup>&#8722;7</sup></td><td>5.32 &#215; 10<sup>&#8722;6</sup></td><td>3.20 &#215; 10<sup>&#8722;6</sup></td><td>3.75 &#215; 10<sup>&#8722;5</sup></td><td>3.61 &#215; 10<sup>&#8722;4</sup></td><td>1.31 &#215; 10<sup>&#8722;3</sup></td><td>1.51 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY2</td><td>1.11 &#215; 10<sup>&#8722;2</sup></td><td>3.62 &#215; 10<sup>&#8722;2</sup></td><td>1.50 &#215; 10<sup>&#8722;5</sup></td><td>4.39 &#215; 10<sup>&#8722;7</sup></td><td>5.24 &#215; 10<sup>&#8722;6</sup></td><td>1.40 &#215; 10<sup>&#8722;5</sup></td><td>1.01 &#215; 10<sup>&#8722;4</sup></td><td>4.98 &#215; 10<sup>&#8722;4</sup></td><td>1.17 &#215; 10<sup>&#8722;3</sup></td><td>1.57 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY3</td><td>1.07 &#215; 10<sup>&#8722;2</sup></td><td>4.72 &#215; 10<sup>&#8722;2</sup></td><td>7.79 &#215; 10<sup>&#8722;6</sup></td><td>3.89 &#215; 10<sup>&#8722;7</sup></td><td>2.75 &#215; 10<sup>&#8722;6</sup></td><td>2.52 &#215; 10<sup>&#8722;6</sup></td><td>3.11 &#215; 10<sup>&#8722;5</sup></td><td>4.22 &#215; 10<sup>&#8722;4</sup></td><td>1.03 &#215; 10<sup>&#8722;3</sup></td><td>1.47 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY4</td><td>1.27 &#215; 10<sup>&#8722;2</sup></td><td>1.23 &#215; 10<sup>&#8722;2</sup></td><td>5.72 &#215; 10<sup>&#8722;6</sup></td><td>3.51 &#215; 10<sup>&#8722;7</sup></td><td>3.52 &#215; 10<sup>&#8722;6</sup></td><td>3.14 &#215; 10<sup>&#8722;6</sup></td><td>3.83 &#215; 10<sup>&#8722;5</sup></td><td>4.59 &#215; 10<sup>&#8722;4</sup></td><td>9.52 &#215; 10<sup>&#8722;4</sup></td><td>1.45 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY5</td><td>2.53 &#215; 10<sup>&#8722;2</sup></td><td>2.24 &#215; 10<sup>&#8722;2</sup></td><td>6.40 &#215; 10<sup>&#8722;6</sup></td><td>1.15 &#215; 10<sup>&#8722;7</sup></td><td>3.01 &#215; 10<sup>&#8722;6</sup></td><td>4.56 &#215; 10<sup>&#8722;6</sup></td><td>3.91 &#215; 10<sup>&#8722;5</sup></td><td>4.52 &#215; 10<sup>&#8722;4</sup></td><td>1.42 &#215; 10<sup>&#8722;3</sup></td><td>1.84 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY6</td><td>1.04 &#215; 10<sup>&#8722;2</sup></td><td>3.46 &#215; 10<sup>&#8722;2</sup></td><td>5.34 &#215; 10<sup>&#8722;6</sup></td><td>2.63 &#215; 10<sup>&#8722;7</sup></td><td>2.75 &#215; 10<sup>&#8722;6</sup></td><td>2.34 &#215; 10<sup>&#8722;6</sup></td><td>4.95 &#215; 10<sup>&#8722;5</sup></td><td>6.70 &#215; 10<sup>&#8722;4</sup></td><td>8.78 &#215; 10<sup>&#8722;4</sup></td><td>1.59 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY7</td><td>1.54 &#215; 10<sup>&#8722;2</sup></td><td>9.36 &#215; 10<sup>&#8722;3</sup></td><td>6.40 &#215; 10<sup>&#8722;6</sup></td><td>5.64 &#215; 10<sup>&#8722;7</sup></td><td>1.20 &#215; 10<sup>&#8722;6</sup></td><td>2.62 &#215; 10<sup>&#8722;6</sup></td><td>3.19 &#215; 10<sup>&#8722;5</sup></td><td>4.04 &#215; 10<sup>&#8722;4</sup></td><td>8.42 &#215; 10<sup>&#8722;4</sup></td><td>1.76 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY8</td><td>1.54 &#215; 10<sup>&#8722;2</sup></td><td>3.56 &#215; 10<sup>&#8722;2</sup></td><td>4.03 &#215; 10<sup>&#8722;6</sup></td><td>4.89 &#215; 10<sup>&#8722;7</sup></td><td>1.20 &#215; 10<sup>&#8722;6</sup></td><td>2.37 &#215; 10<sup>&#8722;6</sup></td><td>2.71 &#215; 10<sup>&#8722;5</sup></td><td>4.32 &#215; 10<sup>&#8722;4</sup></td><td>9.52 &#215; 10<sup>&#8722;4</sup></td><td>1.36 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY9</td><td>1.73 &#215; 10<sup>&#8722;2</sup></td><td>1.67 &#215; 10<sup>&#8722;2</sup></td><td>7.82 &#215; 10<sup>&#8722;6</sup></td><td>7.27 &#215; 10<sup>&#8722;7</sup></td><td>4.04 &#215; 10<sup>&#8722;6</sup></td><td>3.14 &#215; 10<sup>&#8722;6</sup></td><td>9.58 &#215; 10<sup>&#8722;5</sup></td><td>8.49 &#215; 10<sup>&#8722;4</sup></td><td>9.92 &#215; 10<sup>&#8722;4</sup></td><td>1.38 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY10</td><td>1.50 &#215; 10<sup>&#8722;2</sup></td><td>2.08 &#215; 10<sup>&#8722;2</sup></td><td>6.13 &#215; 10<sup>&#8722;6</sup></td><td>4.64 &#215; 10<sup>&#8722;7</sup></td><td>3.44 &#215; 10<sup>&#8722;6</sup></td><td>6.49 &#215; 10<sup>&#8722;6</sup></td><td>4.39 &#215; 10<sup>&#8722;5</sup></td><td>5.99 &#215; 10<sup>&#8722;4</sup></td><td>8.12 &#215; 10<sup>&#8722;4</sup></td><td>1.45 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY11</td><td>1.34 &#215; 10<sup>&#8722;2</sup></td><td>3.39 &#215; 10<sup>&#8722;2</sup></td><td>7.22 &#215; 10<sup>&#8722;6</sup></td><td>3.76 &#215; 10<sup>&#8722;7</sup></td><td>3.01 &#215; 10<sup>&#8722;6</sup></td><td>4.71 &#215; 10<sup>&#8722;6</sup></td><td>4.07 &#215; 10<sup>&#8722;5</sup></td><td>6.73 &#215; 10<sup>&#8722;4</sup></td><td>8.34 &#215; 10<sup>&#8722;4</sup></td><td>1.69 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY12</td><td>1.23 &#215; 10<sup>&#8722;2</sup></td><td>1.08 &#215; 10<sup>&#8722;2</sup></td><td>7.26 &#215; 10<sup>&#8722;6</sup></td><td>1.50 &#215; 10<sup>&#8722;7</sup></td><td>5.58 &#215; 10<sup>&#8722;6</sup></td><td>5.54 &#215; 10<sup>&#8722;6</sup></td><td>8.62 &#215; 10<sup>&#8722;5</sup></td><td>5.81 &#215; 10<sup>&#8722;4</sup></td><td>1.05 &#215; 10<sup>&#8722;3</sup></td><td>1.73 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PNY13</td><td>1.04 &#215; 10<sup>&#8722;2</sup></td><td>1.40 &#215; 10<sup>&#8722;2</sup></td><td>4.85 &#215; 10<sup>&#8722;6</sup></td><td>3.89 &#215; 10<sup>&#8722;7</sup></td><td>7.30 &#215; 10<sup>&#8722;6</sup></td><td>2.25 &#215; 10<sup>&#8722;6</sup></td><td>2.63 &#215; 10<sup>&#8722;5</sup></td><td>4.23 &#215; 10<sup>&#8722;4</sup></td><td>9.08 &#215; 10<sup>&#8722;3</sup></td><td>1.31 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>Mean</td><td>1.38 &#215; 10<sup>&#8722;2</sup></td><td>2.32 &#215; 10<sup>&#8722;2</sup></td><td>7.14 &#215; 10<sup>&#8722;6</sup></td><td>4.86 &#215; 10<sup>&#8722;7</sup></td><td>3.72 &#215; 10<sup>&#8722;6</sup></td><td>4.38 &#215; 10<sup>&#8722;6</sup></td><td>4.98 &#215; 10<sup>&#8722;5</sup></td><td>5.25 &#215; 10<sup>&#8722;4</sup></td><td>1.01 &#215; 10<sup>&#8722;3</sup></td><td>1.55 &#215; 10<sup>&#8722;3</sup></td></tr><tr><td>PLY1</td><td>1.65 &#215; 10<sup>&#8722;1</sup></td><td>2.24 &#215; 10<sup>&#8722;2</sup></td><td>3.30 &#215; 10<sup>&#8722;5</sup></td><td>7.77 &#215; 10<sup>&#8722;7</sup></td><td>3.86 &#215; 10<sup>&#8722;6</sup></td><td>7.20 &#215; 10<sup>&#8722;6</sup></td><td>1.75 &#215; 10<sup>&#8722;4</sup></td><td>5.54 &#215; 10<sup>&#8722;4</sup></td><td>8.86 &#215; 10<sup>&#8722;4</sup></td><td>5.21 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY2</td><td>2.23 &#215; 10<sup>&#8722;1</sup></td><td>1.27 &#215; 10<sup>&#8722;1</sup></td><td>3.20 &#215; 10<sup>&#8722;5</sup></td><td>9.03 &#215; 10<sup>&#8722;7</sup></td><td>4.47 &#215; 10<sup>&#8722;6</sup></td><td>9.02 &#215; 10<sup>&#8722;6</sup></td><td>1.43 &#215; 10<sup>&#8722;4</sup></td><td>8.09 &#215; 10<sup>&#8722;4</sup></td><td>7.03 &#215; 10<sup>&#8722;4</sup></td><td>4.66 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY3</td><td>2.61 &#215; 10<sup>&#8722;1</sup></td><td>1.93 &#215; 10<sup>&#8722;1</sup></td><td>3.18 &#215; 10<sup>&#8722;5</sup></td><td>8.40 &#215; 10<sup>&#8722;7</sup></td><td>4.04 &#215; 10<sup>&#8722;6</sup></td><td>1.11 &#215; 10<sup>&#8722;6</sup></td><td>5.91 &#215; 10<sup>&#8722;5</sup></td><td>3.56 &#215; 10<sup>&#8722;4</sup></td><td>5.51 &#215; 10<sup>&#8722;4</sup></td><td>4.51 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY4</td><td>3.26 &#215; 10<sup>&#8722;1</sup></td><td>5.02 &#215; 10<sup>&#8722;2</sup></td><td>4.76 &#215; 10<sup>&#8722;5</sup></td><td>7.02 &#215; 10<sup>&#8722;7</sup></td><td>6.01 &#215; 10<sup>&#8722;6</sup></td><td>8.74 &#215; 10<sup>&#8722;6</sup></td><td>9.10 &#215; 10<sup>&#8722;5</sup></td><td>6.38 &#215; 10<sup>&#8722;4</sup></td><td>7.85 &#215; 10<sup>&#8722;4</sup></td><td>5.17 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY5</td><td>2.69 &#215; 10<sup>&#8722;1</sup></td><td>6.10 &#215; 10<sup>&#8722;2</sup></td><td>4.46 &#215; 10<sup>&#8722;5</sup></td><td>7.52 &#215; 10<sup>&#8722;7</sup></td><td>5.84 &#215; 10<sup>&#8722;6</sup></td><td>1.02 &#215; 10<sup>&#8722;5</sup></td><td>1.59 &#215; 10<sup>&#8722;4</sup></td><td>5.20 &#215; 10<sup>&#8722;4</sup></td><td>8.83 &#215; 10<sup>&#8722;4</sup></td><td>5.68 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY6</td><td>2.26 &#215; 10<sup>&#8722;1</sup></td><td>1.16 &#215; 10<sup>&#8722;1</sup></td><td>3.62 &#215; 10<sup>&#8722;5</sup></td><td>5.89 &#215; 10<sup>&#8722;7</sup></td><td>6.36 &#215; 10<sup>&#8722;6</sup></td><td>8.25 &#215; 10<sup>&#8722;6</sup></td><td>9.18 &#215; 10<sup>&#8722;5</sup></td><td>3.15 &#215; 10<sup>&#8722;4</sup></td><td>3.70 &#215; 10<sup>&#8722;4</sup></td><td>4.00 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY7</td><td>3.68 &#215; 10<sup>&#8722;1</sup></td><td>3.24 &#215; 10<sup>&#8722;2</sup></td><td>3.19 &#215; 10<sup>&#8722;5</sup></td><td>7.40 &#215; 10<sup>&#8722;7</sup></td><td>7.64 &#215; 10<sup>&#8722;6</sup></td><td>9.45 &#215; 10<sup>&#8722;6</sup></td><td>9.42 &#215; 10<sup>&#8722;5</sup></td><td>7.58 &#215; 10<sup>&#8722;4</sup></td><td>6.76 &#215; 10<sup>&#8722;4</sup></td><td>7.33 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY8</td><td>2.26 &#215; 10<sup>&#8722;1</sup></td><td>9.66 &#215; 10<sup>&#8722;2</sup></td><td>2.11 &#215; 10<sup>&#8722;5</sup></td><td>8.90 &#215; 10<sup>&#8722;7</sup></td><td>3.69 &#215; 10<sup>&#8722;6</sup></td><td>5.82 &#215; 10<sup>&#8722;6</sup></td><td>8.46 &#215; 10<sup>&#8722;5</sup></td><td>4.33 &#215; 10<sup>&#8722;4</sup></td><td>4.22 &#215; 10<sup>&#8722;4</sup></td><td>4.73 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY9</td><td>3.99 &#215; 10<sup>&#8722;1</sup></td><td>8.74 &#215; 10<sup>&#8722;2</sup></td><td>2.61 &#215; 10<sup>&#8722;5</sup></td><td>7.27 &#215; 10<sup>&#8722;7</sup></td><td>7.39 &#215; 10<sup>&#8722;6</sup></td><td>6.59 &#215; 10<sup>&#8722;6</sup></td><td>1.87 &#215; 10<sup>&#8722;4</sup></td><td>6.98 &#215; 10<sup>&#8722;4</sup></td><td>4.27 &#215; 10<sup>&#8722;4</sup></td><td>4.69 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY10</td><td>3.07 &#215; 10<sup>&#8722;1</sup></td><td>7.40 &#215; 10<sup>&#8722;2</sup></td><td>3.11 &#215; 10<sup>&#8722;5</sup></td><td>6.14 &#215; 10<sup>&#8722;7</sup></td><td>4.64 &#215; 10<sup>&#8722;6</sup></td><td>9.33 &#215; 10<sup>&#8722;6</sup></td><td>9.10 &#215; 10<sup>&#8722;5</sup></td><td>6.75 &#215; 10<sup>&#8722;4</sup></td><td>5.01 &#215; 10<sup>&#8722;4</sup></td><td>4.51 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY11</td><td>3.07 &#215; 10<sup>&#8722;1</sup></td><td>7.94 &#215; 10<sup>&#8722;2</sup></td><td>3.82 &#215; 10<sup>&#8722;5</sup></td><td>8.90 &#215; 10<sup>&#8722;7</sup></td><td>6.27 &#215; 10<sup>&#8722;6</sup></td><td>8.50 &#215; 10<sup>&#8722;6</sup></td><td>5.99 &#215; 10<sup>&#8722;5</sup></td><td>1.96 &#215; 10<sup>&#8722;4</sup></td><td>5.17 &#215; 10<sup>&#8722;4</sup></td><td>5.43 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY12</td><td>2.34 &#215; 10<sup>&#8722;1</sup></td><td>2.67 &#215; 10<sup>&#8722;2</sup></td><td>4.04 &#215; 10<sup>&#8722;5</sup></td><td>5.02 &#215; 10<sup>&#8722;7</sup></td><td>4.72 &#215; 10<sup>&#8722;6</sup></td><td>8.28 &#215; 10<sup>&#8722;6</sup></td><td>5.51 &#215; 10<sup>&#8722;5</sup></td><td>2.95 &#215; 10<sup>&#8722;4</sup></td><td>3.36 &#215; 10<sup>&#8722;4</sup></td><td>3.34 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>PLY13</td><td>3.42 &#215; 10<sup>&#8722;1</sup></td><td>8.86 &#215; 10<sup>&#8722;2</sup></td><td>4.14 &#215; 10<sup>&#8722;5</sup></td><td>1.09 &#215; 10<sup>&#8722;7</sup></td><td>5.93 &#215; 10<sup>&#8722;6</sup></td><td>1.39 &#215; 10<sup>&#8722;5</sup></td><td>2.32 &#215; 10<sup>&#8722;4</sup></td><td>7.44 &#215; 10<sup>&#8722;4</sup></td><td>5.29 &#215; 10<sup>&#8722;4</sup></td><td>5.28 &#215; 10<sup>&#8722;4</sup></td></tr><tr><td>Mean</td><td>2.81 &#215; 10<sup>&#8722;1</sup></td><td>8.11 &#215; 10<sup>&#8722;2</sup></td><td>3.50 &#215; 10<sup>&#8722;5</sup></td><td>7.71 &#215; 10<sup>&#8722;7</sup></td><td>5.45 &#215; 10<sup>&#8722;6</sup></td><td>8.95 &#215; 10<sup>&#8722;6</sup></td><td>1.17 &#215; 10<sup>&#8722;4</sup></td><td>5.38 &#215; 10<sup>&#8722;4</sup></td><td>5.84 &#215; 10<sup>&#8722;4</sup></td><td>4.96 &#215; 10<sup>&#8722;4</sup></td></tr></table>
caa48295a9b0b7b852963cb4970add762dbb21997f2d4ca2e61ed734515883ff.png
simple
<table><tr><td>Protein Name</td><td>Uniprot ID</td><td>Function</td><td>Up- or downregulated<sup>a</sup></td></tr><tr><td>DNA-dependent protein kinase catalytic subunit</td><td>P78527</td><td>Serine/threonine-protein kinase, molecular sensor for DNA damage.</td><td>Up</td></tr><tr><td>Lumican</td><td>P51884</td><td>Collagen fibril organization, epithelial cell migration and tissue repair.</td><td>Down</td></tr><tr><td>Tetranectin</td><td>P05452</td><td>Binds plasminogen and isolated kringle 4. Packaging molecules for exocytosis.</td><td>Down</td></tr><tr><td>Gelsolin</td><td>P06396</td><td>Key regulator of actin filament assembly and disassembly.</td><td>Down</td></tr><tr><td>Cartilage acidic protein 1</td><td>Q9NQ79</td><td>Upregulated by BMP4 in mesenchymal stem cells undergoing chondrogenic differentiation.</td><td>Down</td></tr><tr><td>Matrin-3</td><td>P43243</td><td>Transcription and interaction with other nuclear matrix proteins to form the internal fibrogranular network.</td><td>N/A</td></tr><tr><td>Glucose-6-phosphate isomerase</td><td>P06744</td><td>Glycolytic enzyme and angiogenic factor (AMF) that stimulates endothelial cell motility.</td><td>N/A</td></tr><tr><td>Coactosin-like protein</td><td>Q14019</td><td>Binds to F-actin in a calcium-independent manner.</td><td>N/A</td></tr><tr><td>Peptidyl-prolyl cis-trans isomerase A</td><td>P62937</td><td>Accelerates the folding of proteins.</td><td>N/A</td></tr><tr><td>Myeloperoxidase</td><td>P05164</td><td>Produces hypochlorous acid (HOCl) used by the neutrophils to kill bacteria and other pathogens.</td><td>N/A</td></tr><tr><td>Golgin subfamily B member 1</td><td>Q14789</td><td>Forms intercisternal cross-bridges of the Golgi complex.</td><td>N/A</td></tr><tr><td>2&#8242;-deoxynucleoside 5&#8242;-phosphate N-hydrolase 1</td><td>O43598</td><td>Catalyses cleavage of the N-glycosidic bond of deoxyribonucleoside 5&#8242;-monophosphates.</td><td>N/A</td></tr></table>
67ae8c0f32a149652914751f02a84301ba18413eeab6a7a272bc1d81cea7e55d.png
simple
<table><tr><td> </td><td>Group P (<i>n</i> = 13)</td><td>Group R(<i>n</i> = 28)</td><td><i>P</i> value</td></tr><tr><td>Mean decrease in Hb<sup>&#8224;</sup> (g/dL &#177; SD<sup>&#8225;</sup>)</td><td>0.21 &#177; 0.66</td><td>0.37 &#177; 0.67</td><td>0.55</td></tr><tr><td>Mean procedure time (min &#177; SD)</td><td>87.5 &#177; 51.3</td><td>99.5 &#177; 46.1</td><td>0.28</td></tr><tr><td>Incidence of perforation, % (<i>n</i>)</td><td>0.0 (0)</td><td>3.6 (1)</td><td>0.49</td></tr><tr><td>Incidence of clip use, % (<i>n</i>)</td><td>38.5 (5)</td><td>57.1 (16)</td><td>0.27</td></tr><tr><td>Incidence of muscle injury, % (<i>n</i>)</td><td>15.4 (2)</td><td>28.6 (8)</td><td>0.36</td></tr><tr><td>Incidence of postoperative fever, % (<i>n</i>)</td><td>7.7 (1)</td><td>10.7 (3)</td><td>0.76</td></tr><tr><td>Incidence of postoperative bleeding, % (<i>n</i>)</td><td>0.0 (0)</td><td>3.6 (1)</td><td>0.49</td></tr><tr><td>Percentage of patients who resumed eating on the day after ESD, % (<i>n</i>)</td><td>76.9 (10)</td><td>82.1 (23)</td><td>0.81</td></tr></table>
fa879fccab71bf44e9f4c02bf748930fd6c65534d44f30a9a22a9d4a58f35a72.png
complex
<table><tr><td rowspan="2">Material</td><td>Thermal conductivity</td><td>Specific heat</td><td>Density</td><td>Electrical conductivity</td></tr><tr><td><i>k</i>(W/m&#8901;K)</td><td><i>c</i>(J/kg&#8901;K)</td><td><i>&#961;</i>(kg/m<sup>3</sup>)</td><td><i>&#963;</i>(S/m)</td></tr><tr><td>Plastic</td><td>0.026</td><td>1045</td><td>70</td><td>10<sup>-5</sup></td></tr><tr><td>Electrode</td><td>70</td><td>840</td><td>6450</td><td>10<sup>8</sup></td></tr><tr><td>Saline</td><td>0.58</td><td>3200</td><td>1004</td><td><i>a</i><sup>(3)</sup></td></tr><tr><td rowspan="2">Hepatic tissue</td><td rowspan="2">0.502</td><td>3455 <sup>(1)</sup></td><td>1080 <sup>(1)</sup></td><td rowspan="2"><i>b</i><sup>(3)</sup></td></tr><tr><td>2155 <sup>(2)</sup></td><td>370.44 <sup>(2)</sup></td></tr></table>
d02a0000a11b70f0c61e1864c1efd16228cfcc149abb0d8768c8c55bdcae8f95.png
simple
<table><tr><td></td><td>Beijing (<i>n</i> = 151)</td><td>Suzhou (<i>n</i> = 180)</td><td>Guangzhou (<i>n</i> = 178)</td><td><i>p</i>-Value <sup>1</sup></td><td><i>Post hoc</i> Test <sup>2</sup></td></tr><tr><td>B-carotene</td><td>1.7 (1.3&#8211;3.2)</td><td>2.4 (1.7&#8211;4.3)</td><td>2.7 (1.7&#8211;5.0)</td><td>&lt;0.001 *</td><td>C1 &lt; C2 = C3</td></tr><tr><td>&#946;-cryptoxanthin</td><td>1.1 (0.8&#8211;2.0)</td><td>3.6 (2.1&#8211;7.7)</td><td>2.8 (1.7&#8211;5.2)</td><td>&lt;0.001 *</td><td>C1 &lt; C3 &lt; C2</td></tr><tr><td>Lutein</td><td>2.2 (1.0&#8211;4.1)</td><td>4.9 (2.6&#8211;7.9)</td><td>5.8 (2.9&#8211;8.7)</td><td>&lt;0.001 *</td><td>C1 &lt; C2 = C3</td></tr><tr><td>Lycopene</td><td>1.7 (1.3&#8211;2.8)</td><td>1.7 (1.3&#8211;2.7)</td><td>2.1 (1.4&#8211;3.8)</td><td>0.006 *</td><td>C1 = C2 &lt; C3</td></tr><tr><td>Zeaxanthin</td><td>0.8 (0.4&#8211;1.4)</td><td>1.1 (0.7&#8211;2.0)</td><td>1.1 (0.7&#8211;1.5)</td><td>&lt;0.001 *</td><td>C1 &lt; C2 = C3</td></tr><tr><td>&#945;-tocopherol</td><td>215 (117&#8211;333)</td><td>296 (208&#8211;478)</td><td>285 (148&#8211;479)</td><td>&lt;0.001 *</td><td>C1 &lt; C2 = C3</td></tr><tr><td>&#947;-tocopherol</td><td>71 (48&#8211;107)</td><td>94 (59&#8211;148)</td><td>53 (31&#8211;88)</td><td>&lt;0.001 *</td><td>C3 &lt; C1 &lt; C2</td></tr></table>
00ba3f200f40da2b9a24785051671b63ba0fe1b864891507b32723dfd434e6e8.png
complex
<table><tr><td></td><td>Stats</td><td>infAP</td><td>infNDCG</td><td>P@10 (+partial)</td><td>NDCG@10</td><td>P@10 (-partial)</td><td>UIR</td></tr><tr><td rowspan="2">SIB Text Mining</td><td>rank</td><td>1/10</td><td>5/10</td><td>5/10</td><td>3/10</td><td>2/10</td><td>2/10</td></tr><tr><td>score</td><td>0.3664</td><td>0.4258</td><td>0.7533</td><td>0.6271</td><td>0.3467</td><td>0.51</td></tr><tr><td rowspan="5">All participants</td><td>median</td><td>0.2994</td><td>0.4250</td><td>0.7500</td><td>0.5806</td><td>0.3100</td><td>0.13</td></tr><tr><td>min</td><td>0.0876</td><td>0.3580</td><td>0.5333</td><td>0.4265</td><td>0.1600</td><td>&#8722;1.00</td></tr><tr><td>1st quartile</td><td>0.2570</td><td>0.3954</td><td>0.7150</td><td>0.5546</td><td>0.2700</td><td>&#8722;0.43</td></tr><tr><td>3rd quartile</td><td>0.3219</td><td>0.4433</td><td>0.7600</td><td>0.6234</td><td>0.3333</td><td>0.40</td></tr><tr><td>max</td><td>0.3664</td><td>0.5132</td><td>0.8267</td><td>0.6861</td><td>0.4267</td><td>0.82</td></tr></table>
e0cf862499cc941b9e9c315b2f9039e8dd3575a40576c00a07e2f6254f8add35.png
complex
<table><tr><td rowspan="2">Level</td><td colspan="2">Snail</td><td colspan="2">NF-&#954;B</td></tr><tr><td>Mean (95% CI)</td><td>Median (95% CI)</td><td>Mean (95% CI)</td><td>Median (95% CI)</td></tr><tr><td>Low</td><td>38.36 (34.54&#8211;42.19)</td><td>39.0 (36.74&#8211;41.26)</td><td>37.96 (34.42&#8211;41.50)</td><td>39.0 (37.04&#8211;40.96)</td></tr><tr><td>High</td><td>29.20 (25.76&#8211;32.64)</td><td>28.0 (20.58&#8211;35.42)</td><td>28.42 (24.42&#8211;32.41)</td><td>27.0 (16.27&#8211;37.73)</td></tr></table>
e8e43385a9d4afe9c3c7527ecb09d8714b157f68d12918a70cd458602f9956b9.png
complex
<table><tr><td rowspan="2">Variable</td><td colspan="2">Simple myopia</td><td><i>P</i> value</td><td colspan="2">Astigmatism</td><td><i>P</i> value</td><td rowspan="2">ANOVA (four groups)</td></tr><tr><td>MMC</td><td>No MMC</td><td>Paired <i>t</i>-test</td><td>MMC</td><td>No MMC</td><td>Paired <i>t</i>-test</td></tr><tr><td>UCVA (in logMAR)</td><td>0 &#177; 0</td><td>0.1 &#177; 0.141</td><td><i>P</i> = 0.1872</td><td>0.04 &#177; 0.137</td><td>0 &#177; 0</td><td><i>P</i> = 0.1872</td><td>0.4624</td></tr><tr><td>BCVA (in logMAR)</td><td>0 &#177; 0</td><td>0.05 &#177; 0.070</td><td><i>P</i> = 0.1631</td><td>0.04 &#177; 0.137</td><td>0 &#177; 0</td><td><i>P</i> = 0.1703</td><td>0.5193</td></tr><tr><td>Refractive error</td><td>0</td><td>&#8722;0.03 &#177; 0.08</td><td><i>P</i> = 0.1631</td><td>&#8722;0.027 &#177; 0.098</td><td>&#8722;0.016 &#177; 0.056</td><td><i>P</i> = 0.0613</td><td>0.4798</td></tr><tr><td>K-reading</td><td>39.23 &#177; 2.1</td><td>40.58 &#177; 1.23</td><td><i>P</i> = 0.0495</td><td>39.33 &#177; 1.7</td><td>40.98 &#177; 1.35</td><td><i>P</i> &lt; 0.0001</td><td>0.0049</td></tr><tr><td>Haze formation</td><td>0</td><td>0.14 &#177; 0.287</td><td><i>P</i> = 0.0560</td><td>0</td><td>0.31 &#177; 0.32</td><td><i>P</i> &lt; 0.0001</td><td>&lt;0.0001</td></tr></table>
c63419962810183d48dcb76150fd12cfa6e193f3d690cee6a7172a5b44a1ae79.png
complex
<table><tr><td></td><td colspan="4">Mean genome size (1C; pg) </td></tr><tr><td></td><td>*R1</td><td>*R2</td><td>*R3</td><td>Mean &#177; SD</td></tr><tr><td><i>Lestrimellita</i> sp (diploid males)</td><td>0.460</td><td>0.465</td><td>0.465</td><td>0.463 &#177; 0.003</td></tr><tr><td><i>Lestrimellita</i> sp (females)</td><td>0.455</td><td>0.465</td><td>0.470</td><td>0.463 &#177; 0.008</td></tr></table>
ad968d2cf0566e259bf56f266dcad914764666e23fed16c1fbeece0f4fbb5ddc.png
simple
<table><tr><td></td><td>E-KNG</td><td>Q-KNG</td><td>Q-TSR</td><td>E-TSR</td></tr><tr><td>Number of values</td><td>105</td><td>105</td><td>105</td><td>105</td></tr><tr><td>Minimum</td><td>-0.435</td><td>0.051</td><td>0.029</td><td>-0.009</td></tr><tr><td>25% Percentile</td><td>0.308</td><td>0.465</td><td>0.200</td><td>0.164</td></tr><tr><td>Median</td><td>0.971</td><td>1.181</td><td>0.968</td><td>0.796</td></tr><tr><td>75% Percentile</td><td>1.585</td><td>1.772</td><td>1.695</td><td>1.625</td></tr><tr><td>Maximum</td><td>2.126</td><td>2.081</td><td>2.109</td><td>2.075</td></tr><tr><td>Mean</td><td>0.963</td><td>1.139</td><td>0.983</td><td>0.904</td></tr><tr><td>Std. Deviation</td><td>0.663</td><td>0.629</td><td>0.696</td><td>0.693</td></tr><tr><td>Std. Error</td><td>0.065</td><td>0.061</td><td>0.068</td><td>0.068</td></tr><tr><td>Lower 95% CI of mean</td><td>0.835</td><td>1.017</td><td>0.848</td><td>0.770</td></tr><tr><td>Upper 95% CI of mean</td><td>1.091</td><td>1.260</td><td>1.118</td><td>1.038</td></tr><tr><td>Coeff. of variation</td><td>68.84%</td><td>55.23%</td><td>70.84%</td><td>76.62%</td></tr></table>
3660ce505b5eaed2da2c2a95bfd697f25e50ce950d5e8139524f19cd5a3e64c5.png
simple
<table><tr><td>Gestational age</td><td>n</td><td>Colonization with enterococci</td><td>Colonization with multidrug-resistant enterococci</td><td>% multidrug-resistant enterococci</td></tr><tr><td>All patients</td><td>274</td><td>63 (22.9%)</td><td>36 (13.1%)</td><td>57.1%</td></tr><tr><td>&#8805; 37 weeks of gestation</td><td>117</td><td>24 (20.5%)</td><td>10 (8.5%)</td><td>41.7%</td></tr><tr><td>32 &#8211; 36 weeks of gestation</td><td>94</td><td>18 (19.1%)</td><td>7 (7.4%)</td><td>38.9%</td></tr><tr><td>&lt; 32 weeks of gestation</td><td>63</td><td>21 (33.3%)</td><td>19 (30.2%)</td><td>90.5%</td></tr></table>
b2202a1185a1e04beec7a73900c190313aa4335d93a337ed7ba532224416cb0b.png
simple
<table><tr><td>Dimensions of KCSE scale</td><td>n</td><td>Score range</td><td>Mean (SD)</td><td>No of items</td><td>Cron-bach&#8217;s alpha</td><td>Item-total correlation r &gt; 0.20</td><td>Inter-item correlations r &gt; 0.20 &amp; <i>r</i> &lt; 0.70</td></tr><tr><td>Attitude</td><td>174</td><td>2.8&#8211;4</td><td>3.6 (0.27)</td><td>9</td><td>0.63</td><td>8/9, 89%</td><td>12/36, 33%</td></tr><tr><td>Dynamic state</td><td>165</td><td>2.4&#8211;4</td><td>3.4 (0.40)</td><td>5</td><td>0.54</td><td>4/5, 80%</td><td>6/10, 60%</td></tr><tr><td>Knowledge</td><td>172</td><td>1&#8211;4</td><td>3.0 (0.59)</td><td>7</td><td>0.91</td><td>7/7, 100%</td><td>20/21, 95%</td></tr><tr><td>Skills</td><td>170</td><td>1.1&#8211;4</td><td>3.0 (0.50)</td><td>7</td><td>0.86</td><td>7/7, 100%</td><td>21/21, 100%</td></tr><tr><td>Total scale</td><td>150</td><td>8.2&#8211;16.0</td><td>13.0 (1.44)</td><td>28</td><td>0.91</td><td>24/28, 86%</td><td></td></tr></table>
fcc6003941e1cc3d49397b4d0b6323c956e32c5d7bf92a1eb642357980055d34.png
simple
<table><tr><td></td><td>1.5 T</td><td>3 T</td></tr><tr><td>Number</td><td>9</td><td>10</td></tr><tr><td>Male;Female</td><td>3:6</td><td>4:6</td></tr><tr><td>Age (years)</td><td>52 [45.5&#8211;61.5]</td><td>50 [45.25&#8211;53]</td></tr><tr><td>Body-mass Index (kg/m<sup>2</sup>)</td><td>22.9 [20.1&#8211;26.9]</td><td>25.9 [22.5&#8211;29.4]</td></tr><tr><td>Ejection Fraction (%)</td><td>63.6 &#177; 4.9</td><td>61.1 &#177; 4.1</td></tr></table>
710239fabfc74540bff02b936d46ff8bbadebca06a9309fce8ec6067f0fe5e41.png
complex
<table><tr><td rowspan="2"> </td><td colspan="4">Grade 10</td><td colspan="4">Grade 11</td><td colspan="4">Grade 12</td><td colspan="4">TOTAL</td></tr><tr><td colspan="2">boys</td><td colspan="2">girls</td><td colspan="2">boys</td><td colspan="2">girls</td><td colspan="2">boys</td><td colspan="2">girls</td><td colspan="2">boys</td><td colspan="2">girls</td></tr><tr><td>Scale</td><td><i>M</i></td><td><i>SD</i></td><td><i>M</i></td><td><i>SD</i></td><td><i>M</i></td><td><i>SD</i></td><td><i>M</i></td><td><i>SD</i></td><td><i>M</i></td><td><i>SD</i></td><td><i>M</i></td><td><i>SD</i></td><td><i>M</i></td><td><i>SD</i></td><td><i>M</i></td><td><i>SD</i></td></tr><tr><td>(1) AV</td><td>5.32</td><td>4.11</td><td>3.43</td><td>2.76</td><td>5.93</td><td>4.56</td><td>3.54</td><td>2.88</td><td>5.22</td><td>3.93</td><td>3.22</td><td>2.48</td><td>5.51</td><td>4.24</td><td>3.41</td><td>2.72</td></tr><tr><td>(2) RB</td><td>3.69</td><td>2.85</td><td>2.86</td><td>1.99</td><td>4.38</td><td>3.27</td><td>2.99</td><td>2.25</td><td>3.91</td><td>2.84</td><td>2.82</td><td>1.99</td><td>3.98</td><td>3.01</td><td>2.89</td><td>2.07</td></tr><tr><td>(3) US</td><td>0.33</td><td>1.50</td><td>0.06</td><td>0.51</td><td>0.57</td><td>1.98</td><td>0.14</td><td>0.79</td><td>0.28</td><td>1.38</td><td>0.04</td><td>0.29</td><td>0.40</td><td>1.66</td><td>0.08</td><td>0.56</td></tr><tr><td>(4) SS</td><td>1.19</td><td>2.24</td><td>1.45</td><td>2.45</td><td>1.34</td><td>2.45</td><td>1.52</td><td>2.45</td><td>1.08</td><td>2.06</td><td>1.18</td><td>2.08</td><td>1.22</td><td>2.28</td><td>1.40</td><td>2.36</td></tr><tr><td>(5) SU</td><td>2.41</td><td>3.32</td><td>1.11</td><td>2.04</td><td>3.37</td><td>3.94</td><td>1.22</td><td>2.08</td><td>2.82</td><td>3.51</td><td>1.10</td><td>1.89</td><td>2.83</td><td>3.61</td><td>1.14</td><td>2.01</td></tr><tr><td>(6) HBICA Total</td><td>12.75</td><td>10.76</td><td>8.88</td><td>7.40</td><td>15.43</td><td>12.31</td><td>9.37</td><td>7.82</td><td>13.18</td><td>10.77</td><td>8.29</td><td>6.39</td><td>13.77</td><td>11.38</td><td>8.86</td><td>7.28</td></tr></table>
e8e3a305b0193ff9041c26e65850ba2854faab964097d73684de20783e0f48d8.png
simple
<table><tr><td>Characteristic</td><td>Partial helmet law</td><td>Universal helmet law</td><td><i>P</i>-value*</td></tr><tr><td>Number of motorcycle operators</td><td><i>N</i> = 28,207</td><td><i>N</i> = 45,552</td><td></td></tr><tr><td>Helmet used</td><td>42 %</td><td>88 %</td><td>&lt;0.01</td></tr><tr><td>Age (Median)</td><td>37</td><td>36</td><td>0.52</td></tr><tr><td>Male</td><td>93 %</td><td>93 %</td><td>0.77</td></tr><tr><td>Single Vehicle Crash</td><td>39 %</td><td>45 %</td><td>&lt;0.01</td></tr><tr><td>Crash at Intersection</td><td>36 %</td><td>40 %</td><td>&lt;0.01</td></tr><tr><td>Night time</td><td>18 %</td><td>17 %</td><td>&lt;0.01</td></tr><tr><td>Speed related<sup>a</sup></td><td>10 %</td><td>17 %</td><td>&lt;0.01</td></tr><tr><td>Suspicion of alcohol or drugs<sup>a</sup></td><td>9 %</td><td>5 %</td><td>&lt;0.01</td></tr><tr><td>Rural location<sup>a</sup></td><td>17 %</td><td>31 %</td><td>&lt;0.01</td></tr><tr><td>Poor Surface Conditions</td><td>6 %</td><td>7 %</td><td>&lt;0.01</td></tr><tr><td>Crash record linked to a medical record</td><td>55 %</td><td>58 %</td><td>&lt;0.01</td></tr><tr><td>Died at the scene</td><td>3 %</td><td>3 %</td><td>0.62</td></tr></table>
b1f4c8bf1f189cb69bb9d1915f1519e70efd5417fa2774d77b08580af392c44f.png
simple
<table><tr><td>Breach Code</td><td>Sprint &#8804;1400 m (<i>n</i>)</td><td>Mile 1406&#8211;1750 m (<i>n</i>)</td><td>Middle 1800&#8211;2400 m (<i>n</i>)</td><td>Total (<i>n</i>)</td></tr><tr><td>8</td><td>55</td><td>24</td><td>13</td><td>92 (23. 90%)</td></tr><tr><td>9</td><td>29</td><td>11</td><td>4</td><td>44 (11.43%)</td></tr><tr><td>16</td><td>33</td><td>10</td><td>11</td><td>54 (14.03%)</td></tr><tr><td>17</td><td>84</td><td>42</td><td>42</td><td>168 (43.64%)</td></tr><tr><td>Other</td><td>18</td><td>6</td><td>3</td><td>27 (7.01%)</td></tr><tr><td>Total</td><td>219 (56.88%)</td><td>93 (24.16%)</td><td>73 (18.96%)</td><td>385</td></tr></table>
60490be02c5a2bc99c93cf253e995b2ac36880388c6e042b567ccbd52646fc90.png
simple
<table><tr><td>Reference</td><td>Basin</td><td>Number of sequences</td><td>Number of species</td><td>Intraspecific distance (%)</td><td>Intrageneric distance (%)</td></tr><tr><td>Pugedo et al., 2016</td><td>Jequitinhonha</td><td>260</td><td>52</td><td>0-11.43 (0.44)</td><td>1.09-21.55 (12.16)</td></tr><tr><td>Nascimento et al., 2016</td><td>Itapecuru</td><td>440</td><td>64</td><td>0-8.9 (0.80)</td><td>2.65-7.70 (5.13)</td></tr><tr><td>Benzaquem et al., 2015<sup>&#8727;</sup></td><td>Amazon</td><td>110</td><td>14</td><td>0-9.8 (2.8)</td><td>2.2-22.5 (19.0)</td></tr><tr><td>Gomes et al., 2015</td><td>Mucuri</td><td>141</td><td>37</td><td>0-3.24 (0.74)</td><td>4.29-18.44 (9.5)</td></tr><tr><td>Pereira et al., 2013</td><td>Upper Parana&#769;</td><td>1244</td><td>254</td><td>0-8.5 (1.3)</td><td>0-24.9 (6.8)</td></tr><tr><td>Carvalho et al., 2011</td><td>Sa&#771;o Francisco</td><td>431</td><td>101</td><td>0-10.54 (0.5)</td><td>0-22.88 (10.61)</td></tr><tr><td>Pereira et al., 2011</td><td>Parai&#769;ba do Sul</td><td>295</td><td>58</td><td>0-3.48 (0.13)</td><td>0.93-22.89 (10.36)</td></tr><tr><td>Present study</td><td>Doce</td><td>306</td><td>68</td><td>0-21.82 (2.59)</td><td>0-24.2 (11.4)</td></tr></table>
cd94981821856a6c6f9ce0747f20fea14c079a2a53b8dad0b779d0e633883006.png
simple
<table><tr><td>Practitioners</td><td>Patients</td></tr><tr><td>1) Theoretical Stance</td><td>1) Reasons for Therapy</td></tr><tr><td>A) Integrity of Self</td><td>A) specific, individual reason based on symptoms, illness, or sense of dis-ease</td></tr><tr><td>B) Human Capacity for Embodiment</td><td>B) motivational drive to seek new resources for active coping</td></tr><tr><td>C) Central Role Of Embodiment And Integrity Of Self To The Practice</td><td></td></tr><tr><td>2) The Practice</td><td>2) Engagement in the practice and what happens from the patients' point of view</td></tr><tr><td>A) Breath and Breathing</td><td>A) Process</td></tr><tr><td>B) Repetition and Training</td><td>B) Shift in Awareness</td></tr><tr><td></td><td>a) Negative Emotion</td></tr><tr><td></td><td>b) Body Sensation</td></tr><tr><td>C) Noticing/Discriminating/Discerning</td><td>C) Engagement in</td></tr><tr><td></td><td>a) Self Regulation</td></tr><tr><td></td><td>b) Self Care</td></tr><tr><td>D) Goal of Practice: Integration of Mind, Body and Life Context</td><td>D) Integration of Mind, Body and Life Context</td></tr><tr><td></td><td>a)Context</td></tr><tr><td></td><td>b) Mind-Body Integration</td></tr></table>
d97f884351bb432302ccb176e713ee57c506a2f5a078109c7bfe4a14b74a8c78.png
complex
<table><tr><td rowspan="3"></td><td colspan="4">ACS</td><td colspan="4">SAP</td></tr><tr><td colspan="2">MACE</td><td colspan="2">MI</td><td colspan="2">MACE</td><td colspan="2">MI</td></tr><tr><td>(-)</td><td>(+)</td><td>(-)</td><td>(+)</td><td>(-)</td><td>(+)</td><td>(-)</td><td>(+)</td></tr><tr><td>VVV of DBP, mm Hg</td><td>6.6 &#177; 3.3</td><td>7.5 &#177; 3.0</td><td>6.7 &#177; 3.3</td><td>6.4 &#177; 3.0</td><td>7.2 &#177; 4.8</td><td>5.1 &#177; 3.8</td><td>7.1 &#177; 4.8</td><td>4.5 &#177; 3.1</td></tr><tr><td>Average of SBP, mm Hg</td><td>124 &#177; 13</td><td>130 &#177; 9</td><td>125 &#177; 13</td><td>135 &#177; 12</td><td>130 &#177; 13</td><td>129 &#177; 17</td><td>130 &#177; 13</td><td>130 &#177; 1</td></tr><tr><td>Average of DBP, mm Hg</td><td>73 &#177; 9</td><td>75 &#177; 8</td><td>73 &#177; 9</td><td>82 &#177; 6</td><td>73 &#177; 8</td><td>74 &#177; 7</td><td>73 &#177; 8</td><td>76 &#177; 3</td></tr><tr><td>Maximum DBP, mm Hg</td><td>79 &#177; 10</td><td>82 &#177; 11</td><td>79 &#177; 10</td><td>87 &#177; 12</td><td>82 &#177; 12</td><td>79 &#177; 10</td><td>81 &#177; 12</td><td>81 &#177; 2</td></tr><tr><td>Minimum SBP, mm Hg</td><td>114 &#177; 15</td><td>117 &#177; 10</td><td>114 &#177; 15</td><td>119 &#177; 14</td><td>119 &#177; 13</td><td>118 &#177; 13</td><td>119 &#177; 13</td><td>121 &#177; 12</td></tr><tr><td>Minimum DBP, mm Hg</td><td>66 &#177; 10</td><td>66 &#177; 8</td><td>65 &#177; 9</td><td>74 &#177; 4</td><td>66 &#177; 9</td><td>67 &#177; 6</td><td>66 &#177; 9</td><td>71 &#177; 6</td></tr></table>
be45baaebb02113ddfd8b4c41d9f511f0647061bd585f6237a7db337152163f7.png
simple
<table><tr><td>Characteristics</td><td>No (%)</td></tr><tr><td><i><underline>Age (years)</underline></i></td><td></td></tr><tr><td>20&#8211;24</td><td>9 (27.3)</td></tr><tr><td>25&#8211;34</td><td>9 (27.3)</td></tr><tr><td>35&#8211;49</td><td>12 (36.3)</td></tr><tr><td>&gt;50</td><td>3 (9.1)</td></tr><tr><td><i><underline>No. of years working as applicator</underline></i></td><td></td></tr><tr><td>2 to 5</td><td>16 (48.5)</td></tr><tr><td>6 to 9</td><td>4 (12.1)</td></tr><tr><td>10 to 20</td><td>10 (30.3)</td></tr><tr><td>&gt;20</td><td>3 (9.1)</td></tr><tr><td><i><underline>Protective measure in use</underline></i></td><td></td></tr><tr><td>Boots</td><td>8 (24)</td></tr><tr><td>Apron</td><td>1 (3)</td></tr><tr><td>Mask</td><td>2 (3)</td></tr><tr><td>Gloves</td><td>0 (0)</td></tr><tr><td>Glasses</td><td>2 (6)</td></tr><tr><td>Respirator</td><td>2 (6)</td></tr><tr><td>Plastic for the back</td><td>15 (46)</td></tr><tr><td>Waterproof garment</td><td>1 (3)</td></tr></table>
9ccee6a78d1344a5e6c2fe9885f2ce61ad72ac43702cc6256da1e402982559a8.png
simple
<table><tr><td>Compound name</td><td>Retention time (min)</td><td>Cells</td><td>Leaves</td><td>[M-H]<sup>&#8722;</sup></td><td>Diagnostic<i>m/z</i>ions</td></tr><tr><td><i>cis</i>-4-<i>p</i>CoQA (4)</td><td>7.35</td><td>&#10003;</td><td>&#10003;</td><td>337.0933</td><td>173</td></tr><tr><td><i>trans</i>-4- <i>p</i>CoQA (1)</td><td>7.96</td><td>&#10003;</td><td>&#10003;</td><td>337.0957</td><td>173</td></tr><tr><td><i>trans</i>-5-<i>p</i>CoQA (2)</td><td>7.69</td><td>&#10003;</td><td>&#10003;</td><td>337.0886</td><td>191</td></tr><tr><td><i>cis</i>-5-<i>p</i>CoQA (3)</td><td>10.54</td><td></td><td>&#10003;</td><td>337.0949</td><td>191</td></tr><tr><td><i>cis</i>-3-CQA (6)</td><td>4.55</td><td>&#10003;</td><td>&#10003;</td><td>353.0875</td><td>191, 179, 135</td></tr><tr><td><i>trans</i>-3-CQA (5)</td><td>4.61</td><td>&#10003;</td><td>&#10003;</td><td>353.0787</td><td>191, 179, 135</td></tr><tr><td><i>trans-</i>4-CQA (7)</td><td>6.13</td><td>&#10003;</td><td>&#10003;</td><td>353.0864</td><td>191, 179, 173, 135</td></tr><tr><td><i>trans</i>-5-CQA (8)</td><td>5.81</td><td>&#10003;</td><td>&#10003;</td><td>353.0829</td><td>191, 135</td></tr><tr><td><i>cis</i>-5-CQA (9)</td><td>7.55</td><td>&#10003;</td><td>&#10003;</td><td>353.0809</td><td>191, 135</td></tr><tr><td><i>trans</i>-4-FQA (12)</td><td>6.17</td><td></td><td>&#10003;</td><td>367.0429</td><td>173</td></tr><tr><td><i>trans</i>-5-FQA (10)</td><td>5.84</td><td>&#10003;</td><td>&#10003;</td><td>367.0708</td><td>191</td></tr><tr><td><i>cis</i>-5-FQA (11)</td><td>9.41</td><td>&#10003;</td><td>&#10003;</td><td>367.0847</td><td>191</td></tr><tr><td>Caffeoylglycoside (13)</td><td>5.60</td><td>&#10003;</td><td>&#10003;</td><td>341.0894</td><td>179</td></tr><tr><td>Feruloylglycoside (14)</td><td>7.09</td><td>&#10003;</td><td></td><td>355.1012</td><td>193</td></tr><tr><td>3,4-<i>di</i>CQA (15)</td><td>5.21</td><td></td><td>&#10003;</td><td>515.1509</td><td>191, 179, 173, 135</td></tr><tr><td>4,5-<i>di</i>CQA (16)</td><td>5.50</td><td>&#10003;</td><td>&#10003;</td><td>515.1404</td><td>191, 179, 135</td></tr><tr><td>3,5-<i>di</i>CQA (17)</td><td>6.30</td><td>&#10003;</td><td>&#10003;</td><td>515.1477</td><td>191, 179, 135</td></tr><tr><td>3-CQA glycoside (18)</td><td>4.78</td><td></td><td>&#10003;</td><td>515.1261</td><td>191, 179, 135</td></tr><tr><td>5-CQA glycoside (19)</td><td>5.47</td><td></td><td>&#10003;</td><td>515.1354</td><td>191, 135</td></tr></table>